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ABSTRACT
SYNTHESIS AND CHARACTERIZATION OF BIOLOGICALLY RELEVANT
FE(II) COMPLEXES CONTAINING REDOX-ACTIVE
(HYDRO)QUINONE LIGANDS

Amanda E. Baum, B.S.

Marquette University, 2016

Redox-active p-(hydro)quinones work in concert with transition-metal centers
to facilitate electron transfers in numerous biological contexts. While p-(hydro)quinones are
known to interact with both heme and nonheme iron cofactors, the nonheme systems are
particularly relevant to photosynthetic and bioremediation processes. In photosynthesis, two pquinones facilitate an electron transfer away from the photoexcited P680 cofactor via a nonheme Fe(II) center. Based on EPR results, this interaction results in formation of transient
Fe(II)/p-semiquinone (pSQ) species. In addition, a superoxo-iron(II)-pSQ species has been
proposed as an intermediate of the oxidative cleavage mechanism of hydroquinone
dioxygenases (HQDOs), which play a central role in the catabolism of aromatic pollutants.
Despite the prevalence of iron-(hydro)quinone interactions observed in nature, there is a dearth
of reported synthetic analogs.
We therefore aimed to synthesize five-coordinate monoiron(II) complexes featuring a
variety of substituted p-quinone ligand or p-hydroquinone ligands. These complexes contain
a tris(3,5-diphenylpyrazolyl)borate (Ph2Tp) or tris(4,5-diphenyl-1-methylimidazol-2yl)phosphine (Ph2TIP) supporting ligand scaffold to mimic the different types of facial triads
found in nonheme iron dioxygenases. The corresponding Fe(II)-pSQ intermediates were
generated via two methods: (i) proton-coupled electron transfer from an iron-hydroquinonate
precursor and (ii) chemical reduction of the mononuclear Fe(II)-p-quinone complexes. The
presence of a pSQ radical coupled to a high-spin Fe(II) center was confirmed by spectroscopic
(UV-vis, EPR, resonance Raman) and computational (DFT) methods. Recent O2 reactivity
studies have examined the ability of these complexes to serve as functional HQDO models.
Additionally, we synthesized a diiron(II) species that, upon treatment with a chemical
oxidant, yields a stable complex in which two Fe(II) centers are bridged by a p-semiquinone
radical. The unique S=7/2 electronic structure of this complex was studied extensively by
spectroscopic and computational methods and represents the first complex to feature Fe(II)
centers bound to a semiquinonate radical. Further studies were focused on the development of
additional dimetal(II) species bridged by varying hydroquinonate ligands to explore their
potential of generating novel species that display a high degree of electronic coupling upon
one-electron oxidation.
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Chapter 1

Introduction: Investigation of Metal-(Hydro)quinone
Interactions Observed in Nature – Toward Elucidation of
the Catalytic Mechanism of the Hydroquinone
Dioxygenases

(Hayes, R. P.; Green, A. R.; Nissen, M. S.; Lewis, K. M.; Xun, L.; Kang, C., Molecular Microbiology 2013, 88, 523-536.)

Abstract: Redox-active molecules, such as para-(hydro)quinones, have the ability to
participate in reversible one and two-electron reactions that are often coupled to proton
transfers. In nature, these cofactors often operate in conjunction with protein-bound metal
centers to carry out critical electron transfers. Furthermore, the ability of hydroquinones to
act in a redox non-innocent manner suggests that these substrates have the ability to directly
participate in the redox reactions encountered during their catabolism as facilitated by a
class of non-heme iron dioxygenases known as the hydroquinone dioxygenases (HQDOs),
to form a reactive intermediate that incorporates a substrate-based radical, however, this
putative intermediate has yet to be observed experimentally. By employing a biomimetic
approach, we hope to gain a better understanding of the geometric, electronic and catalytic
properties of the HQDOs and, ultimately, gain insight into the cooperativity of these redoxactive cofactors associated with metal centers as demonstrated in nature.
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1.A. Non-heme Iron Dioxygenases

Due to the grave environmental concern of the presence of contaminants in
groundwater and soil, recently, researchers have focused interest on the use of
bioremedial technologies to eliminate toxic aromatic pollutants from our environment.
This process can be carried out naturally by a variety of aerobic bacteria proficient in the
catabolism and assimilation of single and multi-ring aromatic hydrocarbons.1,2 In order to
catalyze pollutant breakdown, these microorganisms utilize metalloenzymes classified as
non-heme iron dioxygenases. These metalloenzymes contain an active site capable of
aerobic degradation via oxidative ring cleavage in which both atoms of O2 are
incorporated into the final environmentally-benign product. In order to facilitate the
breakdown of intrinsically stable aromatic hydrocarbons, the first step in many pathways
is the oxidation of the substrate to the corresponding cis-1,2-diol. As demonstrated in
Figure 1.1, the first step of the degradation of benzene involves oxidation to cis-1,2dihydrobenzene-1,2-diol, a reaction that is catalyzed by the metalloenzyme benzene 1,2dioxygenase.3,4 The newly formed 1,2-diol then undergoes aromatization to catechol
followed by oxidative ring cleavage aided by either an intra- or extradiol catechol
dioxygenase.5,6 The final ring-cleaved product can then be broken down further into
intermediates for the citric acid cycle, ultimately allowing the microorganism to harness
the pollutant in question as a source of energy as this overall process lends itself to the
perpetuation of the global carbon cycle.1

3

Figure 1.1. Catabolism of benzene via oxidation to catechol followed by oxidative ring
cleavage.5

In order to overcome the intrinsic stability of aromatic compounds and the high
activation barrier associated with reaction with triplet dioxygen, most ring-cleaving
dioxygenases have been observed to simultaneously bind both O2 and substrate to an
Fe(II) site. Most ring-cleaving dioxygenases employ a recurring, anionic binding motif
known as the 2-His-1-carboxylate facial triad (2H1C). Crystallographic studies of the
resting state of ring-cleaving dioxygenases (Figure 1.2) have indicated the presence of a
high spin Fe(II) center bound facially by two histidines and one glutamate (or aspartate)
as well as 2-3 bound H2O molecules.6-12 Therefore, unlike heme-based systems, which
leave a single coordination site open for a cofactor to bind, the 2H1C motif allows three
additional coordination sites to remain vacant upon displacement of all solvent-derived
ligands. This permits both dioxygen and substrate to bind directly to the ferrous center to
facilitate the C-C bond cleavage reaction.
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Figure 1.2. Resting state active site structure of deacetoxycephalosporin C synthase
(DAOCS)—an α-ketoglutarate dependent mononuclear non-heme iron enzyme bound
by the 2H1C facial triad.7

Non-heme iron dioxygenases are capable of oxidizing a variety of substrates
(Figure 1.3) including catechols, protocatechuates,13 hydroquinones,14-16 oaminophenols17,18 and salicylates.19-21 The most extensively and well-studied of these
enzymes include a class referred to as the extradiol catechol dioxygenases (ECDOs). This
class of enzymes is known for its ability to cleave aromatic substrates at a site adjacent to
the hydroxyl groups, leading to formation of a ring-opened product.9,11,22
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Figure 1.3. Various substrates that can undergo oxidative ring cleavage as facilitated by
non-heme Fe dioxygenases. The solid lines indicate the site of C-C bond cleavage in each
substrate.

1.B. Mechanism of Oxidative Ring Cleavage by Non-heme Iron Dioxygenases

The overall catalytic mechanism of extradiol catechol dioxygenases (ECDOs) has
been studied extensively via experimental and computational means. It has been
determined that upon loss of a proton, the first step of the mechanism involves
coordination of the substrate to the metal center of the active site in its monoanionic
form. The binding of a catechol in a bidentate manner causes the displacement of all
bound solvent ligands, ultimately facilitating the binding of dioxygen in the vacant, sixth
coordination site.6,11,21,23 Upon binding of dioxygen, the Fe(II) center transfers an electron
to the O2 ligand, suggested to result in a short-lived Fe(III)-superoxo intermediate.
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Formation of this fleeting species has been proposed to trigger a further electron transfer
from bound catechol to the metal center. This step is proposed to generate an Fe(II)bound o-semiquinone radical intermediate which would demonstrate the ability of the
ferric center in coordinating a net electron transfer from the bound catechol to dioxygen,
leading to activation of the O2 radical.11 The existence of this putative SQ∙-Fe(II)-O2∙intermediate would require the deprotonation of the distal hydroxyl group by a second
sphere residue. However, it is currently unknown if these catalytic events would occur in
a stepwise or concerted manner. Regardless of the exact electronic identity of the
activated intermediate, there is confidence that an Fe(II)-alkylperoxo intermediate is
generated during the next step of the mechanism. This species would then undergo a
Criegee rearrangement, followed by hydrolysis, to yield the final ring-opened product
(Figure 1.4).24 This proposed catalytic mechanism differs greatly from those of the
cytochrome P450s,25 methane monooxygenase26 and α-ketoglutarate dependent
oxygenases27 which are proposed to generate a high-valent Fe(IV)-oxo intermediate in
order to perform the energetically-demanding hydroxylation of an aliphatic substrate.
Both previous experimental and computational work on the ECDOs has revealed that a
high-valent iron-oxo intermediate is not generated during the catalytic process.21,28-30

7

Figure 1.4. Proposed catalytic cycle of extradiol catechol dioxygenase.24

Despite the extensive work done toward the elucidation of the catalytic
mechanism of the ECDOs, the exact electronic structure of the Fe-O2-substrate adduct is
still disputed in the literature. Work previously completed by Lipscomb31 and Bugg32
suggested that the catalytic mechanism proceeds through the putative semiquinoneiron(II)-superoxo species. This proposal was centered around the premise that the
substrate in its semiquinone form could undergo facile radical coupling with the bound
superoxo ligand, ultimately overcoming the kinetic barrier toward formation of a peroxy
intermediate. Numerous studies confirmed the ability of catecholates to act in a “noninnocent” manner when bound to redox active metal centers, lending support for the
proposed formation a bound semiquinone species.33-35 Additionally, the catalytic cycle of
the ECDO (2,3-dihydroxyphenyl)propionate 1,2-dioxygenase (MhpB) was investigated
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using a cyclopropyl-based radical trap incorporated into a substrate analogue. These
studies indicated the generation of a semiquinone-Fe(II)-superoxo species (II; Figure 1.3)
during the progression of the catalytic cycle.36 Further support for the generation of this
species was provided by computational work completed by Siegbahn, who employed
density functional theory (DFT) calculations.37-39 The formation of this putative
intermediate was further examined through a comparative study of two ECDOs, FeHPCD and Mn-MndD that incorporate iron and manganese, respectively.40 Que, et al.
examined the reactivity of both the native and the opposite metal-substituted states of
HPCD and MndD, determining that both ECDOs remained equally catalytically active,
despite the intrinsic difference in redox potentials between iron and manganese. These
results lead to the proposal that the creation of a semiquinone-Fe(II)-superoxo
intermediate would occur upon reduction of dioxygen via the donation of an electron
from the bound catechol ligand, implying that the iron center acts strictly as a conduit for
electron transfer between the ligands rather than directly undergoing a change in
oxidation state.
Despite the wealth of evidence suggesting that the catalytic cycle of extradiol
catechol dioxygenases proceeds through a SQ·--Fe(II)-superoxo intermediate, recent
studies have questioned the formation of this substrate-based radical during the
mechanism of ring-cleavage. Until recently, studies detailing the isolation of Fe/O2
adducts of ECDOs were nonexistent due to rapid reaction rates and the transient nature of
catalytic intermediates. Lipscomb et al were successful in the isolation and spectroscopic
characterization of an Fe-O2 adduct of an HPCD (H200N) mutant.41 H200 is proposed to
be an important second sphere residue that participates in necessary acid/base reactions
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during the catalytic cycle. Therefore, the H200N mutation was suggested to slow
catalytic activity to allow the observation of intermediates. This study was further
enhanced by the use of the “slow” substrate, 4-nitrocatechol, whose electron-withdrawing
nitro-group effectively reduces the amount of electron density localized on the aromatic
ring, further decreasing the rate of catalysis. The combination of these experimental
conditions allowed for the isolation of an intermediate with S=2, described as a Fe3+,
S=5/2 center antiferromagenetically coupled to a bound superoxide (O2∙-) radical, S=1/2
(I; Figure 1.3). Further experimental work involving the incorporation of the native
substrate into the H200N-HPCD mutant resulted in the observation of a novel
hydroperoxo-Fe(III)-semiquinone adduct (III; Figure 1.3) upon exposure to dioxygen.42
Despite

the

significant

stability

of

a

hydroperoxo-Fe(III)-semiquinone

intermediate, computational analysis by Ye and Neese concluded that this species
represents a thermodynamic sink that is not catalytically viable in the process of oxidative
ring-cleavage.43 Additionally, this study found no evidence for the formation of a subsratebased radical during the ECDO catalytic mechanism. Instead, Ye and Neese favor a
mechanism in which a ferric-superoxo intermediate undergoes a direct conversion to a
bridged hydroperoxo-Fe(II) species. They suggest the kinetic barrier towards formation of
the hydroperoxo species is lowered by coupling with a concurrent proton transfer from a
second-sphere histidine residue to the proximal oxygen of the bound peroxo ligand.
In response to the doubt cast on the formation of a substrate-based radical, Dong
et al. conducted a QM/MM study focused on the O2 activation step in the mechanism of
homoprotocatechuate 2,3-dioxygenase.44 While they determined the presence of an
catechol-Fe(III)-O2∙- species (Fe: S=5/2 antiferromagnetically coupled to O2∙-: S=1/2)
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within the protein environment, they concluded that another semiquinone-Fe(II)-O2∙species (Fe(II)-SQ∙ unit: S=5/2 antiferromagnetically coupled to O2∙-: S=1/2) was present
as well. Interestingly, they suggested that the reactive oxygen species in the cycle could
not be accurately represented solely by either of these electronic configurations. Instead
they proposed the reactive species to be a hybrid state described as containing mixed
character of Cat-Fe(III)-O2∙-/SQ∙-Fe(II)-O2∙- with a hydrogen bond shared between the
proximal oxygen of O2 and the H200 donor (Figure 1.5).

Figure 1.5. Proposed mixed state suggested to act as the reactive Fe-dioxygen adduct
of HPCD, an EDCO, by Dong et al.44

As previously mentioned, the H200 residue of HPCD has been demonstrated to be
essential for catalytic turnover. Dong et al. stress the importance of H200 in their study
and suggest that a simple reorientation of the hydrogen bond initially donated to the
substrate oxygen shifts to interact with the proximal oxygen atom of the Cat-Fe(III)-O2∙moiety, facilitating electronic rearrangement to the hybrid state.44 They propose
stabilization of the Fe(III)-O2∙- species by H200 allows for the partial electron transfer
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from the substrate to the O2 ligand via the metal center, resulting in the catalyticallyactive species.

1.C. Hydroquinone Dioxygenases: A novel class of ring cleaving dioxygenases

Despite the numerous studies that have been conducted toward the elucidation of
the catalytic mechanism of ECDOs, little work has been done in relevance to non-heme
Fe-dioxygenases that oxidatively cleave substrates other than catechols, in particular, phydroquinones. Of the work that has been done, it is currently proposed that the oxidative
mechanism of hydroquinone dioxygenases (HQDOs) closely follows the catalytic cycle
previously proposed for the ECDOs (vide supra). However, it is clear that the native
substrates for ECDOs and HQDOs are intrinsically different due to the positioning of
their hydroxyl groups relative to one another. This observation leads to interesting
mechanistic considerations. For example, the ortho substitution pattern of catechols
allows for facile bidentate ligation of substrate to a Fe(II) center. Conversely,
hydroquinones lacking a carboxylate functional group in an ortho position would be
expected to bind in a monodentate manner through a phenolate donor, allowing an open
coordination site to remain unoccupied. This significant difference in the mode of
substrate binding could lead to differences in the overall mechanism of ring cleavage.
Another important contrast between ECDOs and HQDOs is the difference in substrate
specificity and enzyme inactivation. For example, the HQDO 2,6-dichlorohydroquinone
1,2-dioxygenase (PcpA) is involved in the degradation pathway of the toxic pollutant
pentachlorophenol, by ultimately cleaving the pathway intermediate, 2,6-
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dichlorohydroquinone (Figure 1.6). While the substrate does not contain an ortho –OH
group to allow bidentate chelation of the active site, it contains two chlorine substituents
in both positions ortho to the proximal hydroxyl group. Previous studies have determined
that chlorinated substrates tend to inactivate ECDOS,45-49 yet this chlorinated molecule
acts as the native substrate for PcpA.15

Figure 1.6. Pathway of catabolism for degradation of pentachlorophenol by 2.6dichlorohydroquinone 1,2-dioxygenase (PcpA).15

Despite a potential importance to bioremedial technologies, few studies of
hydroquinone dioxygenases have been conducted and only a few HQDOs have been
reported in literature.14,50 These enzymes can be categorized into two classes based on the
types of substrates they incorporate into their active sites. The first class is characterized
by the ability of the enzyme to degrade hydroquinones with carboxylate donors ortho to
the phenolate donor, such as gentisate14,50 and homogentisate16,51 suggesting bidentate
coordination to an Fe(II) center. The second class includes HQDOs that incorporate
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halogenated or unsubstituted hydroquinone substrates, which coordinate in a
monodentate fashion due to the absence of a metal-binding moiety at the ortho position.
Some examples of these HQDOs include 2,6-dichlorohydroquinone 1,2-dioxygenase
(PcpA),15,52-54 chlorohydroquinone 1,2-dioxygenase (LinE)55,56 and hydroquinone 1,2dioxygenase (MnpC).57
As mentioned previously, the mechanism of hydroquinone dioxygenases has
been proposed to mirror that of the ECDOs. Jeoung, et al. sought to corroborate this
assertion in their study of trapped reaction intermediates of the enzyme homogentisate
1,2-dioxygenase (HGDO) in crystallo.58 Crystallographic studies of the resting state of
HGDO revealed an Fe(II) center bound by a 2H1C motif, with the carboxylate donor
bound as a bidentate ligand, the six-coordinate site being completed by two water
molecules. Upon substrate binding in anaerobic conditions, the phenolate donor of the
singly deprotonated homogentisate (HG) binds in a monodentate fashion upon
displacement of one molecule of H2O. This observation is interesting to note as it is
surprising carboxylate moiety of the substrate does not participate in a binding interaction
with the metal center as previously predicted. X-ray analysis indicates that the distal
hydroxyl group shares a H-bond with a second sphere histidine residue, H288, which is
likely to be involved in acid/base reactions during the catalytic cycle (Figure 1.7).
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Figure 1.7. Active site structure of substrate-bound HGDO. Possible hydrogen–bonding
interactions are shown as dashed lines with distances given in angstroms.58

In order to study reaction intermediates of the process, Jeoung, et al. grew crystals
of HGDO in an anaerobic environment, exposed them to air and rapidly cooled them in
liquid nitrogen to trap three distinct species in one crystal. The first observed intermediate
represents the species formed immediately upon O2 binding. Further investigation of this
species revealed asymmetric, side-on binding of dioxygen to an Fe(II) center bound to a
semiquinone ring. The radical state of the substrate was determined by a distinct
puckering of the ligand at C2HG, compared to its initial planar conformation. This putative
species would require the deprotonation of the distal –OH group by H288, allowing
formation of a semiquinone radical. This proposed SQ∙-Fe(II)-O2∙- intermediate, as
visualized by x-ray crystallography, is strikingly similar to reaction intermediates
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proposed for the ECDOs and lends additional support for the formation of a substratebased radical in the mechanism of a ring-cleaving dioxygenase (Figure 1.8).

Figure 1.8. Reaction intermediate of HGDO trapped and characterized by Jeoung et al.
This structure represents the semiquinone state of HG, visualized by puckering of ring
at C2, upon side-on binding of dioxygen.58

The second observed intermediate is described as an alkylperoxo species, based
on the short distance observed between O1O2 and C2HG, indicating a formation of a new
bond to generate the bridged species. The final trapped intermediate displays a break in
electron density between C1HG and C2HG, signifying cleavage of the C-C bond to give the
final maleylacetoacetate product. The complete proposed catalytic mechanism for the
oxidative ring cleavage of HGDO as elucidated by Jeong et al. is presented in Figure 1.9.
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Figure 1.9. Overall mechanism of homogentisate 1,2-dioxygenase (HGDO) proposed by
Jeong et al.58

Previous to the aforementioned study, computational work utilizing hybrid DFT
methods was employed to study the mechanism of HGDOs; however, crystal structure data
of the enzyme with bound substrate was not yet available.59 In the absence of this data,
Lipscomb, et al. operated under the assumption that homogentisate would bind in a
bidentate fashion. Because the starting geometry of the enzyme is not a faithful model of
the enzyme-substrate complex of HGDO, the study predicted end-on binding of dioxygen
as well as the formation of the alkylperoxo species at C1HG, bearing the 1-acetate group,
rather than at C2HG. As mentioned previously, it is interesting to note that in vivo HG binds
in a monodentate fashion versus the bidentate mode predicted by Lipscomb.
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Despite the lack of additional computational work to support the experimentally
assigned intermediates of HGDO, the current results do not agree with recent studies of
HPCD with 4-nitrocatechol (vide supra). This could be due to the fact that HGDO and
HPCD bear little sequence and structural similarity to one another. For example, HGDO
was been shown to bind its para- substituted HQ substrate in a monodentate fashion,
whereas HPCD binds ortho substituted catechols in a bidentate manner. Another
interesting difference manifests itself in the stabilization of superoxo intermediates by
hydrogen bonds within the active enzyme. The proposed Fe(II)-O2∙- intermediate of
HPCD is shown to be stabilized by a network of H-bonds donated from second sphere
residues, however this same occurrence is not observed in the formation of the Fe(II)superoxo intermediate of HGDO. Instead, the only candidates for donation of stabilizing
H-bonds are the residual water molecules present in the active site, which were
previously displaced upon substrate and dioxygen binding. However, despite structural
differences in these nonhomologous Fe(II)-dependent dioxygenases, the ability of these
enzymes to catalyze cleavage of aromatic rings is suggested to be an intrinsic
characteristic of the 2H1C facial triad.
Despite the widespread utilization of the canonical 2H1C motif by
metalloenzymes to facilitate dioxygenases chemistry, it is interesting to note that two
crystal structures of cysteine dioxygenase were reported in 2006 which indicated the
presence of a mononuclear iron site supported by a neutral 3His facial triad.60,61
Subsequently, several additional metalloenzymes incorporating this 3His motif were
structurally characterized and reported including, β-diketone dioxygenase (Dke1),62,63
salicylate dioxygenase (SDO)19 and most interestingly, gentisate 1,2-dioxygenase
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(GDO),50,64 a member of the hydroquinone dioxygenases. While it is apparent that GDO
catalyzes a similar C-C bond cleavage reaction as demonstrated by the HQDOs
incorporating the 2H1C triad, the catalytic implications of this difference in charge
remains unclear.

1.D. Biomimetic Models of Non-heme Iron Dioxygenases

The study of metalloenzymes has been greatly augmented by the development of
synthetic models that aim to mimic the important structural and functional characteristics
displayed by enzymatic active sites in nature. While many biomimetic models of the
catechol dioxygenases exist, there is a lack of modeling studies in relevance to the
hydroquinone dioxygenases. It has been suggested that the scarcity of characterized
Fe(II)-hydroquinonate complexes in literature is due to the intrinsic ability of
hydroquinones to bridge two metal centers and form dimeric species. This has been
demonstrated previously in the synthesis of ferric complexes supported by salen and
porphyrin ligands that are bridged by dianionic hydroquinonate ligands (Figure 1.10).65-67
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Figure 1.10. Crystal structure obtained by Que et al of a diferric–salen complex bridged
by a hydroquinone ligand.65

In order to avoid the formation of a dimeric species, Holland and Machonkin
recently developed a series of Fe(II)-phenolate complexes using the 1,3,5-tris(tolylideneimino)cyclohexane (TACN-o-tolyl) ligand.68 While these models lack a
hydroxyl group at the para position and are therefore poor functional models, they were
relatively effective structural models, used to study the substrate specificity of HQDOs
by varying phenolate ligands. Characterization by 1H-NMR determined that only
phenolate ligands halogenated at the ortho position(s), such as 2-chlorophenol and 2,6dichlorohydroquinone, were able to form a 1:1:1 (TACN-o-tolyl)-Fe(II)-phenolate
complex with complete binding of the respective phenolate to the ferrous center. The
authors attribute this observation to a proposed secondary binding interaction between
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Fe(II) and the halogen substituent (X) by analyzing the experimentally-determined Fe-X
bond lengths by X-ray crystallography (Figure 1.11).

Figure 1.11. Solid state structure of [Fe(TACH-o-tolyl)(2-chlorophenolate)]OTf. The
dashed line indicates the secondary Fe-Cl interaction, stabilizing the bound ligand.
Hydrogen atoms and triflate anions have been omitted for clarity.68

Although this particular series of experiments did not lend itself to a better
understanding of the catalytic mechanism of HQDOs, it did allow for the rationalization
of substrate specificity of hydroquinone dioxygenases versus other ring cleaving
dioxygenases. In addition to the series of phenolate complexes described above, Holland
and Machonkin also synthesized a mononuclear Fe(II)-2-methylhydroquinone complex
supported by the TACN-o-tolyl ligand. Its formation was confirmed by 1H-NMR
analysis, however, due to the great instability of the complex, crystals of the (TACN-otolyl) were not obtained.
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1.E. Use of bridging dioxolene ligands to facilitate magnetic superexchange

In addition to the biological relevance of the rich redox behavior of benzoquinoid
ligands, particularly di- and tetraoxolene moieties, recent interest has been focused on
exploiting this characteristic in the development of novel magnetic materials. The
integration of radical ligand bridges between paramagnetic metal centers has been
observed to increase not only the observed molecular spin state, but also the magnitude of
magnetic exchange coupling between metals leading to the observation of single
molecule magnet (SMM) behavior.69-71 SMMs are compounds that exhibit magnetic
hysteresis at low temperatures derived purely from the molecule itself, and not from longrange magnetic ordering. The inherent slow relaxation of magnetization of a small
molecule magnet makes this novel class of materials perfect candidates for future
applications in molecular spintronics and quantum information storage and processing.7275

SMM behavior was first reported by Sessoli, et al. upon generation of a high spin
[Mn12O12(O2CMe)16(H2O)4] cluster compound that displays a high degree of magnetic
coupling and an overall spin state of S = 10.76 Because of the success of this cage
compound in mediating significant magnetic exchange, much of the effort devoted to the
development of SMMs has been focused on the preparation of polynuclear complexes
with large predicted spin states. Due to the synthetic challenges in preparing species high
in nuclearity and the widespread use of diamagnetic bridging ligands in SMM targets,
despite their inability to facilitate strong magnetic exchange, developments in the
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generation of species incorporating radical ligands linking paramagnetic centers in low
nuclearity complexes is of great recent interest.77-79

1.F. Project Objectives

Prior to our efforts, there was no report of a crystallographically characterized
Fe(II) complex bound by a p-hydroquinonate ligand. The lack of synthetic prospects was
due not only to the tendency of HQates to bridge metal centers, but also to the
expectation that a faithful HQDO mimic would be 4C prior to binding of dioxygen. This
would leave Fe(II) coordinatively unsaturated in the absence of a coordinating solvent
ligand.
Due to the difficulty faced in generation of stable Fe(II)-HQate complexes, up to
this point, functional HQDO models have not yet been developed. The main focus of this
project involved the development of these models in order to gain a better understanding
of the electronic nature of catalytic intermediates to further elucidate the mechanism of
ring cleavage carried out by hydroquinone dioxygenases. We opted to use biomimetic
models in order to gain insight into the catalytic mechanism of the hydroquinone
dioxygenases as it is possible to modify the properties of our model complexes in a
straightforward and systematic manner. By employing this methodical approach, we are
able to gain a better understanding of factors affecting the electronic structure and
reactivity of catalytic intermediates. Although similar changes can be made through point
mutations made to protein active sites, such alterations can lead to significant changes in
the enzyme, ultimately leading to inactivation. Instead, biomimetic studies allow for the
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flexibility of studying a series of complexes with an extensive variety of geometric and
electronic properties. In addition, while it is difficult to isolate and characterize catalytic
intermediates within metalloenzymes, the creation of synthetic analogues allows for
control over ligand properties and reaction conditions to trap and examine these elusive
species.
In order to further our understanding of the catalytic mechanism of oxidative ring
cleavage carried out by hydroquinone dioxygenases, we employed an integrated approach
through a combination of synthetic methods, structural and spectroscopic characterization
and computational analysis. Through use of this systematic process, we have laid the
basis for further mechanistic studies of hydroquinone dioxygenases and the exploration
of electronic communication between metal centers and paramagnetic (radical) ligands,
similar to those observed in nature. The remaining chapters of this report will discuss the
following results:


Chapter 2: Herein, we report the preparation of mono- and dinuclear Fe(II)
complexes with the (3,5-diphenylpyrazol-1-yl)borate(1-) supporting ligand
(Ph2Tp) and the investigation of the O2 reactivity of several Fe(II)-HQate
complexes. Notably, we were successful in the generation of the first
crystallographically-characterized mononuclear Fe(II) complex featuring an
untethered hydroquinonate ligand.



Chapter 3: In order to gain insight into the variance of neutral and anionic binding
motifs observed in the HQDOs, we developed a biomimetic model of the EScomplex of gentisate dioxygenase (GDO) which features a neutral scorpionate
ligand and the monoanion of 2-(1-methylbenzimidazol-2-yl)hydroquinone. The
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reactivity of this complex was compared to a previously synthesized HQDO
model (as reported in Chapter 2). Oxidation of each species yielded the
corresponding Fe(III) complexes that can undergo deprotonation, triggering a
(de)protonation-induced valence tautomerization to yield two Fe(II)-pSQ species
as proven by detailed spectroscopic and computational analysis.


Chapter 4: The dioxygen reactivity of several Fe(II)-hydroquinonate complexes
was studied in order to evaluate their viability as functional models of the
enzyme-substrate complex of the hydroquinone dioxygenases.



Chapter 5: The structure and reactivity of a new series of Fe(II) complexes
featuring substituted 1,4-naphthoquinone ligands is reported. Two metastable
mononuclear iron (II) p-semiquinonate complexes were generated upon treatment
with an appropriate chemical reductant. Existence of a coordinated pSQ·- radical
in each complex was confirmed via detailed spectroscopic and computational
analysis. To the best of our knowledge, these species represent the first reported
examples of mononuclear Fe(II) complexes featuring pSQ·- ligands.



Chapter 6: The synthesis of a dinuclear Fe(II)-HQate bridged complex that
incorporates a bound semiquinone radical upon one electron oxidation is reported.
The complex was structurally characterized via X-ray crystallography and its
electronic structure was probed via spectroscopic (absorption, EPR and resonance
Raman) and computational methods. To the best of our knowledge, this complex
represents the first crystallographically-characterized complex to feature ferrous
centers bound to a semiquinone radical.

25



Chapter 7: The syntheses of a variety of (hydro)quinonate-bridged dimetal(II)
complexes are reported. The structure and reactivity of a dimanganese(II) analog
is compared to that of the complex reported in Chapter 5. Additional species
containing varying (hydro)quinonate ligands are explored.
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Chapter 2

Structural, Spectroscopic and Electrochemical Properties of
Non-heme Fe(II)—Hydroquinonate Complexes: Synthetic
Models of Hydroquinone Dioxygenases

Abstract: Using the tris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) supporting ligand, a
series of mono- and dinuclear ferrous complexes containing hydroquinonate (HQate)
ligands have been prepared and structurally characterized. The monoiron(II) complexes
serve as faithful mimics of the substrate-bound form of hydroquinone dioxygenases
(HQDOs). Additionally, the formation of the first crystallographically-characterized
example of a monoiron complex bound to an untethered HQate ligand is reported. The
geometric and electronic structures of the Fe/HQate complexes were further probed with
spectroscopic (UV-vis absorption, 1H NMR) and electrochemical methods.

Reproduced in part with permission from Baum, A. E.; Park, H.; Wang, D; Lindeman, S.
V.; Fiedler, A. T.; Dalton Trans., 2012, 41, 12244-12253. Copyright 2012 Royal Society
of Chemistry.
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2.A. Introduction

The degradation and assimilation of single ring and polycyclic aromatic
hydrocarbons by bacteria represents a key component of the global carbon cycle and the
basis of bioremediation technologies. In aerobic environments, the catabolism of
aromatic compounds is dependent on non-heme iron dioxygenases that cleave aromatic
rings with incorporation of both atoms of O2 into the product.80-82 Such transformations
are challenging due to the intrinsic stability of aromatic systems and the high activation
barrier to reaction with triplet dioxygen. With the notable exception of the intradiol
catechol dioxygenases, the active sites of ring-cleaving dioxygenases overcome these
obstacles by coordinating both substrate and O2 to a single Fe(II) site.6,83 The iron center
is typically supported by a facial array of one carboxylate (Asp or Glu) and two His
residues (Figure 2.1),7 although variants of this 2-His-1-carboxylate motif (e.g. the 3 His
facial triad exhibited by gentisate 1,2-dioxygenase) have recently been reported.63,84
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Figure 2.1. Schematic of the resting state of the hydroquinone dioxygenases pictured
with various substrates degraded by hydroquinone dioxygenases.

While the well-studied extradiol catechol dioxygenases (ECDOs) are the
prototypical ring-cleaving dioxygenases,6,22,30,38,83,85-86 members of this enzymatic family
employ a remarkable variety of substrates, including protocatechuates,13 2aminophenols,17,18,28 and salicylates.19-21 Of particular relevance to this document are
dioxygenases that cleave hydroquinones (HQs = 1,4-dihydroxybenzene and its
derivatives). The HQ-cleaving dioxygenases (HQDOs) can be grouped into two
categories. The first class oxidizes substrates with carboxylate groups at the 2-position of
the aromatic ring, namely, gentisate14,50 and homogentisate16,51 (2,5-dihydroxybenzoate
and 2,5-dihydroxyphenylacetate, respectively; Figure 2.1). In these enzymes, the
substrate likely binds to iron in a bidentate manner via the phenolate and carboxylate
donors.87 In the second class, the substrate coordinates in a monodentate fashion, due to
the lack of a metal binding moiety at the ortho position of the substrate. Examples include
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2,6-dichlorohydroquinone 1,2-dioxygenase (PcpA),52-54,88 chlorohydroquinone
dioxygenase (LinE),55,56 and hydroquinone 1,2-dioxygenase (MnpC).57
While there have been few mechanistic studies of the hydroquinone 1,2dioxygenases, the proposed catalytic cycles largely follow the pattern derived from
extensive studies of the ECDOs.52 Coordination of the monoanionic HQ substrate to the
Fe(II) center displaces some or all of the H2O ligands present in the resting state (Figure
2.1), thereby facilitating O2 binding to the iron center. Upon activation of dioxygen, the
generation of a transient ferric-superoxo intermediate is thought to trigger the transfer of
one electron from the substrate ligand to the iron center, resulting in a bound pbenzosemiquinone radical. The existence of this putative intermediate would likely
require deprotonation of the distal –OH group by a second-sphere residue, although at
this time it is unknown if these events (O2 coordination, electron transfer and proton
transfer) would occur in a stepwise or concerted manner. The degree of semiquinone
character on the substrate ligand in the O2-bound form of the enzyme is also uncertain;
for instance, a recent computational study by Ye and Neese43 has cast doubt on the
existence of a superoxo-Fe(II)-semiquinone intermediate in the ECDO (and, by
extension, the HQDO) mechanism. While the nature of this intermediate remains
disputed, it is well-established that the next step of the catalytic cycle involves generation
of an Fe(II)-alkylperoxo species, which undergoes a Criegee rearrangement and
hydrolysis to eventually yield the ring-opened product.12,43,89
Unanswered questions regarding the HQDOs can be answered, in part, through
the development of synthetic complexes that replicate the structure and/or function of the
enzyme-substrate complex. Remarkably, a survey of the literature found only a single
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example of a crystallographically-characterized monoiron(II)–hydroquinonate complex:
Fe(L)2, where is L is a deprotonated Schiff base of 2,5-dihydroxybenzaldehyde.90 The
lack of reported Fe/HQ complexes is partly due to the ability of hydroquinonate (HQate)
ligands to adopt a bridging position between metal centers, as demonstrated by structures
of diiron(III)–porphyrin and –salen complexes with bridging HQate dianions.65-67
Recently, Machonkin and Holland described the formation and 1H NMR characterization
of a mononuclear iron(II)–2-methylhydroquinonate complex supported by the 1,3,5tris(tolylideneimino)cyclohexane ligand;68 however, this species is unstable and it was
not possible to obtain crystals suitable for crystallographic analysis.
In this chapter, we report the synthesis and X-ray structural characterization of
several monoiron(II) complexes containing HQate ligands. Each complex features the
tris(3,5-diphenylpyrazol-1-yl)borate(1-) supporting ligand (Ph2Tp), as substituted Tp
ligands are well-known to faithfully mimic the coordination environment of the 2-His-1carboxylate facial triad.91,92 We found that inclusion of bulky phenyl groups at the 3positions of the pyrazole rings generally discourages formation of the diiron(II) μhydroquinonate(2-) complexes, although dinuclear species were generated with certain
HQs. As shown in Figure 2.2, two types of HQ ligands were employed in this study: (i)
bidentate (or “tethered”) ligands that feature an ortho substituent capable of metal
coordination (H2L1-5), and (ii) the monodentate (or “untethered”) ligand 2,6dimethylhydroquinone (H2L6). These HQs were selected because they reflect the range of
substrates oxidized by HQDOs, with the monodentate and bidentate ligands resembling
(homo)gentisates and (chloro)hydroquinones, respectively. The ligand series also
includes 2-hydroxyacetophenone (H2L3) as a control to properly evaluate the role of the
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distal –OH group in tuning the structural and electronic properties of our HQDO models.
Each of the resulting complexes was characterized with crystallographic, spectroscopic
(UV-vis absorption, 1H NMR), and electrochemical techniques. Indeed, we report here
the first X-ray structure of a mononuclear Fe complex featuring an untethered
hydroquinonate ligand. We also employed spectroscopic methods, including electron
paramagnetic resonance (EPR), to examine the ferric species generated upon one-electron
oxidation of the monoiron(II) complexes. These results lay the foundation for future
studies that will explore the O2 reactivity of complexes that mimic the enzyme-substrate
intermediates of HQDOs.

Figure 2.2. Hydroquinonate ligands utilized in this study. The use of both bidentate and
monodentate ligands is intended to model the two substrate binding modes as observed
in nature.
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2.B. Results and Discussion

2.B.i. Fe(II) complexes with tethered hydroquinonate ligands

The mononuclear iron(II) complexes 1-4 (Figure 2.2) were prepared by mixing
equimolar amounts of K(Ph2Tp) and FeX2 (X = Cl or OTf) with the corresponding singlydeprotonated ligands, in MeCN (or MeCN–CH2Cl2 solvent mixture). The resulting airsensitive complexes dissolve easily in CH2Cl2, but are largely insoluble in more polar
solvents like MeCN and MeOH. With the exception of 3, which contains a 2acetylphenolate ligand, the FTIR spectrum of each complex exhibits a ν(O–H) feature
arising from the distal hydroxyl group, indicating that the HQ ligands are monoanionic
and coordinated to a single Fe center.
Crystals of 1-4 suitable for X-ray structure determination were obtained by
layering concentrated CH2Cl2 solutions with either MeCN or pentane. Details concerning
data collection and analysis are provided in Table 2.4, and selected bond distances and
angles for 1-4 are shown in Table 2.1. As illustrated in Figure 2.3, each complex features
a five-coordinate (5C) Fe(II) center bound to a facially coordinating Ph2Tp ligand and
bidentate HQate ligand. The Fe–NTp bonds exhibit an average distance of 2.14 Å across
the series, characteristic of high-spin (S = 2) ferrous complexes.93-95 The Fe1–O1
distances, which range between 1.927(1) and 1.961(1) Å, are also typical for iron(II)–
phenolate units in 5C complexes.96,97
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Figure 2.3. Thermal ellipsoid plots (50% probability) derived from the X-ray structures
of 1·CH2Cl2 (top), 2·2CH2Cl2 (middle), and 4·[HNEt3]OTf (bottom). Non-coordinating
solvent molecules and most hydrogen atoms have been omitted for clarity, as well as the
Ph-rings at the 5-positions of the Ph2Tp ligand. The HNEt3+ counter cation in the
4·[HNEt3]OTf structure is not shown.
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Table 2.1. Selected bond distances (Å) and bond angles (°) from the X-ray structures of
monoiron(II) hydroquinonate complexes 1-4 and 6.
1∙CH2Cl2
2∙2CH2Cl2
3
4∙[HNEt3]OTf
6
Fe–O1
1.961(1)
1.937(4)
1.927(1)
1.931(3)
1.893(1)
Fe–N1
2.122(1)
2.131(5)
2.108(1)
2.130(4)
2.085(1)
Fe–N3
2.148(2)
2.089(5)
2.093(1)
2.129(4)
2.085(1)
Fe–N5
2.147(2)
2.185(5)
2.228(1)
2.186(4)
2.285(1)
a
Fe–L
2.139(2)
2.079(4)
2.103(1)
2.317(3)
2.341(2)
O1–C46
1.341(2)
1.303(7)
1.304(2)
1.337(6)
1.338(2)
O2–C49
1.370(2)
1.370(7)
1.371(6)
1.390(2)
O1–Fe–N1
O1–Fe–N3
O1–Fe–N5
O1–Fe–LX
N1–Fe–N3
N1–Fe–N5
N3–Fe–N5
LX–Fe–N1
LX–Fe–N3
LX–Fe–N5
valueb

110.64(5)
153.34(5)
94.78(5)
88.90(5)
95.65(6)
92.11(5)
79.38(6)
90.69(6)
95.37(6)
174.27(6)
0.35

129.5(2)
139.9(2)
97.9(2)
86.4(2)
90.6(2)
90.2(2)
81.2(2)
87.4(2)
95.3(2)
175.7(2)
0.60

128.04(5)
140.01(5)
100.61(4)
85.28(4)
91.50(4)
88.25(4)
84.39(4)
91.32(4)
88.47(4)
172.83(4)
0.55

128.5(2)
130.0(2)
115.6(1)
75.7(1)
94.2(1)
89.4(2)
85.6(2)
85.3(1)
84.5(1)
168.4(1)
0.64

134.21(6)
131.98(6)
101.45(5)
89.04(5)
93.61(5)
85.41(5)
83.65(5)
89.01(5)
87.53(5)
169.24(5)
0.58

L is the N or O atom of the pendant donor of the HQ anion. b For a definition of the τ-value, see ref 98. A
five-coordinate complex with ideal square-pyramidal geometry would have a τ-value of 0.0, while those with
ideal trigonal bipyramidal geometry would have a value of 1.0.
a

The coordination geometry of 1 is intermediate between square pyramidal and
trigonal bipyramidal (τ = 0.3598), and the BIHQ ligand adopts a twisted conformation with
a dihedral angle of 35° between the planes of the HQate and benzimidazolyl rings (Figure
2.3). This orientation is likely the result of π-stacking interactions between the
benzimidazolyl moiety and a 3-phenyl substituent of the Ph2Tp ligand, in addition to steric
repulsion between the HQate ring and a second phenyl group. Compared to 1, the structures
of 2 and 3 lie much further towards the trigonal-bipyramidal limit (τ = 0.60 and 0.55,
respectively) with the acetyl group in an axial position trans to a pyrazole donor (N5). The
metric parameters for 2 and 3 are nearly identical, suggesting that the structural effects of
the para hydroxyl group are minimal. The O1–C46 distances in 2 and 3 are shorter than the
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corresponding distance in 1 (1.303 vs. 1.341 Å; Table 2.1) due to delocalization of the
negative charge onto the 2-acetyl group. The O1–C46 bond of the acetophenone-derived
ligands therefore acquires some double-bond character, whereas the twisted conformation
of the HLA ligand indicates a lack of electronic conjugation between the π-systems.
In contrast to the HL1-3 donors of complexes 1-3, the 2-methoxyhydroquinonate
ligand in 4 forms a five-membered ring chelate with the Fe(II) center. This fact, coupled
with the intrinsically weak donating ability of methoxy substituents, results in a rather
lengthy Fe1–O3 distance of 2.317(3) Å. Thus, in certain respects, 4 can be considered to
possess an intermediate coordination number between 4 and 5. As evidence, the O1–Fe1–
N5 angle increases from an average of 97.8° in 1-3 to 115.6° in 4 (with a corresponding
decrease in the O3–Fe1–NTp angles), as the HQate donor shifts out of the equatorial plane
(Table 2.1). Thus, if the weakly-bound –OCH3 group is ignored, 4 appears to adopt a
distorted trigonal pyramidal geometry with the O1 donor in the axial position. Notably,
complex 4 co-crystallizes with one equivalent of [HNEt3]OTf salt, and the triflate anion
participates in a hydrogen-bonding interaction with the distal –OH group in the solid state
(Figure 2.3; the O2 O4 distance is 2.782(6)). This feature is reminiscent of acid/base
interactions between HQ substrates and conserved second-sphere residues that have been
proposed to play an important role in HQDO catalysis.50,52
The diiron(II) μ-HQate complexes were never observed in preparations of 1-4,
and we initially attributed the lack of dinuclear side-products to the steric demands of the
Ph2

Tp ligand. To evaluate this hypothesis, we generated the compound 2,5-

dimethoxyhydroquinone, which is capable of coordinating two metal centers in a
bidentate fashion. Interestingly, use of this ligand provides the diiron(II) complex 5 as the
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only isolated product even when the reactants are mixed in equimolar ratios, thereby
proving that the Ph2Tp framework is capable of supporting dinuclear complexes. The Xray structure of 6 is shown in Figure 2.4 and key metric parameters are listed in the
caption. The complex is centrosymmetric with an Fe Fe distance of 8.15 Å. The Fe–
O/N distances of 5 are nearly identical to those of the analogous monoiron(II) complex 4,
although the position of the HQate ligand with respect to the NTp donors is somewhat
different (e.g., ∠O1–Fe1–N5 = 98.1(2)° and 115.6(1)° in 5 and 4, respectively). The fact
that the 2,5-dimethoxyhydroquinonate ligand exclusively yields 5, whereas the HQate
ligands incorporated by complexes 1-4 favor monomeric species, suggests that the
thermodynamic benefit of bidentate chelation at both Fe(II) centers is able to overcome
the steric barrier to dimerization.
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Figure 2.4. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
5·CH2Cl2. Non-coordinating solvent molecules and hydrogen atoms have been omitted
for clarity, in addition to Ph-rings at the 5-positions of the Ph2Tp ligand. Ellipsoids are not
shown for four Ph rings due to disorder. [note: the complex is centrosymmetric] Metric
parameters are provided in Chapter 6.

2.B.ii. Fe(II) complexes with an untethered hydroquinonate ligand

As noted in previously, several HQDOs oxidize “untethered” HQs that lack
additional metal-coordinating groups. To replicate the monodentate binding mode of
these HQ substrates, we employed the ligand 2,6-dimethylhydroquinone. Reaction of
H2L6 with equimolar amounts of K(Ph2Tp), FeCl2, and NaOMe in MeCN generates a
bright orange solid, which was recrystallized by slow diffusion of MeCN into a
concentrated 1,2-dichloroethane (DCE) solution. X-ray analysis of the crystals revealed a
diiron(II) structure (7(MeCN); Figure 2.5). Unlike 5, the Fe(II) centers in 7(MeCN) are
not equivalent: Fe2 is 4C due to steric hindrance from the methyl substituents of the
bridging 2,6-dimethylhydroquinonate dianion, and Fe1 is 5C with an additional solvent
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MeCN ligand. The Fe1 center exhibits a distorted trigonal bipyramidal coordination
geometry (τ = 0.58), while the Fe2 geometry is best described as trigonal pyramidal
(∠O2–Fe2–NTp = 125 ± 5°). The low Fe2 coordination number leads to relatively short
metal–ligand bond lengths, especially the Fe2–O2 distance of 1.784(6) Å (see Figure 2.5
caption for additional metric parameters). The high-spin Fe ions are separated by 8.72 Å.
While the initial synthesis of 7 employed equimolar amounts of reagents, the complex
can also be prepared in greater yield by using only 0.5 equivalent of the HL6 ligand.

Figure 2.5. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[7(MeCN)]·2DCE. Non-coordinating solvent molecules, hydrogen atoms, and Ph-rings at
the 5-positions of the Ph2Tp ligand have been omitted for clarity. Selected bond lengths
(Å): Fe1–O1 1.852(6), Fe1–N1 2.111(5), Fe1–N3 2.136(6), Fe1–N5 2.187(5), Fe1–N13
2.289(8), O1–C93 1.348(10), Fe2–O2 1.784(6), Fe2–N7 2.105(5), Fe2–N9 2.119(5), Fe2–
N11 2.136(5), O2–C96 1.352(10).
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In an effort to prevent formation of 7(MeCN), one equivalent of 3,5diphenylpyrazole (Ph2pz) was included in the reaction mixture described above. Under
these conditions, the reaction provided a yellow product that was recrystallized by
DCE/pentane layering. X-ray diffraction analysis revealed that the crystals contain the 5C
monoiron(II) complex, [6(Ph2pz)]. As shown in Figure 2.6, 6(Ph2pz) features a trigonal
bipyramidal coordination geometry (τ = 0.58) with the HQate and Ph2pz donors in
equatorial and axial positions, respectively. These two ligands form an intramolecular
hydrogen-bond that closes a five-membered ring, as evident in the O1–N8 distance of
2.840(2) Å and O1–H7 distance of 2.17(2) Å (the H2 and H7 atoms were found
objectively and refined). The Fe1–O1 bond distance of 1.893(1) is shorter than the
corresponding distances in the tethered complexes 1-4, whereas the axial Ph2pz ligand is
weakly bound with an Fe1–N7 distance of 2.341(2) Å (Table 2.1). As expected, HL5
coordinates to the Fe(II) center via the more sterically-accessible O-atom at the 4-position
of the HQ. Without the constraint of a pendant ligand, the HQate ring in 6(Ph2pz) rotates
away from the Fe center, as signified by the large Fe1–O1–C46 bond angle of 148.7(1)°
(compared to values of 125 ± 5° for 1-4).
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Figure 2.6. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
6(Ph2pz). Hydrogen atoms and Ph-rings at the 5-positions of the Ph2Tp ligand have been
omitted for clarity. Selected bond lengths and angles are provided in Table 2.1.

2.B.iii. Spectroscopic and electrochemical properties of Fe(II)–HQate complexes

Electronic absorption spectra of complexes 1-4 and 6 in CH2Cl2 are shown in
Figure 2.7. Complexes 2 and 3 are both brightly colored due to a weak absorption
manifold (ε

0.7 mM−1 cm−1) in the visible region and an intense peak in the near-UV (ε

5.5 mM−1 cm−1). The application of time-dependent density functional theory (TD-DFT)
to 2 revealed that the lower-energy band arises from an Fe(II) → HLB MLCT transition in
which the acceptor molecular orbital (MO) has primarily acetyl(C O*) character. The
higher-energy feature is assigned to a HLB-based π → π* transition (see Experimental
section for details concerning the TD-DFT calculations). While 1 does not exhibit
visible-region MLCT transitions like 2 and 3, a very intense ligand-based π → π* band is
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observed with λmax = 369 nm (Figure 2.7). In contrast, complexes containing ligands
derived from methoxy- and alkyl-substituted HQs (H2L4,6) have pale yellow colors due to
broad UV absorption features that tail into the visible region (Figure 2.7 and Figure 2.8).

Figure 2.7. Electronic absorption spectra of complexes 1-4 and 6 in CH2Cl2 at 20°C.
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Figure 2.8. Electronic absorption spectra of 5 and 7(MeCN) in CH2Cl2 at 20°C.

H NMR spectra of complexes 1-4 and 6 in CD2Cl2 display paramagnetically-

1

shifted signals characteristic of high-spin monoiron(II) centers (Figure 2.9). Peaks arising
from the Ph2Tp supporting ligand are easily assigned by comparison to earlier literature
reports (e.g., the signal from the 4-pyrazole protons consistently appears near 55 ppm).
93,94

In each case, the resonance arising from the distal hydroxyl substituent was identified

through H/D exchange with a small amount of added MeOH-d4. These peaks appear
downfield with chemical shifts of 23 ± 3 ppm, although the hydroxyl proton is observed
at 59 ppm in the 4 spectrum (Figure 2.9) The observation of paramagnetically-shifted –
OH resonances confirms that the HQate ligands do not adopt bridging positions in
solution.

43

Figure 2.9. 1H NMR spectra of 1-4 and 6 in CD2Cl2 at ambient temperature. Peaks marked
with an asterisk (*) disappeared upon addition of a small amount of MeOH-d4 and are
therefore assigned to the exchangeable proton of the distal –OH moiety. Resonances arising
from protons at the 4-positions of the Ph2Tp pyrazole rings are also identified (4-pz).

The electrochemical behavior of the monoiron(II) complexes 1-4 and 6 were
studied by cyclic voltammetry in CH2Cl2 or THF solutions containing 100 mM [NBu4]PF6
as the supporting electrolyte. The cyclic voltammograms are displayed in Figure 2.10 and
the results are summarized in Table 2.2. All redox potentials are referenced to the
ferrocenium/ferrocene couple (Fc+/Fc). Complexes 1-3 display quasi-reversible oneelectron oxidation waves between −290 and −30 mV that correspond to the Fe(II/III)
couple. The Fe redox potential of 1 is significantly lower than those of 2 and 3, reflecting

44

the stronger donating ability of benzimidazolyl relative to acetyl groups. When the
window is expanded to more positive potentials, both 1 and 2 exhibit a highly irreversible
wave that likely corresponds to oxidation of the respective HQate ligands. The
irreversible nature of the hydroquinonate-based oxidation is probably due to subsequent
loss of the distal –OH proton to the surrounding medium. Notably, 3 is redox inactive at
higher potentials, which is not surprising given that phenolates are intrinsically harder to
oxidize than HQates.99

Table 2.2. Redox potentials of complexes 1-4 and 6a
Complex
Solvent
Redox Potentialsb (mV vs. Fc+/0)
1
CH2Cl2
E1/2 (ΔE) = -290 (110); Ep,a = +740 mV
2
CH2Cl2
E1/2 (ΔE) = -110 (140); Ep,a = +1050 mV
3
CH2Cl2
E1/2 (ΔE) = -30 (150)
4
THF
Ep,a = -50, +370, and +780 mV
6
THF
Ep,a = -100, +580, and +850 mV
a

Conditions: solutions contained 100 mM (NBu4)PF6; scan rate of 100 mV s-1 at room temperature. b E1/2
and ΔE values are provided for (quasi)reversible processes; Ep,a values are given for irreversible oxidation
events.
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Figure 2.10. Cyclic voltammograms of 1-4 and 6. Data was collected in CH2Cl2 (1-3) or
THF (4 and 6) with 100 mM (NBu4)PF6 as the supporting electrolyte and a scan rate of
100 mV s−1. Each voltammogram was initiated by the anodic sweep.

As shown in Figure 2.10, reversible electrochemical processes were not observed
in the cyclic voltammograms of 4 and 6; instead, each complex displays a weak anodic
wave (Ep,a = −50 and −100 mV for 4 and 6, respectively) that is assigned to one-electron
oxidation of the Fe(II) center. The corresponding cathodic waves appear at much more
negative potentials (Ep,c

−600 mV in both cases), suggesting an irreversible change
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following oxidation to Fe(III). Additional irreversible events arising from HQate-based
oxidation are evident at higher potentials for 4 and 6 (Table 2.2; Figure 2.10). As
expected, the potential of the first HQate-based oxidation shifts to more negative
potentials as the HQate substituents become more electron-donating: E(HL4) < E(HL6) <
E(HL1) < E(HL2). The ill-defined electrochemical behavior of 4 and 6 is likely a result of
the greater conformational flexibility of their HQate ligands, which are not locked into a
stable six-membered ring chelate like the HL1-3 ligands.
Given that complexes 1-3 display reversible Fe(II/III) redox couples, we sought to
examine the corresponding ferric species, Xox, with spectroscopic methods. As shown in
Figure 2.11, treatment of the Fe(II) complexes with one equivalent of a one-electron
oxidant, such as acetylferrocenium or [N(C6H4Br-4)3]+, yields chromophores with broad,
intense absorption features centered near 480 nm. Based on literature precedents,100,101
these bands are confidently assigned to HL1-3 → Fe(III) LMCT transitions. The high
intensities of the LMCT bands are indicative of strong Fe1–O1 covalency in the oxidized
state, arising from overlap between the out-of-plane π-orbital of the phenolate ligand and
the partially-occupied Fe(xy) orbital.102
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Figure 2.11. Electronic absorption spectra of 1ox–3ox in CH2Cl2 at room temperature. The
1Xox species were obtained by treating the Fe(II) precursors with one equivalent of
acetylferrocenium (1ox) or [N(C6H4Br-4)3]+ (2ox and 3ox).

EPR spectra of the oxidized species 1ox–3ox (Figure 2.12) each reveal an intense
derivative-shaped feature at g = 4.3 and a very weak peak near g = 9.4, characteristic of
rhombic high-spin Fe(III) centers.
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Figure 2.12. X-band EPR spectra of 1ox-3ox in frozen CH2Cl2 solutions. The Xox species
were obtained by treating the Fe(II) precursors with one equivalent of acetylferrocenium
(1Aox) or [N(C6H4Br-4)3] (2ox and 3ox). The spectra were collected under the following
conditions: frequency = 9.63 GHz; power = 2.0 mW; modulation = 12 G; temperature =
10 K.

2.C. Conclusion

We have reported the synthesis and X-ray structure analysis of a series of
monoiron(II) hydroquinonate complexes (1-4, 6) that represent the first
crystallographically-characterized models of Fe/HQate interactions in HQDO active sites.
The spectroscopic and electrochemical properties of the complexes were also described.
The models employed bidentate (“tethered”) and monodentate (“untethered”) HQate
ligands, since HQDOs oxidize both types of substrates. Although HQate ligands are
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known to bridge multiple metal centers, the tethered ligands (H2L1-4) cleanly provided 5C
mononuclear complexes supported by the tridentate Ph2Tp framework. It was possible,
though, to obtain the diiron(II) complex 2E by inclusion of an additional donor
substituent at the 5-position of the HQate ring. Compared to the bidentate HQates, the
untethered ligand, H2L6, readily adopted a bridging position between Fe(II) centers, as
evident in the facile formation of 7. Addition of one equivalent of free pyrazole (Ph2pz) to
the reaction mixture, however, provided the complex 6(Ph2pz) – the only structurallycharacterized example of a monoiron(II) complex with an untethered HQate ligand
reported to date. The stability of 6(Ph2pz) isundoubtedly enhanced by an intramolecular
hydrogen bond between the HQate and Ph2pz ligands (Figure 2.6). While crystallographic
studies of substrate-bound HQDOs are not currently available, structures of ECDO :
substrate complexes have revealed similar hydrogen-bonding interactions between the
deprotonated O-atom of the catecholate ligand and second sphere residues.6,10,23 Thus,
6(Ph2pz) replicates important aspects of the enzymatic coordination environment. The
results presented here provide a basis for future modeling studies of the HQDOs. As
noted in the introduction, the noninnocent nature of HQate ligands is thought to play an
important role in the HQDO mechanism. Indeed, the cyclic voltammograms of 1 and 2
reveal an irreversible wave that likely corresponds to HQate oxidation coupled to loss of
the distal –OH proton. Detailed studies of the electron- and proton-transfer capabilities of
our mono- and dinuclear HQate complexes with the aim of generating novel Fe benzo
(semi)quinone species are reported in subsequent chapters. In addition, O2 reactivity
studies of complexes 1 and 2 are reported in Chapter 4.
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Table 2.3. Summary of X-ray Crystallographic Data Collection and Structure Refinement
empirical formula
formula weight
crystal system
space group
a, Å
b, Å
c, Å
, deg
deg
, deg
V, Å3
Z
Dcalc, g/cm3
, Å
mm-1
 -range, deg
reflections collected
independent
reflections
data/restraints/
parameters
GOF (on F2)
R1/wR2 (I > 2(I)) c
R1/wR2 (all data)

1•CH2Cl2
C60H47BCl2FeN8O2
1049.62
Monoclinic
P21/c
14.5859(5)
13.6416(4)
25.2090(8)
90
93.779(3)
90
5005.0(3)
4
1.393
1.5418
3.831
7 to 148
35336
9913
[Rint = 0.0382]

2•2CH2Cl2 a
C55H45BCl4FeN6O3
1046.46
Orthorhombic
P212121
11.2362(4)
17.7643(6)
25.2782(8)
90
90
90
5045.6(3)
4
1.351
1.5418
4.518
7 to 148
19096
8984
[Rint = 0.0435]

3
C53H41BFeN6O2
860.58
Monoclinic
P21/n
10.4129(2)
30.8300(5)
13.1758(2)
90
90.634(2)
90
4229.6(1)
4
1.351
0.7107
0.408
7 to 59
58359
10931
[Rint = 0.0402]

4•[HNEt3]OTf
C59H57BF3FeN7O6S
1115.84
Triclinic
P -1
9.6832(4)
9.8868(5)
28.3671(15)
85.740(4)
86.952(4)
81.003(4)
2672.5(2)
2
1.387
1.5418
3.209
9 to 148
15029
15029

5•2Et2O
C106H96B2Fe2N12O6
1767.27
Triclinic
P -1
9.6359(10)
13.4413(14)
18.205(2)
95.633(9)
105.298(10)
99.002(9)
2222.1(4)
1
1.321
1.5418
3.131
7 to 148
15573
8687
[Rint = 0.0622]

6
C68H55BFeN8O2
1082.86
Monoclinic
P21/c
17.8034(7)
22.3235(10)
13.6123(6)
90
99.746(4)
90
5331.9(4)
4
1.349
0.7107
0.340
7 to 59
62124
13600
[Rint = 0.0409]

[7(MeCN)]•2DCE b
C104H87B2Cl4Fe2N13O2
1826.02
Monoclinic
Pn
13.4895(3)
10.0544(3)
32.9607(9)
90
96.806(3)
90
4438.9(2)
2
1.342
1.5418
4.018
7 to 148
23318
12059
[Rint = 0.0406]

9913 / 0 / 672

8984/0/634

10931 /0 / 569

15029 / 0 / 709

8687 / 24 / 569

13600/ 0 / 731 12059 / 31 / 1132

1.041
0.0354/0.0891
0.0449/0.0954

1.103
0.0814/0.2410
0.0838/0.2437

1.027
0.0375/0.0891
0.0462/0.0953

1.074
0.0864/0.2278
0.1008/0.2402

1.026
0.0718/0.1807
0.1152/0.2227

1.058
1.024
0.0414/0.1005 0.0638/0.1662
0.0552/0.1083 0.0821/0.1826

One of the solvate molecules in 1B•2CH2Cl2 is only partially (77%) populated. b One of the solvate molecules in [2F(MeCN)]•2DCE is only partially (68%) populated c R1 =  ||Fo|
 |Fc|| / |Fo|; wR2 = [w(Fo2  Fc2)2 / w(Fo2)2]1/2
a
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2.D. Experimental

2.D.i. General methods

Unless otherwise noted, all reagents and solvents were purchased from commercial
sources and used as received. Acetonitrile, dichloromethane, and tetrahydrofuran were
purified and dried using a Vacuum Atmospheres solvent purification system. The synthesis
and handling of air-sensitive materials were performed under inert atmosphere using a
Vacuum Atmospheres Omni-Lab glovebox. The ligands K(Ph2Tp)103 and 2,5dimethoxyhydroquinone (H2L5)104 were prepared according to literature procedures.
Elemental analyses were performed at Midwest Microlab, LLC in Indianapolis,
IN. UV-vis absorption spectra were obtained with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for temperature control. Fourier-transform infrared (FTIR) spectra of solid
samples were measured with a Thermo Scientific Nicolet iS5 FTIR spectrometer
equipped with the iD3 attenuated total reflectance accessory. 1H spectra were collected at
room temperature with a Varian 400 MHz spectrometer. EPR experiments were
performed using a Bruker ELEXSYS E600 equipped with an ER4415DM cavity
resonating at 9.63 GHz, an Oxford Instruments ITC503 temperature controller, and an
ESR-900 He flow cryostat. Electrochemical measurements were conducted in the
glovebox with an epsilon EC potentiostat (iBAS) at a scan rate of 100 mV s−1 with 100
mM (NBu4)PF6. A three-electrode cell containing a Ag/AgCl reference electrode, a
platinum auxiliary electrode, and a glassy carbon working electrode was employed for
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cyclic voltammetric (CV) measurements. Under these conditions, the
ferrocene/ferrocenium (Fc+/0) couple has an E1/2 value of +0.52 V in CH2Cl2 and +0.61 V
in THF.

2.D.ii. Synthetic procedures:

2-(1-Methyl-1H-benzimidazol-2-yl)hydroquinone (H2L1). To 2,5-dihydroxybenzaldehyde (690 mg, 5.0 mmol) dissolved in 25 mL of ethanol, N-methyl-1,2benzenediamine (0.56 mL, 5.0 mmol) in 15 mL of ethanol was added dropwise over the
course of 30 min. The mixture was then stirred at 50 °C for two days. After cooling, 30
mL of H2O was added and the mixture was placed overnight in a freezer. The resulting
brown precipitate was filtered and dried under vacuum to give the product (0.79 g, 66%).
Anal. Calcd for C14H12N2O2 (MW = 240.26 g mol−1): C, 69.99; H, 5.03; N, 11.66. Found:
C, 69.84; H, 5.15; N, 11.70. 1H NMR (δ, DMSO): 3.81 (s, 3H, NCH3), 6.83 (m, 2H), 7.02
(d, 1 H), 7.27 (m, 2H), 7.63 (m, 2H), 9.10 (br s, 1H, –OH), 10.43 (br s, 1H, –OH).
C[1H] NMR (δ, DMSO): 31.6, 110.4, 116.0, 116.1 117.2, 118.5, 118.6, 121.9, 122.4,

13

135.8, 141.5, 149.1, 149.6, 151.9.
[Fe(Ph2Tp)(HL1)] (1). 2-(1-Methyl-1H-benzimidazol-2-yl)hydroquinone (H2L1) (120 mg,
0.50 mmol) was deprotonated by reaction with one equivalent of NaOMe in 10 mL of
MeCN. To this solution was added FeCl2 (64.2 mg, 0.50 mmol) and K(Ph2Tp) (350 mg,
0.49 mmol). The mixture was stirred for overnight and the solvent removed under
vacuum to give a yellow-brown solid. The crude product was dissolved in CH2Cl2 and
filtered; the resulting solution yielded yellow crystals suitable for crystallographic
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analysis after standing for several days (0.37 g, 77%). Anal. Calcd for C59H45BFeN8O2
(MW = 964.70 g mol−1): C, 73.56; H, 4.70; N, 11.62. Found: C, 73.18; H, 4.87; N, 11.72.
UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 369 (10 100). FTIR (cm−1, solution): 3592
(OH), 3047, 2988, 2901, 2611 (BH), 1543, 1484, 1415, 1332, 1243, 1171, 1070, 1007,
963, 914, 818, 760, 692.
[Fe(Ph2Tp)(HL2)] (2). Under an inert atmosphere, 182 mg (1.20 mmol) of 2′,5′dihydroxyacetophenone (H2L2) was deprotonated by mixing with one equivalent of
NaOMe in THF for 30 min, after which the solvent was removed to yield the Na(HLB)
salt as a white solid. To this compound was added anhydrous FeCl2 (146 mg, 1.15 mmol)
and K(Ph2Tp) (815 mg, 1.15 mmol) in 15 ml of MeCN. After stirring the reaction mixture
overnight, the resulting solid was collected by vacuum filtration, dried, and redissolved in
CH2Cl2. Layering with pentane provided reddish brown crystals suitable for X-ray
diffraction (0.26 g, 26%). Anal. Calcd for C53H41BFeN6O3 (MW = 876.59 g mol−1): C,
72.62; H, 4.71; N, 9.59. Found: C, 72.49; H, 4.79; N, 9.73. UV-vis [λmax, nm (ε, M−1
cm−1) in CH2Cl2]: 394 (5410), 485 (780), 527 (690). FTIR (cm−1, solid): 3559 (OH),
3058, 2608 (BH), 1604 (COacetyl), 1547, 1475, 1462, 1430, 1411, 1359, 1340, 1327, 1299,
1197, 1164, 1062, 1006, 965, 917, 810, 759, 693.
[Fe(Ph2Tp)(HL3)] (3). The method of preparation was similar to the one described for 2,
except that 2′-hydroxyacetophenone (H2L3) was substituted for H2L2. Orange crystals
were obtained by layering a concentrated CH2Cl2 solution with MeCN. Yield = 24%.
Anal. Calcd for C53H41BFeN6O2 (MW = 860.59 g mol−1): C, 73.97; H, 4.80; N, 9.77.
Found: C, 74.15; H, 4.92; N, 9.83. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 368
(5950), 441 (540), 485 (570). FTIR (cm−1, solid): 3060, 2618 (BH), 1613 (COacetyl), 1529,
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1479, 1463, 1432, 1414, 1361, 1346, 1331, 1225, 1167, 1063, 1010, 966, 912, 863, 804,
753, 692.
[Fe(Ph2Tp)(HL4)] (4). This compound was prepared via two methods. Method A: 2methoxyhydroquinone (H2L4), 151 mg, 1.1 mmol) and triethylamine (1.1 mmol) were
stirred in MeCN, followed by addition of K(Ph2Tp) (710 mg, 1.0 mmol) and Fe(OTf)2
(372 mg, 1.05 mmol) dissolved in CH2Cl2 and MeCN, respectively. The mixture was
stirred overnight, filtered, and the solvent removed under vacuum. The resulting solid
was washed multiple times with MeCN to remove triflate salts and other impurities and
then dried again. The solid was dissolved in CH2Cl2 and layered with hexane to yield a
yellow crystalline powder (0.28 g, 33%). Anal. Calcd for C52H41BFeN6O3 (MW = 864.58
g mol−1): C, 72.24; H, 4.78; N 9.72. Found: C, 69.69; H, 5.65; N 10.63 (the discrepancies
indicate the presence of small amounts of impurities). UV-vis [λmax, nm (ε, M−1 cm−1) in
CH2Cl2]: 383 (1490). FTIR (cm−1, solid): 3563 (OH), 3056, 2931, 2615 (BH), 1543,
1495, 1477, 1461, 1410, 1357, 1305, 1260, 1226, 1164, 1060, 1008, 913, 818, 754, 690.
Method B: Equimolar amounts of the four reagents – Fe(OTf)2, K(Ph2Tp), H2LD, and NEt3
– were mixed in CH2Cl2 and stirred overnight. The solution was filtered and the solvent
removed under vacuum. The solid was taken up in CH2Cl2 and layered with pentane to
yield yellow crystals suitable for X-ray diffraction.
[Fe2(Ph2Tp)2(μ-L5)] (5). 2,5-Dimethoxyhydroquinone (H2L5, 91 mg, 0.53 mmol) was first
deprotonated by treatment with two equivalents of NaOMe in THF. After removal of the
solvent, the resulting white solid Na2(L5) was mixed with FeCl2 (131 mg, 1.03 mmol) and
K(Ph2Tp) (715 mg, 1.01 mmol) in MeCN, and the solution was stirred overnight. After
removal of the solvent under vacuum, the yellow solid was taken up CH2Cl2 and the
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solution filtered to remove unwanted salts. Vapor diffusion of Et2O into this CH2Cl2
solution provided yellow-orange needles suitable for X-ray crystallography (0.11 g,
13%). Anal. Calcd for C98H76B2Fe2N12O4 (MW = 1619.07 g mol−1): C, 72.70; H, 4.73; N
10.38. Found: C, 72.45; H, 4.67; N, 10.36. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]:
317 (9300), 370 (sh), 444 (sh). FTIR (cm−1, solid): 3058, 2926, 2614 (BH), 1541, 1478,
1465, 1438, 1407, 1359, 1260, 1221, 1194, 1167, 1154, 1061, 1008, 888, 802, 756, 690.
[Fe(Ph2Tp)(HL6)(Ph2pz)] (6). 3,5-Diphenylpyrazole (236 mg, 1.04 mmol), K(Ph2Tp) (714
mg, 1.01 mmol), and 2,6-dimethylhydroquinone (H2L6, 164 mg, 1.19 mmol) were
dissolved in a 3 : 1 mixture of DCE–MeCN. To this solution was added FeCl2 (129 mg,
1.02 mmol) in MeCN and NaOMe (0.23 mL of 4.37 M MeOH solution, 1.00 mmol). The
reaction was stirred overnight. The solvent was evaporated under vacuum to give a pale
orange solid. The crude solid was taken up into DCE and filtered, providing a bright
yellow solution. Yellow crystals were obtained by layering this DCE solution with
pentane. Anal. Calcd for C68H55BFeN8O2 (MW = 1082.88 g mol−1): C, 75.42; H, 5.12; N
10.35. Found: C, 75.22; H, 5.00; N 10.21. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]:
374 (2530). FTIR (cm−1, solid): 3355 (OH), 3060, 3038, 2912, 2631 (BH), 1598, 1543,
1477, 1465, 1430, 1410, 1339, 1306, 1212, 1165, 1062, 1004, 967, 913, 851, 810, 754,
688.
[Fe2(Ph2Tp)2(μ-L6)(MeCN)] [7(MeCN)]. Anhydrous FeCl2 (130 mg, 1.02 mmol) and
K(Ph2Tp) (715 mg, 1.01 mmol) were combined with 0.5 equivalent of 2,6dimethylhydroquinone (H2LF, 70.0 mg, 0.51 mmol) in 10 mL of MeCN. To this mixture
was added 0.23 mL of 4.37 M solution of NaOMe (1.01 mmol). The reaction was stirred
overnight, and the solvent removed under vacuum. The resulting solid was dissolved in
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DCE, filtered, and then layered with MeCN to provide reddish-brown needles (0.21 g,
26%) suitable for crystallographic analysis. The X-ray structure revealed two
uncoordinated DCE molecules in the asymmetric unit, and elemental analysis suggest
that a small amount of solvent ( 0.8 equiv.) remains even after drying. Anal. Calcd for
C100H79B2Fe2N13O2·0.8DCE (MW = 1707.27 g mol−1): C, 71.48; H, 4.85; N 10.67. Found:
C, 71.47; H, 4.77; N, 10.37. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 288 (11 500),
377 (3600). FTIR (cm−1, solid): 3052, 2925, 2608 (BH), 1542, 1465, 1477, 1431, 1412,
1358, 1242, 1162, 1065, 1029, 1009, 969, 916, 847, 810.

2.D.iii. Crystallographic studies

Each complex was characterized with X-ray crystallography; details concerning
the data collection and analysis are summarized in Table 2.4. The X-ray diffraction data
were collected at 100 K with an Oxford Diffraction SuperNova kappa-diffractometer
equipped with dual microfocus Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD
detector and a low-temperature Cryojet device. The data were processed with
CrysAlisPro program package (Oxford Diffraction Ltd, 2010) typically using a numerical
Gaussian absorption correction (based on the real shape of the crystal) followed by an
empirical multi-scan correction using SCALE3 ABSPACK routine. The structures were
solved using the SHELXS program and refined with the SHELXL program105 within the
Olex2 crystallographic package.106 All computations were performed on an Intel PC
computer with Windows 7 OS. Some structures contain disorder that was detected in
difference Fourier syntheses of electron density and accounted for using capabilities of
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the SHELX package. In most cases, hydrogen atoms were localized in difference
syntheses of electron density but were refined using appropriate geometric restrictions on
the corresponding bond lengths and bond angles within a riding/rotating model (torsion
angles of methyl hydrogens were optimized to better fit the residual electron density).
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Chapter 3

Synthetic Models of Intermediates in the Hydroquinone
Dioxygenase Mechanism: Generation of Fe(II)-pSQate
Species via Proton-Induced Valence Tautomerization

Abstract: While the nonheme Fe center in nearly all HQDOs is coordinated to one Asp (or
Glu) and two His residues, 1,2-gentisate dioxygenase (GDO) is unique in featuring a three
His triad instead. A synthetic GDO model was therefore prepared with the neutral tris(4,5diphenyl-1-methylimidazol-2-yl)phosphine (Ph2TIP) ligand. The gentisate substrate was
mimicked with the bidentate ligand 2-(1-methylbenzimidazol-2-yl)hydroquinonate
(BIHQ) to yied complex [8]OTf, [Fe(Ph2TIP)(BIHQ)]OTf. Structural and electrochemical
data collected for [8]OTf were compared to those previously reported for
[Fe(Ph2Tp)(BIHQ)] [1], which features an anionic hydrotris(3,5-diphenylpyrazol-1yl)borate (Ph2Tp) ligand. Oxidation of [8]OTf and [1] provides the corresponding Fe(III)
complexes ([8b]2+/[1b]+) and the crystal structure of [1b]PF6 is reported. Both complexes
undergo reversible deprotonation to yield the brown chromophores, [8c]+ and [1c].
Detailed studies of [8c]+ and [1c] with spectroscopic (UV-vis absorption, EPR, resonance
Raman) and computational methods determined that each complex consists of a high-spin
Fe(II) center ferromagnetically coupled to a p-semiquinonate radical (BISQ). The
(de)protonation-induced valence tautomerization described here resembles key steps in the
putative HQDO mechanism.
Reproduced in part with permission from Baum, A. E.; Lindeman, S. V.; Fiedler, A. T.;
Eur. J. Inorg. Chem 2016, Early View. Copyright 2016 Wiley-VCH.
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3.A. Introduction

In the past, biomimetic studies have proven to be fruitful in the investigation of
metalloenzymes as the geometry, function and ultimately, the electronic structure of
reactive intermediates can be examined especially considering that models have the
capability to be modified and studied in a straightforward and systematic manner. In
order to gain a better understanding of the structure and function of a specific class of
mononuclear non-heme iron dioxygenases (MNIDs), we chose to pursue the study of
small molecule mimics of the enzyme-substrate complex with an ultimate goal of
trapping catalytically-relevant species. These metalloenzymes are responsible for
catalyzing the incorporation of dioxygen into a variety of aromatic substrates upon ring
cleavage in their respective pathways of catabolism. A vast majority of MNIDs
incorporate a high-spin Fe(II) center bound by one Asp (or Glu) and two His residues in a
facial orientation – namely, the canonical 2-His-1-carboxylate (2H1C) facial triad.7
Numerous studies have employed the RTp scaffold to replicate the monoanionic charge,
facial arrangement, and ligand-field strength of the 2H1C triad.85,107 Other chemists have
prepared N,N,O-heteroscorpionates with one carboxylate and two nitrogen donors to
more accurately reproduce the enzymatic ligand set.108,109
Given the prevalence of the 2H1C coordination motif among MNIDs, it was
rather surprising when two crystal structures of mammalian cysteine dioxygenase (CDO),
published in 2006, revealed a mononuclear iron site with a neutral 3-histidine (3His)
facial triad instead.60,61 Other members of the “3His family” were subsequently reported
and structurally characterized, including -diketone dioxygenase (Dke1), 62,63 salicylate
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1,2-dioxygenase (SDO),19 and gentisate 1,2-dioxygenase (GDO).50,64 Of particular
relevance to this chapter is GDO, which catalyzes the oxidative cleavage of the C1C2
bond within the hydroquinone ring of its substrate (Figure 3.1).14,110 Interestingly, GDO is
the only known example of a hydroquinone dioxygenase (HQDO) featuring the 3His
triad;111 all other HQDOs, including homogentisate dioxygenase, possess the canonical
2H1C triad.51

Figure 3.1. (top) Overall bond cleavage reaction facilitated by gentisate 1,2dioxygeanse. (bottom) Enzyme-substrate complex formed upon binding of gentisate to the
ferrous center of the GDO active site.

The HQDO family is unique in containing both 2H1C and 3His enzymes, and the
catalytic implications of this variation in first-sphere coordination environment currently
remains unclear. Biomimetic studies involving both neutral and anionic scorpionates
have the potential to elucidate the role of the facial triad in tuning the electronic structure
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of nonheme iron sites. In the previous chapter, we reported a series of HQDO model
complexes using the hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) supporting
ligand to mimic the 2H1C triad found in most HQDOs.112 Each complex featured a
mono- or bidentate hydroquinonate (HQate) ligand attached to the [Fe2+(Ph2Tp)]+
scaffold, thereby replicating the structure of substrate-bound HQDOs in which the
deprotonated HQ coordinates directly to iron. The discovery of a 3His triad in the GDO
active site has since prompted us to prepare HQDO models using a neutral, imidazolebased scorpionate ligand, specifically, tris(4,5-diphenyl-1-methylimidazol-2yl)phosphine (Ph2TIP; Figure 3.2).

Figure 3.2. Shown here are the anionic Ph2Tp and neutral Ph2TIP ligands utilized in this
chapter to model the 2H1C and 3His binding motifs, respectively.

Tris-(imidazolyl)phosphine ligands were initially developed in the 1980s to model
the active sites of Zn and Cu enzymes.113-120 Our previous spectroscopic studies of Dke1
models found that TIP ligands accurately reproduce the coordination environment and
donor strength of the 3His triad, whereas the properties of Tp ligands align better with the
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2H1C triad.94 The Ph2Tp- and Ph2TIP-based complexes are therefore complimentary
models of the two types of HQDO active sites.

Figure 3.3. Pictorial representation of complexes [8]OTf and [1]. Both complexes contain
a high-spin Fe(II) center bound to the BIHQ ligand and supported by the Ph2TIP or Ph2Tp
scaffold, respectively, to mimic the metalloenzyme-derived facial binding motifs.

This chapter describes the synthesis and X-ray crystal structure of
[Fe(Ph2TIP)(BIHQ)]OTf ([8]OTf, where BIHQ is the monoanion of 2-(1-methyl-1Hbenzimidazol-2-yl)hydroquinone; Figure 3.3). The BIHQ ligand forms a six-membered
chelate ring upon metal binding, which resembles the bidentate coordination of gentisate
to iron in the GDO mechanism. The structural and electrochemical properties of [8]OTf
are then compared to those previously reported for [Fe(Ph2Tp)(BIHQ)] ([1] in Figure 3.3;
Ph2

TIP-based complexes are designated a [8x] and Ph2Tp-based complexes are labeled

[1x]). In addition, we have explored the ability of these complexes to perform protonand electron-transfers via stepwise or concerted processes. For [8]OTf and 1, oneelectron oxidation generates the corresponding Fe(III)-HQate complexes [8b]2+ and
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[1b]+. Interestingly, both [8b]2+ and [1b]+ undergo reversible deprotonation to yield
metastable species ([8c]+ and [1c], respectively) in which the Fe(II) center is bound to a
p-semiquinonate (pSQ•) radical. The existence of this proton-induced valence
tautomerization has been confirmed through extensive spectroscopic and computational
studies. Complexes [8c]+ and [1c] serve as a models of the elusive Fe(II)-pSQ•
intermediate proposed for the enzymatic mechanisms of HQDOs.52,87,121 Moreover, the
pairs of valence tautomers highlight the interplay of “noninnocent” behavior and
protonation state for ligands associated with nonheme iron centers.

3.B. Results and Discussion

3.B.i. Preparation, Solid-State Structures, and Electrochemical Properties.

Complex [8]OTf was synthesized by the reaction of
[Fe(Ph2TIP)(MeCN)3](OTf)2122 with an equimolar amount of Na(BIHQ) salt in THF.
Yellow crystals, of sufficient quality for X-ray diffraction (XRD) analysis, were grown
by vapor diffusion of diethyl ether into a concentrated 1,2-dichloroethane (DCE)
solution. The asymmetric unit of the X-ray structure consists of the cationic monoiron
complex, the triflate counteranion, and two Et2O solvates. As shown in Figure 3.4(a), the
five-coordinate (5C) Fe(II) center of [8]OTf is attached to a facially-capping Ph2TIP
ligand and bidentate BIHQ anion. The distorted coordination geometry is intermediate
between square-pyramidal and trigonal-pyramidal. The two rings of the BIHQ chelate are
rotated by 27° with respect to each other, largely to accommodate the - stacking
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interaction between the benzimidazole unit and a nearby 4-phenyl substituent of Ph2TIP.
The distal –OH moiety of BIHQ forms a hydrogen bond with one of the Et2O solvates.
The Fe-NTIP bond lengths of [8]OTf range from 2.11 Å for N3 to 2.22 Å for the
pseudo-axial N5 donor (Table 3.1). The anionic BIHQ ligand exhibits Fe1-O1 and Fe1N7 distances of 1.91 and 2.15 Å, respectively, typical of phenolate68,123,124 and
benzimidazole125-127 donors in high-spin ferrous complexes. The observed magnetic
moment of eff = 4.93 B at room temperature (RT) is also proof that [8]OTf possesses a
high-spin (S = 2) Fe(II) center.
Table 3.1 compares the metric parameters of Ph2TIP-based [8]OTf to those
previously reported for Ph2Tp-based [1]. The coordination geometries of the two
complexes are quite similar, as evident in the overlay of solid-state structures shown in
Figure 3.4(b). The structure of 1 falls somewhat closer to the square-pyramidal limit than
[8]OTf, as indicated by the respective -values98 of 0.35 and 0.43 (Table 3.1). The
average Fe-NTIP bond length in [8]OTf is about 0.03 Å longer than the average Fe-NTp
bond length in [1], in line with our previous comparisons of Fe(II) Tp/TIP pairs.24,94
The redox properties of [8]OTf were examined using electrochemical methods in
CH2Cl2 solution with 0.1 M [NBu4]PF6 as the supporting electrolyte. All redox potentials
are referenced to the ferrocene (Fc+/0) couple. Two features are evident in the cyclic
voltammogram (CV): a quasi-reversible couple at -190 mV (E = 200 mV) and an
irreversible oxidation at Ep,a = 950 mV (Figure 3.5). Based on our prior experience with
[1] and related complexes, the lower-potential event is assigned to the Fe2+/3+ couple,
while the high-potential peak is attributed to oxidation of the BIHQ ligand.24,94,112 CV
data obtained for [1] is provided in Figure 3.5 for the sake of comparison. The Fe2+/3+
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potential of [8]OTf is shifted positively by 100 mV relative to [1] due to the weaker
donor strength of neutral Ph2TIP relative to anionic Ph2Tp.

Figure 3.4. (a) Thermal ellipsoid plot (50% probability) obtained from the X-ray
crystal structure of [8]OTf. The phenyl rings at the 5-positions of the Ph2TIP ligand
have been omitted for clarity, as well as non-coordinating solvent molecules and most
hydrogen atoms. (b) Overlays of the crystallographically-derived structures of [8]OTf
(white), [1] (orange), and [1b]PF6 (magenta). The phenyl and methyl substituents of
the Ph2Tp and Ph2TIP ligands are not shown.
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Table 3.1. Selected Bond Distances (Å) and Bond Angles (°) for Complexes [8]OTf, [1],
and [1b]PF6 as Measured by X-ray Crystallography.
Bond Distances
Fe–N1
Fe–N3
Fe–N5
Fe–O1
Fe–N7
FeNTp/TIP (ave)
FeL (ave)
O1–C1
O2–C4
C1–C2
C1–C6
C2–C3
C3–C4
C4–C5
C5–C6
C–C (ave)
C–C (dev) b
Bond Angles
O1–Fe–N1
O1–Fe–N3
O1–Fe–N5
O1–Fe–N7
N1–Fe–N3
N1–Fe–N5
N1–Fe–N7
N3–Fe–N5
N3–Fe–N7
N5–Fe–N7
τ-value c
a

[8]OTf
2.1681(12)
2.1149(12)
2.2214(12)
1.9144(10)
2.1503(13)
2.168
2.114
1.321(2)
1.377(2)
1.423(2)
1.409(2)
1.410(2)
1.380(2)
1.393(2)
1.385(2)
1.400
0.017

[1]a
2.1218(14)
2.1481(15)
2.1470(15)
1.9609(12)
2.1393(15)
2.139
2.103
1.341(2)
1.370(2)
1.417(2)
1.405(2)
1.410(2)
1.379(2)
1.397(2)
1.383(2)
1.399
0.015

[1b]PF6
2.0409(17)
2.0464(18)
2.1138(17)
1.8292(15)
2.0693(17)
2.067
2.020
1.337(2)
1.373(3)
1.412(3)
1.399(3)
1.403(3)
1.384(3)
1.390(3)
1.376(3)
1.394
0.013

117.31(5)
147.79(5)
98.33(4)
88.20(5)
94.87(5)
88.04(5)
89.69(5)
83.23(5)
90.82(5)
173.42(5)
0.43

110.64(5)
153.34(5)
94.78(5)
88.90(5)
95.65(6)
92.11(5)
90.69(6)
79.38(6)
95.37(6)
174.27(6)
0.35

115.58(7)
147.84(7)
94.80(7)
88.92(7)
96.52(7)
90.95(7)
91.19(7)
82.10(7)
92.54(7)
174.42(7)
0.44

The structure of 1 was originally reported in reference 112. b This number reflects the standard
deviation of C-C bond distances. c See reference 98 for the definition of the τ-value.
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On the basis of the CV data, we sought to isolate the ferric complexes [8b]2+ and
[1b]+ using chemical means of oxidation. To this end, treatment of the yellow Fe(II)
complexes with one equivalent of a ferrocenium (Fc+) salt in CH2Cl2 gives rise to dark
brown chromophores with intense absorption bands in the visible region (Figure 3.6).
The spectrum of [8b]2+ exhibits a broad feature with max = 630 nm ( = 2600 M-1cm-1),
while [1b]+ displays two intense, overlapping bands between 400 and 600 nm. These
features likely arise from phenolate-to-Fe(III) charge transfer (CT) transitions.100,101
Indeed, both complexes exhibit EPR signals characteristic of rhombic, high-spin Fe(III)
centers; namely, an intense derivative-shaped feature at g = 4.3 and a much weaker peak
at g = 9.4 (Figures 3.7 and 3.8).

Figure 3.5. Cyclic voltammograms of [8]OTf and [1] in CH2Cl2 (conc. = 2.0 mM) with
0.1 M (NBu4)PF6 as the supporting electrolyte.
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Crystals of [1b]PF6 suitable for XRD studies were generated by oxidation with
[Fc]PF6, followed by diffusion of pentane into a concentrated DCE solution (to date, we
have not been able to grow crystals of [8b]2+ with any counteranion). Metric parameters
derived from the resulting crystal structure are shown in Table 3.1. Complex [1b]PF6
retains the five-coordinate geometry of its ferrous precursor, as illustrated by the high
degree of overlap between the [1] and [1b]PF6 structures depicted in Figure 3.4(b). The
presence of the distal –OH moiety of BIHQ is evident from the hydrogen bond it forms
with the PF6 counteranion. Compared to [1], the average Fe-NTp and Fe-O1 bond
distances in [1b]PF6 are contracted by 0.07 and 0.13 Å, respectively, while the OC and
CC distances of the BIHQ ligand are unchanged within experimental error (Table 3.1).
Therefore, the XRD data confirm that conversion of [1] into [1b]PF6 involves an ironcentered oxidation, and there is no detectable amount of radical character on the BIHQ
ligand. Although XRD data is lacking for [8b]2+, the spectroscopic results (vide supra)
indicate that this complex also contains an Fe(III) center bound to a HQate ligand.
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Figure 3.6. UV-visible absorption spectra measured in CH2Cl2. The red spectra of
[8c]+/[1c] were obtained by treating solutions of [8b]2+/[1b]+ (black solid lines) with 5
equiv. of NEt3 at -30 oC. The black spectra of [8c]+/[1c] (dashed lines) were collected after
treating solutions of [8]OTf/[1] with one equiv. of the TTBP• radical at RT.
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Figure 3.7. X-band EPR spectra of [8b]2+ (red line) and [8c]+ (black line) in frozen CH2Cl2
solution ([Fe] = 1.4 mM) at 15 K. The intensity of the [8b]2+ spectrum has been reduced
by 50%. The feature labeled with an asterisk (*) in the [8c]+ spectrum arises from residual
[8b]2+. The simulated [8c]+ spectrum (grey line) was obtained with the following
parameters: D = 0.63 cm-1, E/D = 0.03, and g = 2.02, 2.0, 2.0.
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Figure 3.8. X-band EPR spectra of [1b]PF6 (red line) and [1c] (black line) in frozen
CH2Cl2 solution ([Fe] = 1.2 mM) at 10 K.

3.B.ii. Formation and Spectroscopic Features of [8c]+ and [1c].

Treatment of complexes [8b]2+ and [1b]+ with 5-10 equivalents of triethylamine
in CH2Cl2 immediately yields the golden-brown chromophores [8c]+ and [1c],
respectively (Figure 3.6). The absorption spectra of the new species are nearly identical,
with each displaying three bands of increasing intensity at 540, 440, and 370 nm. The
reaction is reversible, as addition of excess acid (HBF4) to solutions of [8c]+/[1c]
regenerates the [8b]2+/[1b]+ spectra with only 15% reduction in intensity (Figure 3.9).
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Figure 3.9. UV-visible absorption spectra demonstrating the reversible deprotonation of
complex [1b]PF6. The black solid line corresponds to the spectrum of [1b]PF6 [conc. =
0.11 mM] at -60 oC in CH2Cl2. Addition of 10 equivalents of NEt3 at -60 oC yielded the
red (solid line) spectrum characteristic of [1c]. Finally, treatment with excess acid (HBF4
in Et2O, 20 equivalents) at -60 oC, followed by warming to RT, provided the grey (dashed
line) spectrum, indicating nearly complete regeneration of [1b]+. All three spectra were
collected using the same sample, which was prepared by dissolving crystalline [1b]PF6 in
CH2Cl2.

Given the structure of the Fe(III) complexes, it is reasonable to assume that the
Xb  Xc conversion involves deprotonation of the distal –OH group of the BIHQ ligand.
In support of this conclusion, [8c]+ and [1c] can also be prepared by treatment of the
ferrous precursors ([8]OTf and [1]) with 2,4,6-tri-tert-butylphenoxy radical (TTBP•) – a
well-established H-atom transfer (HAT) agent (Figure 3.6).128 Thus, the three complexes
in each series ([8]OTf/[1], [8b]2+/[1b]+, [8c]+/[1c]) can be interconverted by concerted or
stepwise transfers of one electron and/or one proton, as indicated in Figure 3.10.
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Figure 3.10. Summary of interconversion of species examined in this chapter via concerted
or stepwise transfers of one electron and one proton.

Bases other than NEt3 were used in an attempt to estimate the pKa of [8b]2+ and
[1b]+. For both complexes, addition of the weaker base 2,6-lutidine in CH2Cl2 failed to
generate the corresponding [8c]+/[1c] species. Similar results were observed for [8b]2+ in
MeCN solutions, where the pKa-values of triethylammonium (HNEt3+) and 2,6lutidinium (2,6-LutH+) are known to be 18.6 and 14.0, respectively.129 Bordwell and
Mayer have proven that the bond dissociation free energy (BDFE) of an XH bond is a
function of both pKa and redox potential (Eo), according to the following equation:
BDFE (XH) = 1.37 pKa + 23.06 Eo + CG,solv, where CG,solv is a solvent-dependent
constant equal to 54.9 kcal mol-1 in MeCN.99 Using the experimental redox potential, and
assuming that a pKa-value halfway between HNEt3+ and 2,6-LutH+, provides a BDFE of
72.9 kcal mol-1 for [8]OTf. This bond energy is reasonable given that [8]OTf transfers a
H-atom to TTBP• (BDFE = 77.1 kcal mol-1) but not to the TEMPO• radical (BDFE = 66.5
kcal mol-1; all values in MeCN).99
Unfortunately, it was not possible to grow crystals of [8c]+ or [1c] for XRD
studies; therefore, electronic-structure insights were gathered using spectroscopic
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methods, in conjunction with the DFT calculations described in the next section. Two
limiting descriptions are possible: [8c]+/[1c] could consist of an Fe(III) center bound to a
closed-shell hydroquinonate dianion (HQate2), or an Fe(II) center bound to a psemiquinonate radical anion (pSQ•). Significantly, the UV-vis absorption spectra of
[8c]+/[1c] closely resemble those published for para- and ortho-semiquinone radicals in
various contexts.130,131 For example, our group recently prepared a Ph2Tp-based Fe(II)
complex that features a 1,4-naphthosemiquinone ligand. This complex displays a threeband pattern between 380 and 560 nm with intensities very similar to those observed for
[8c]+/[1c].131 Transient absorption studies of “free” p-semiquinones likewise report a
series of -* transitions in the near-UV region.132-134 Indeed, the close similarity of the
[8c]+ and [1c] spectra suggests that the observed transitions are primarily ligand-based –
a hypothesis supported by time-dependent DFT calculations (vide infra).
EPR samples of [8c]+ and [1c] were prepared via stepwise oxidation and
deprotonation of [8]OTf/[1]. Interestingly, it was observed that CH2Cl2 solutions of [1c]
change color from golden-brown to green upon freezing, whereas [8c]+ maintains its
brown color at all temperatures. Variable-temperature absorption studies found that the
440 and 540 nm bands of [1c] diminish as the temperature is lowered to -70 oC, while a
new chromophore (labeled [1d]) appears with a broad band at max = 825 nm. This
thermochromic behavior is reversible, as [1d] converts back to [1c] when the temperature
is returned to 25 oC (Figure 3.11).
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Figure 3.11. Thermochromism of complex [1c]. A solution of [1] in CH2Cl2 (conc. = 0.25
mM) was treated with one equivalent of the TTBP• radical at -70 oC, providing the
absorption spectrum of [1d] (green dashed line). The sample changed color from green to
brown upon warming to RT, eventually yielding a spectrum characteristic of [1c] (brown
solid line).

The EPR spectrum of [1d] measured at 15 K is featureless apart from a weak peak
at g = 4.3 due to residual [1b]+ (Figure 3.8). While further studies are required, we
postulate that [1d] arises from dimerization of [1c] at low temperatures, which would
yield the EPR-silent species observed experimentally.
Thankfully, the absence of thermochromism for [8c]+ indicates that the structure
of this complex is maintained upon freezing. Unlike [1d], complex [8c]+ exhibits an
intense EPR signal at 10 K with features at g = 6.55, 5.32, and 1.98, along with a small
derivative at g = 4.3 from residual [8b]2+ (Figure 3.7). This spectrum is characteristic of a
S = 5/2 paramagnet with an axial D-tensor; the data was nicely simulated with spinHamiltonian parameters of g = 2.02, 2.0, 2.0; D = 0.63 cm-1, E/D = 0.03 (Figure 3.7;

76

where D and E are the axial and rhombic zero-field splitting parameters, respectively).
Given the rhombic nature of the [8b]2+ spectrum (E/D ~ 0.33) noted above, the EPR
results make it clear that the [8b]2+[8c]+ conversion causes a dramatic rearrangement of
unpaired spin-density within the S = 5/2 manifold. The origin of this change has been
elucidated with the aid of DFT calculations described in the next section.

3.B.iii. Geometric and Electronic Structures of DFT-optimized Models.

Table 2 provides relevant metric parameters for energy-minimized structures of
complexes [1b]+, [8c]+, and [1c] obtained via DFT geometry optimizations. Truncated
versions of the complexes were employed in which the Ph rings at the 5-positions of the
Ph2

Tp and Ph2TIP ligands were removed. Unless otherwise noted, all calculations

employed the hybrid B3LYP functional and assumed a S = 5/2 ground state. The
accuracy of our computational approach was gauged by comparing the XRD and DFT
structures of complex [1b]+. While DFT slightly overestimates the Fe(III)-N/O bond
lengths (by 0.05 Å on average), it accurately reproduces the C-C and O-C bond distances
of the HQate ligand, with a root-mean-square deviation of only 0.01 Å (i.e., near the
experimental 3 error of the XRD measurement). We therefore felt confident in
proceeding with calculations of [8c]+ and [1c], for which structural data are lacking.
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Table 3.2. DFT-Calculated Bond Distances (Å) for Models of [1b]+, [1c], [8c], and
the BISQ Radical
Free
[1b]+
[1c]
[8c]
a
BISQ• b
Bond
Fe–N1
2.110
2.180
0.070
2.214
Distances Fe–N3
2.084
2.177
0.093
2.186
Fe–N5
2.162
2.250
0.088
2.348
Fe–O1
1.861
1.982
0.121
1.952
Fe–N7
2.152
2.190
0.038
2.185
Fe–L (ave) 2.074
2.156
0.082
2.177

Mulliken
spins

O1–C1
O2–C4
C1–C2
C1–C6
C2–C3
C3–C4
C4–C5
C5–C6
C–C (ave)
C–C (dev) c

1.320
1.360
1.421
1.409
1.404
1.388
1.401
1.409
1.400
0.016

1.293
1.256
1.444
1.432
1.386
1.442
1.448
1.361
1.419
0.036

-0.027
-0.104
0.023
0.023
-0.018
0.054
0.047
-0.048
0.019

1.303
1.254
1.438
1.428
1.386
1.441
1.448
1.362
1.417
0.035

1.327
1.253
1.441
1.416
1.383
1.444
1.447
1.362
1.416
0.036

Fe
O,N-ligand

4.14
0.34

3.81
1.09

-0.33
+0.75

3.80
1.13


1.04

a

Difference between corresponding [1b]+ and [1c] bond lengths. b Geometry-optimized model of the BISQ
radical (H-atom removed from the 4-OH position). c Standard deviation of the six C-C bond distances within
the BIHQ or BISQ ring.

The structural differences between [1b]+ and [1c]/[8c]+ are highlighted in Table
3.2. The iron-ligand bonds in [1c] are longer than their counterparts in [1b]+ by an
average of 0.082 Å; indeed, the computed Fe-L distances in [8c]+ and [1c] are more
similar to those observed experimentally for the Fe(II) complexes [8]OTf and [1].a The
bidentate O,N-ligand derived from BIHQ also experiences sizable changes. The closedshell nature of the HQate donor in [1b]+ is evident in the uniformity of its six C-C bond

a

This statement is true even when accounting for the systematic overestimation of Fe-L bonds by DFT.
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lengths (standard deviation of 0.016 Å). In the [8c]+ and [1c] models, however, this
deviation increases to 0.035 Å and the CC bonds display the “four long/two short”
pattern characteristic of semiquinones.35,135 This quinoidal-type distortion is also apparent
in the dramatic shortening of the O2C4 bond from 1.360 Å in [1b]+ to ~1.255 Å in
[8c]+/[1c]. Significantly, the metric parameters of the bidentate O,N-ligand in [8c]+/[1c]
are very similar to those computed for the “free” 2-(1-methylbenzimidazol-2yl)semiquinone radical (BISQ•; Table 2). Collectively, the DFT results indicate that
deprotonation of the distal –OH moiety triggers an electron transfer (ET) from BIHQ to
the Fe center, giving rise to an Fe(II)-BISQ configuration. This conclusion is further
supported by the Mulliken spin populations of the Fe center (3.8  spins) and BISQ
ligand (1.1  spins) in the [8c]+/[1c] models (Table 3.2).
DFT calculations of [1c] were used to generate the molecular orbital (MO)
diagram shown in Figure 3.12. The most critical orbitals for evaluating the electronic
configuration of this complex are the frontier MOs in the spin-down () manifold. The
highest-occupied MO (203) possesses 81% Fe character with electron density
primarily located in the Fe dyz orbital, confirming the presence of a high-spin Fe(II) ion.
By contrast, the lowest-unoccupied MO (204) has 84% ligand character localized in
a*-orbital on the pSQ• unit, clear evidence of a ligand-based radical. Ferromagnetic
coupling between the Fe(II) center (S = 2) and BISQ radical (S = 1/2) yields the axial S =
5/2 paramagnet observed in the EPR spectrum of [8c]+.
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Figure 3.12. Energy-level diagram for the spin-down ( spin) MOs obtained from an
unrestricted DFT calculation of [8c]+. MOs are labeled according to their principal
contributor. Surface contour plots for the highest-occupied and lowest-unoccupied orbitals
are also shown.

The time-dependent DFT (TD-DFT) approach was employed to compute the
absorption spectrum of [8c]+. As shown in Figure 3.13, the calculated spectrum
adequately reproduces the energies and intensities of the experimental absorption
features, suggesting that our DFT model of [8c]+ provides an accurate description of the
complex’s electronic structure. Analysis of the computed transitions indicate that the
lowest-energy feature near 550 nm arises from an Fe(II)BISQ charge transfer (CT)
transition, while the higher-energy peaks (350 nm < max < 450 nm) are due to BISQbased * transitions. These findings are consistent with our prior studies of a
monoiron(II) complex containing a 1,4-naphthosemiquinone ligand.131
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To ensure that our computational results were not simply due to our chosen
methodology, we also performed parallel calculations of [8c]+ and [1c] with the nonhybrid Becke Perdew 86 functional (BP). As shown in Table 3.3, the ligand metric
parameters of the BP optimized structures are nearly identical to those obtained with
B3LYP (rms deviation of 0.009 Å), although the Fe-N/O distances computed by BP are
shorter by ~0.04 Å on average. Importantly, the bonding descriptions and spin-density
distributions provided by the BP calculations are indicative of an Fe(II)-BISQ electronic
configuration for [8c]+/[1c], in agreement with the B3LYP results.
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Table 3.3. DFT-Calculated Bond Distances (Å) for Models of [8c]+ and [1c] Using
the BP and B3LYP Functionals.
3a
(B3LY
P)

3a
(BP)

a

3b
(B3LYP)

3b
(BP)

a

2.214
2.186
2.348
1.952
2.185
2.177

2.137
2.157
2.285
1.928
2.139
2.129

-0.077
-0.029
-0.063
-0.024
-0.046
-0.048

2.180
2.177
2.250
1.982
2.190
2.156

2.141
2.152
2.213
1.930
2.148
2.117

-0.039
-0.025
-0.037
-0.052
-0.042
-0.039

O1–C1
O2–C4
C1–C2
C1–C6
C2–C3
C3–C4
C4–C5
C5–C6
C–C (ave)
C–C (dev) b

1.303
1.254
1.438
1.428
1.386
1.441
1.448
1.362
1.417
0.035

1.313
1.263
1.447
1.423
1.396
1.449
1.454
1.370
1.423
0.034

0.010
0.009
0.009
-0.005
0.010
0.008
0.006
0.008
0.006

1.293
1.256
1.444
1.432
1.386
1.442
1.448
1.361
1.419
0.036

1.313
1.266
1.445
1.431
1.398
1.448
1.454
1.372
1.425
0.033

0.020
0.010
0.001
-0.001
0.012
0.006
0.006
0.011
0.006

Fe
O,N-ligand

3.80
1.13

3.77
1.13

3.81
1.09

3.83
0.99

Bond
Fe–N1
Distances Fe–N3
Fe–N5
Fe–O1
Fe–N7
Fe–L (ave)

Mulliken
spins
a

Difference between BP- and B3LYP-computed bond distances. b Standard deviation of the six C-C bond
distances within the BIHQ or BISQ ring.
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Figure 3.13. Experimental (black dashed line) and TD-DFT computed (solid red line)
absorption spectra of [8c]+. The experimental spectrum was obtained by treating [8]OTf
with the TTBP• radical in CH2Cl2. The red sticks mark the wavelengths and intensities of
computed transitions.

3.B.iv. Resonance Raman Spectroscopic Studies

The electronic structures of complexes [8c]+ and [1c] were further examined with
resonance Raman (rR) spectroscopy – a well-established method for the characterization
of semiquinone radicals. The experiments employed 457.9 nm laser excitation, in
resonance with the ligand-based -* transition observed near 440 nm. Spectra of [1c]
and its [1b]+ precursor were measured at 273 K due to the thermochromic nature of the
former complex (vide supra), whereas the [8c]+ spectrum was collected at 77 K on a
frozen sample. Figure 3.14 highlights the 1200-1700 cm-1 region where peaks due to
aromatic CC and OC stretching modes are typically found. The [8c]+ and [1c] spectra
exhibit an intense feature near 1527 cm-1 that is not apparent in the [8b]2+ spectrum, and
it arises regardless of the route of preparation (concerted H-atom transfer or sequential
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oxidation/deprotonation). A series of peaks is also evident between 1400 and 1500 cm-1,
especially in the low-temperature [8c]+ spectrum.
To aid in assignment of the observed rR peaks, DFT frequency calculations were
performed for the BIHQ ligand in three oxidation states: the hydroquinonate anion
(BIHQate; deprotonated at 4-OH position), semiquinone radical (BISQ; H-atom
removed from 4-OH position), and benzoquinone (BIBQ). We focused specifically on
the predicted frequency of the distal O-C stretching mode [(O2C4)], since studies of
ortho-dioxolene compounds have demonstrated that (O-C) modes give rise to intense rR
peaks that are diagnostic of ligand oxidation state.136-142 The computed (O2C4)-based
mode appears at 1414 and 1681 cm-1 for BIHQate and BIBQ, respectively, following the
expected increase in frequency as the ligand becomes more oxidized. The BISQ
calculation predicts two modes with significant (O2C4) character at intermediate
frequencies of 1449 and 1521 cm-1. The 1449 cm-1 vibration couples the (O2C4)
stretch with the breathing motion of the pSQ ring, while the 1521 cm-1 vibration couples
the (O2C4) stretch to nearby bending motions. Significantly, these calculated
(O2C4) frequencies are consistent with previous studies of pSQ radicals143 and
remarkably close to the experimentally-observed peaks at 1527 and ~1450 cm-1 in the
[8c]+/[1c] spectra (Figure 3.14). Thus, the rR data provide further evidence that
complexes [8c]+ and [1c] possess a BISQ ligand.
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Figure 3.14. Resonance Raman spectra obtained with 457.9 nm excitation (40 mW at
sample) of [1b]+, [8c]+, and [1c] in CD2Cl2 solutions. The [8c]+ sample was prepared by
treatment of the [8]OTf precursor with TTBP•. The rR spectrum of [8c]+ (black line) was
collected at 77 K. Samples of [1c] were prepared via two routes: treatment of [1] with
TTBP• (red spectrum) or addition of 5 equiv. of NEt3 to [1b]+ (blue spectrum). rR spectra
of [1c] and [1b]+ (gray line) were measured at 273 K (ice/water bath).

3.C. Conclusion

This chapter has described the preparation and X-ray structural characterization of
complex [8]OTf (Figure 3.3) – the first synthetic model of the nonheme iron enzyme
GDO. The mononuclear Fe(II) center in the GDO active site is coordinated by a 3His
facial triad (Figure 3.2), in contrast to the 2H1C triad found in all other HQDOs.50,64
Complex [8]OTf features a neutral Ph2TIP scorpionate ligand to mimic the enzymatic
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3His triad, while the bidentate BIHQ ligand models the coordination of gentisate to the
Fe(II) ion. The structural and electrochemical properties of [8]OTf were compared to
those previously reported for the analogous complex [1], which contains a monoanionic
Ph2

Tp scorpionate ligand (Figure 3.3) that better resembles the 2H1C triad. Overall, the

differences between [8]OTf and [1] are modest: the FeNTIP bonds are longer than the
FeNTp distances by an average of 0.03 Å (Table 1), and the Fe3+/2+ redox potential of
[8]OTf is shifted positively by ~100 mV relative to [1] (Figure 3.5).
Spectroscopic and crystallographic methods confirmed that one-electron
oxidation of [8]OTf and 1 yields the Fe(III)-HQate complexes [8b]2+ and [1b]+.
Treatment of the Fe(III) complexes with excess NEt3 gives rise to the brown
chromophores [8c]+ and [1c], which can also be generated by treatment of [8]OTf/[1]
with the H-atom abstracting agent, TTBP• (Scheme 4). Extensive spectroscopic (UV-vis,
EPR, rR) and computational (DFT) studies provided overwhelming evidence that [8c]+
and [1c] feature a high-spin Fe(II) center ferromagnetically coupled to a pSQ• ligand
(BISQ). Thus, the conversion of [8b]2+/[1b]+[8c]+/[1c] involves both deprotonation of
the distal hydroxyl group and intra-molecular ligand-to-metal ET, as illustrated in Figure
3.15(a). The ET occurs because loss of the distal proton destabilizes of the frontier MOs
of the HQate ligand relative to those of the iron center; indeed, it has been shown that
deprotonation of free p-hydroquinonate lowers its redox potential by more than 0.9 V in
DMSO.99,144 Keramidas and coworkers have similarly demonstrated that tetranuclear
vanadium(V) complexes with bridging HQate ligands undergo deprotonation to give the
corresponding V(IV)-SQate species.145 Thus, there is literature precedent for the type of
reversible, proton-induced valence tautomerization described presently in this chapter.
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Noninnocent (i.e., redox-active) ligands have garnered increasing attention due to
their ability to function as electron reservoirs in the cycles of (bio)inorganic catalysts,
thereby permitting multi-electron transformations.146-151 By comparison, less attention has
been paid to ligands, such as HQates, that are capable of donating (or accepting) both
electrons and protons. The advantage of this type of noninnocent ligand is its potential to
participate in proton-coupled electron transfers (PCETs), which play a critical role in
numerous biological and synthetic processes.99,152 The interconversions of [8b]2+/[8c]+
and [1b]+/[1c] highlight the ability of protonation state to modulate the noninnocent
nature of ligands such as BIHQ.
Significantly, this series of complexes ([8]OTf/[1], [8b]2+/[1b]+, [8c]+/[1c])
replicates key aspects of the proposed GDO mechanism, as shown in Figure 3.15. The
active site of GDO contains a conserved second-sphere Asp residue that forms a
hydrogen bond to the distal –OH group of the coordinated gentisate substrate.50,64 It has
been proposed that this second-sphere carboxylate moiety deprotonates gentisate during
(or immediately after) O2 binding to the Fe center, thereby giving rise to a superoxoFe(II)-pSQ• intermediate (Figure 3.15(b)).50,52,64,87,121 While this intermediate has not
been observed experimentally, the synthetic results described here suggest that formation
of an Fe(II)-pSQ• intermediate via transfer of 1e and 1H+ is a viable option for the GDO
catalytic cycle.
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Figure 3.15. (a) Interconversion of [8]OTf- and 1-derived species via reversible stepwise
transfer of one electron and one proton. (b) Proposed reaction mechanism of GDO to form
the putative superoxo-Fe(II)-pSQ·- intermediate.

3.D. Experimental

3.D.i. General Methods

Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Solvents CH2Cl2 and MeCN were purified and
dried using a Vacuum Atmospheres solvent purification system. The synthesis and
handling of air-sensitive materials were performed under inert atmosphere using a
Vacuum Atmospheres Omni-Lab glovebox. The compounds ferrocenium
hexaflurorphosphate ([Fc]PF6),153 2,4,6-tri-tert-butylphenoxyl radical (TTBP•),128
Ph2

TIP122 and 2-(1-methyl-benzimidazol-2-yl)hydroquinone112 were prepared according to

published procedures. The syntheses and X-ray crystal structures of complexes
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[Fe(Ph2TIP)(MeCN)3](OTf)2 and 1b were reported previously.112,122 Elemental analyses
were performed at Midwest Microlab, LLC in Indianapolis, IN.
UV-vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for experiments at reduced temperatures. Infrared (IR) spectra were measured with
a Thermo Scientific Nicolet iS5 FTIR spectrometer equipped with the iD3 attenuated
total reflectance accessory for solid-state samples. EPR experiments were performed
using a Bruker EleXsys E650 instrument equipped with an ER4415DM cavity, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat. The
program EasySpin4 was used to simulate the experimental spectra.154 Resonance Raman
(rR) spectra were measured with 457.9 nm excitation from a Coherent I-305 Ar+ laser
using ~40 mW of power at the sample. The scattered light was collected using a 135°
backscattering arrangement, dispersed by an Acton Research triple monochromator and
detected with a Princeton Instruments Spec X 100BR CCD camera. The samples were
held in a dewar cooled with either water/ice (273 K) or liquid nitrogen (77 K).
Electrochemical measurements were performed with an epsilon EC potentiostat
(iBAS) under nitrogen atmosphere at a scan rate of 100 mV/s with 0.1 M (NBu4)PF6 as
the electrolyte. A three-electrode cell containing a Ag/AgCl reference electrode, a
platinum auxiliary electrode, and a glassy carbon working electrode was employed for
cyclic and square-wave voltammetric measurements. Under these conditions, the
ferrocene/ferrocenium (Fc+/0) couple has an E1/2 value of +0.52 V in CH2Cl2.
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3.D.ii. Synthetic Procedures

[Fe(Ph2TIP)(BIHQ)]OTf ([8]OTf): Under an inert atmosphere, 2-(1-methyl-1Hbenzimidazol-2-yl)hydroquinone (33 mg, 0.14 mmol) as deprotonated by stirring with
one equivalent of NaOMe in THF. After 30 minutes, a solution of
[Fe(Ph2TIP)(MeCN)3](OTf)2 (165 mg, 0.14 mmol) in THF was added to the reaction vial.
The mixture was stirred overnight, and the solvent was then removed under vacuum. The
crude product was taken up in 1,2-dichloroethane and filtered through Celite. Vapor
diffusion of Et2O into this solution provided yellow crystals suitable for X-ray diffraction
(113 mg, 71 %). Anal. Calcd for C63H50F3FeN8O5PS (MW = 1175.02 g mol-1): C, 64.40;
H, 4.29; N, 9.54. Found: C, 63.80; H, 4.82; N, 9.04. UV-Vis (CH2Cl2): max (, M-1cm-1)
= 378 (7800), 440 (2200) nm. FTIR (solid):  = 3590 [(O-H)], 3047, 2985, 2871, 1604,
1578, 1504, 1488, 1461, 1444, 1386, 1325, 1253, 1155, 1074, 1031, 949, 833, 638 cm-1.
[Fe(Ph2Tp)(BIHQ)]PF6 ([1b]PF6): Complex 1 (149 mg, 0.15 mmol) was treated with
one equivalent of [Fc]PF6 (50 mg, 0.15 mmol) in MeCN (10 mL) for 30 minutes. The
resulting dark brown solution was filtered through Celite to eliminate any unreacted
precursor complex, and the solvent was removed under vacuum. The resulting brown
solid was washed twice with a pentane (3 mL each time) to extract the ferrocene
byproduct. The crude product was then taken up in 1,2-dichloroethane (4 mL), and vapor
diffusion of pentane into this solution yielded dark brown needles suitable for X-ray
crystallography (145 mg, 87%). Anal. Calcd for C59H45BF6FeN8O2P (MW = 1109.68 g
mol-1): C, 63.86; H, 4.09; N, 10.10. Found: C, 63.49; H, 4.25; N, 10.05. UV-Vis
(CH2Cl2): max (, M-1cm-1) = 339 (12800), 441 (6250), 506 (5800) nm. FTIR (solid):
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3529 [(O-H)], 3057, 2987, 2626 [(B-H)], 1545, 1479, 1425, 1354, 1255, 1165, 1067,
1013, 848, 781, 559 cm-1.

3.D.iii. Crystallographic Studies

X-ray diffraction (XRD) data were collected with an Oxford Diffraction SuperNova
kappa-diffractometer (Agilent Technologies) equipped with dual microfocus Cu/Mo X-ray
sources, X-ray mirror optics, Atlas CCD detector, and low-temperature Cryojet device. The
data were processed with CrysAlis Pro program package (Agilent Technologies, 2011),
followed by an empirical multi-scan correction using SCALE3 ABSPACK routine.
Structures were solved using SHELXS program and refined with SHELXL program105
within Olex2 crystallographic package.106 X-ray crystallographic parameters are provided
in Table 3 and experimental details are available in the CIFs.

3.D.iv. DFT Computations

DFT calculations were performed using the ORCA 3.0 software package
developed by Dr. F. Neese (MPI for Chemical Energy Conversion).155 Geometry
optimizations employed either (i) Becke’s three-parameter hybrid functional for
exchange along with the Lee-Yang-Parr correlation functional (B3LYP),156,157 or (ii) the
Becke-Perdew (BP86) functional.158,159 All calculations used Ahlrichs’ valence triple-ζ
basis set (TZV) and TZV/J auxiliary basis set, in conjunction with polarization functions
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on all atoms.160,161,162 In the geometry optimized models, the Ph2TIP and Ph2Tp ligands
were modified by replacing the Ph-groups at the 5-positions of the imidazolyl and
pyrazolyl rings, respectively, with H-atoms. Time-dependent DFT (TD-DFT)
calculations of 3a used a truncated version of the optimized model with Me groups
(instead of Ph groups) at the 4-positions of the imidazolyl rings. TD-DFT
calculations163,164,165, calculated absorption energies and intensities for 60 excited states
with the Tamm-Dancoff approximation.166,167 Vibrational frequency calculations were
performed on the BIHQ ligand in various oxidation state; calculation of the harmonic
force fields proved that the optimized structure is a local minima on the potential energy
surface. Isosurface plots of molecular orbitals and electron-density difference maps
(EDDMs) were prepared with Laaksonen’s gOpenMol program.168
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Table 3.4. Summary of X-ray Crystallographic Data Collection and Structure
Refinement for [8]OTf and [1b]PF6.
empirical formula
formula weight
crystal system
space group
a, Å
b, Å
c, Å
, deg
deg
, deg
V, Å3
Z
calc, g/cm3
, Å
mm-1
 -range, deg
reflections collected
independent reflections
data/restraints/parameters
GOF (on F2)
R1/wR2 (I > 2(I))
R1/wR2 (all data)
a

[8]OTf·2Et2O a

[1b]PF6·C2H4Cl2

C71H70F3FeN8O7PS
1323.26
monoclinic
P21/c
21.2966(19)
20.2553(16)
15.4880(15)
90
101.9938(8)
90
6535.20(10)
4
1.348
1.5418
3.042
6 to 149
63087
13122 [Rint = 0.0320]
13122 / 0 / 868
1.021
0.0348 / 0.0907
0.0378 / 0.0932

C61H49BCl2F6FeN8O2P
1208.61
triclinic
P-1
12.8542(5)
14.8267(4)
16.1415(5)
75.336(6)
68.675(3)
88.313(3)
2765.67(15)
2
1.451
1.5418
3.970
6 to 149
52535
11084 [Rint = 0.0418]
11084 / 0 / 777
1.078
0.0460 / 0.1234
0.0495 / 0.1271

One of the Et2O solvates is partially (11%) occupied by 1,2-dichloroethane solvent.
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Chapter 4

Dioxygen Reactivity of Fe(II)-Hydroquinonate Complexes:
Generation of Catalytically-Relevant Intermediates of the
Hydroquinone Dioxygenases

Abstract: This chapter describes the initial dioxygen reactivity studies of a series of
mononuclear iron(II)-hydroquinonate complexes featuring the facially coordinating
hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) ligand. These complexes have been
previously reported as biologically-relevant models that nicely replicate the geometric
structure of the enzyme-substrate complex formed during the mechanism of hydroquinone
dioxygenases (HQDOs). The O2 reactivity of these complexes was monitored via UV-vis
absorption spectroscopy and attempts were made to isolate organic products formed upon
reaction with O2. The results described here indicate upon treatment with O2, complexes 1
and 2 (Chapter 2) undergo a one-electron oxidation and deprotonation of their HQate
ligands to generate Fe(II)-pSQ·- species, providing interesting implications for the
mechanism of the HQDOs in nature.
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4.A. Introduction

Mononuclear non-heme iron dioxygenases (MNIDs) are involved in the
catabolism of a wide variety of aromatic substrates in biological systems.13-14,16-21,28,50-51
A crucial feature of the non-heme iron active sites of these enzymes is their ability to
simultaneously bind dioxygen and substrate, effectively activating O2 and facilitating the
oxidative C-C bond cleavage reaction of each MNID. To better understand the electronic
structures of reactive intermediates formed during the catalytic mechanisms of particular
MNIDs, researchers have performed modeling studies using biomimetic complexes that
can be modified in a straightforward and systematic manner. The ultimate goal of this
work is to determine structure-reactivity correlations that can be applied back to the
biological system to elucidate their exquisite mechanism of action.
The literature describes several studies of model complexes that aim to replicate
the observed function of MNIDs. Associated reactivity studies of these species have
indicated that the reaction of a proposed non-heme Fe dioxygenase model with O2 tends
to follow three major trends (Figure 4.1). While studies of mononuclear Fe(II)-HQate
complexes are rare, we can envision our HQDO models reacting in an analogous fashion.
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Figure 4.1. Possible outcomes of reaction of mononuclear Fe-HQate model complexes, 1
and 2: (A) oxidative cleavage of bound model substrate and generation of possible autooxidation product(s) (B) metal- or ligand-centered oxidation of species facilitated by O2
(C) generation of an Fe-O2·- adduct upon binding of dioxygen to the metal center.

The first predicted outcome of the O2 reaction is that the model will exhibit the
reactivity that mirrors the function of the corresponding metalloenzyme in nature,
resulting in oxidative cleavage of an incorporated model substrate. An early example of
biomimetic extradiol cleavage was demonstrated by the complex [FeIII(tacn)Cl(dbc)]
(tacn = 1,4,7-triazacyclononane; dbc = 3,5-di-tert-butylcatecholate) as reported by Dei et
al.169 Upon treatment of the starting iron complex with O2 in either a MeCN or DMF
solution, they noted that the oxygenation reaction is virtually complete within 6 h, as
monitored by UV-vis absorption spectroscopy. Upon examination of the final reaction
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mixture, Dei et al. noted a 35% yield of extradiol cleavage products, as confirmed by
NMR and mass spectrometry. While the literature presents an abundance of additional
examples of complexes that can carry out both intra- and extradiol cleavage of catechols,
recent attention has focused on the development of models that instead aim to facilitate
the ring cleavage reactions of other substrates, such as aminophenols and β-diketones.170173

Interestingly, MNID model complexes have also demonstrated the ability to
undergo direct metal- or ligand-based oxidation(s) upon treatment with O2. Several
examples of Fe(II)-catecholate complexes exist that are observed to undergo oxidation to
the corresponding Fe(III) form. Que, et al. report an example of a pale yellow Fe(II)catecholate complex [Fe2+(6TLA)(DBCH)](ClO4), (6TLA = tris[(6-methyl-2pyridyl)methyl]amine) that undergoes loss of an electron to generate the corresponding
ferric species upon treatment with dioxygen.174 By monitoring the oxygenation reaction,
Que, et al. observe the formation of a deep purple-blue species that displays two intense
bands at 600 and 1020 nm, characteristic of catecholate  Fe(III) charge transfer
transitions.175-177 The generation of a high-spin ferric species was further confirmed via
EPR spectroscopy. Similar reactivity was reported and spectroscopically confirmed by
Fiedler and Bittner. upon treatment of the complex [(Ph2TIP)Fe2+(tBuCatH)]+ (tBuCatH = 4tert-butylcatecholate) with dioxygen.178 Notably, both of these ferric species have been
demonstrated to react further with an additional equivalent of O2 to yield extradiol
cleavage products. In contrast, Bittner et al. also report two complexes similar to the
aforementioned 4-tert-butylcatecholate species that can undergo two-electron oxidation
processes facilitated by dioxygen. The first of these complexes is
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[(Ph2TIP)Fe2+(tBuPDA)]2+ which displays a two-electron ligand-based oxidation to yield
[(Ph2TIP)Fe2+(tBuDIBQ)]2+ (tBuDIBQ = o-diiminobenzoquinone). Conversely, they report
the preparation of a similar complex, [(Ph2TIP)Fe2+(tBu2APH)]+ (tBu2APH = 2-amino-4,6di-tert-butylphenolate), that undergoes a two-electron oxidation process upon exposure to
dioxygen, however, in this case, the final product arises from oxidation of both the Fe(II)
center and the bound ligand to yield a species best described as [(Ph2TIP)Fe3+(tBuISQ)]
(tBuISQ = o-iminobenzosemiquinone).178 These studies highlight the interesting dioxygen
reactivity of non-heme iron models which results in metal- and/or ligand-based
oxidation(s). In particular, the last two species mentioned demonstrate the ability of
model species to undergo oxidative processes in aerobic solutions without incorporation
of either atom of dioxygen in the final oxidized product.
The last major trend that has been observed upon the reaction of dioxygen with a
model non-heme iron dioxygenase complex is the formation of (quasi)stable Fesuperoxo or Fe-peroxo adducts. The literature includes several examples of species that
incorporate dioxygen bound directly to the iron center of a complex. Kitajima et al first
described the dioxygen reactivity of the complex, [(iPr2Tp)Fe(OBz)] (OBz = benzoate),
which was observed to generate a deep-green chromophore at -50 °C with λmax = 682 nm
(ε = 3450 M-1 cm-1).179 Further studies utilizing rRaman spectroscopy revealed two new
bands (876 and 418 cm-1) upon treatment of [(iPr2Tp)Fe(OBz)] with 16O2, characteristic of

(O-O) and (Fe-O) frequencies, respectively, diferric-peroxo species. They noted an
isotopic shift upon incorporation of 18O2 (827 and 409 cm-1, respectively), in reasonable
agreement with predicted values based on the diatomic harmonic-oscillator
approximation (shifts of 50 and 15 cm-1, respectively). They note that based on their
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rRaman results, they did not observe isotopically-active bands in the range of 1000-1200
cm-1 characteristic of (O-O) of a superoxide complex, further supporting the generation
of a μ-peroxo dinuclear ferric complex. Que et al. observed formation of a similar species
upon oxygenation of [(iPr2Tp)Fe(PRV)] (PRV = pyruvate) at -40 °C which exhibits a
broad absorption band with λmax = 680 nm (ε = 1600 M-1 cm-1).180 Interestingly, because
the pyruvate-bound complex demonstrates similar behavior to that reported previously by
Kitajima et al., Que et al. noted that these complexes are remarkable due to the fact that,
while there are many (μ-η1:η1-peroxo)diiron(III) complexes present in the literature, very
few are derived from mononuclear ferrous complexes that bind O2 in a bridging
fashion.180
Additional reports described formation of mononuclear Fe-superoxo species upon
treatment of a non-heme iron model complex with dioxygen. Lee et al. reported the
synthesis of a non-heme Fe2+(BDPP) (BDPP = 2,6-bis[((S)-2-(diphenylhydroxymethyl)1-pyrrolidinyl)methyl]pyridine) complex that readily reacts with O2 at -80 °C to form a
paramagnetic Fe3+-superoxo species.181 A solution of the precursor complex in THF
undergoes a drastic color change (from red to bright yellow) upon introduction of O2 and
displays an intense absorption feature at 330 nm. Literature precedent indicates that this
new feature corresponds to the formation of an Fe(III)-O2·- adduct.182 rRaman
spectroscopy confirmed the binding of dioxygen to the metal center as a resonanceenhanced mode at 1125 cm-1 is displayed in the spectrum obtained for the oxygenated
species (introduction of 18O2 induces a reasonable isotopic shift to 1062 cm-1). Additional
evidence for the generation of a Fe3+-superoxo adduct was derived from the use of
Mössbauer and EPR spectroscopies.
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Inspired by the aforementioned investigations and the continuing questions
regarding the identity of catalytic intermediates, we chose to study the dioxygen
reactivity of a series of complexes that accurately mimic the structure of the enzymesubstrate complex of the hydroquinone dioxygenases (HQDOs), as described in Chapter
2. In order to establish the ability of these complexes to act as viable functional models,
we explored the O2 reactivity of each complex and monitored the subsequent reaction via
UV-vis spectroscopy. Further studies were completed to assess the capacity of these
complexes to facilitate oxidative ring cleavage of their respective model substrates. While
the work reported here is somewhat preliminary, we believe these results lay the
foundation for future studies of the viability of our systems to act as functional models of
the HQDOs.

4.B. Results and Discussion

This chapter details the dioxygen reactivity of complexes 1 and 2. Both
complexes feature a monoiron(II) center supported by the facially capping
hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) ligand. The monoanion of 2-(1methyl-1H-benzimidazol-2-yl)hydroquinone (1) or 2′,5′-dihydroxyacetophenone (2) bind
in a bidentate manner. As reported in Chapter 2, each complex consists of a 5C high-spin
Fe(II) center with distorted geometries between square planar and trigonal bipyramidal;
however, the coordination geometry of 2 lies closer to the trigonal bipyramidal limit (τ =
0.35 and 0.60, respectively98). In order to assess the ability of 1 and 2 to react with
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dioxygen, we exposed each complex to O2 in DCM solutions at low temperatures. The
resulting reactions were monitored via UV-vis absorption spectroscopy.

4.B.i. Dioxygen reactivity of complex 1 – [(Ph2Tp)Fe(2-BIHQ)]

Upon treatment of 1 with dioxygen at -50 °C, the generation of [1]O2 is signified
by formation of a new absorption band at λmax = 445 nm in addition to a weak shoulder
centered at approximately 530 nm (Figure 4.2). In conjunction with the appearance of the
two new features, the intense π  π* transition of the starting ferrous complex 1 (λmax =
365 nm) noticeably decreases in intensity.
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; [1c]

Figure 4.2. Electronic absorption spectra demonstrating formation of [1]O2 upon addition
of O2 to complex 1 in CH2Cl2 at -50 °C. The spectrum for [1c] is included for comparison

Addition of O2 to 1 at room temperature first generates the [1]O2 species observed
at low temperature which slowly decays overnight to a brown species with a broad
absorption band between 400-800 nm (Figure 4.3). Attempts to isolate and characterize
oxidative cleavage products from the reaction of 1 with O2 have been made, but the
resulting NMR and GC-MS data have not provided conclusive evidence for specific
products.
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.

Figure 4.3. Electron absorption data of the reaction of 1 with O2 at 20 °C in CH2Cl2
overnight (grey dashed line – starting spectrum; brown solid line – reaction of 1 with O2
after approximately 12 hours). The absorption data for [1]O2 generated at -50 °C is also
included for comparison.

Interestingly, the band shapes of newly generated [1]O2 are reminiscent of those
observed in the absorption spectrum of [1c], the previously reported Fe2+-pSQ·- species
(Chapter 3). However, the absorption intensity of the dioxygen-treated form of 1 are
somewhat diminished with respect to [1c]. Addition of 5 equivalents of Et3N at -50 °C
leads to an increase in intensity of each feature (Figure 4.4).
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Figure 4.4. Electronic absorption data comparing the reaction of [1] with O2 and Et3N and
[1b]+ with Et3N in CH2Cl2. The starting spectrum of [1]O2 is included for comparison.

Based on these results, we surmised that addition of O2 does not result in
formation of the corresponding Fe3+-HQate species (UV-vis absorption data for the ferric
species is reported in Figure 3.6), but instead leads to the generation of a new species that
is spectroscopically similar to [1c], especially upon addition of base at low temperatures.
Reversing the order of addition of dioxygen and base only yields minor changes in the
resulting electronic absorption data. Formation of a ligand-based radical assumes that
dioxygen is acting as a one-electron oxidant in the presence of Et3N. While further
spectroscopic evidence is required to confirm this assignment (vide infra), if this
prediction holds, it has interesting implications for the HQDO mechanism.
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4.B.ii. Dioxygen reactivity of complex 2 – [(Ph2Tp)Fe(2′,5′-DHAP)]

Because complexes 3, 4 and 7 displayed very little change upon exposure to O2 in
solution, we instead pursued further studies of the dioxygen reactivity of complex 2.
Significant spectral changes are observed upon exposure of a solution of 2 in CH2Cl2 to
O2 at -40 °C, as demonstrated by the absorption spectrum of [2]O2 displayed in Figure 4.5.

Figure 4.5. Electronic absorption spectra of the species formed upon treatment of complex
2 with O2 in CH2Cl2 at -40 °C.

As shown previously, the absorption spectrum of 2 contains a sharp band with
λmax= 397 nm (ε= 4710 M-1 cm-1). Addition of O2 to a solution of 2 in DCM at -40 °C
generates a dark green chromophore that exhibits two new absorption bands: one at λmax=
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360 nm (ε= 5220 M-1 cm-1), as well as a broad feature centered around λmax= 783 nm (ε=
2900 M-1 cm-1). Due to the observation that this new species did not persist at room
temperature, attempts to crystallize [2]O2 at low temperature (< -70 °C) were made, but
these trials proved unsuccessful.
Based on the observed absorption features of [2]O2 and their similarity to those
reported by Kitajima179 and Que180 upon formation of a diferric-(μ-1,2-peroxo) species,
we investigated the ability of dioxygen to bind to the ferrous center of complex 2.
Specifically, the electronic structure of [2]O2 was probed with resonance Raman
(rRaman) spectroscopy . Two oxygenated samples were prepared in DCM at low
temperature; one sample was exposed to naturally-abundant O2 and the other to 18O2. The
resulting spectrum of [2]ox, obtained with 647 nm excitation, failed to display any
isotopically-active peaks, providing evidence against the incorporation of dioxygen in
[2]O2. While 2 is EPR silent, the X-band EPR spectrum of [2]O2 revealed an intense
signal corresponding to a S = 5/2 system with rhombic zero-field splitting parameters
(Figure 4.6). The preliminary spectral data suggests that the complex is undergoing a
one-electron oxidation facilitated by the addition of dioxygen. Comparison of the
absorption features of the ferric form of 2 (vide supra) and [2]O2 indicates that the two
species are not spectroscopically similar and we therefore surmise that the oxygenation of
2 involves a ligand-based oxidation. In order to provide further evidence for the
generation of a ligand-based radical, we treated 2 with one equivalent of AcFc+ followed
by an excess of Et3N and monitored the reaction via UV-vis spectroscopy. As illustrated
in Figure 4.7, the resulting chromophore is similar in appearance to the oxygenation
product [2]O2.
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Figure 4.6. X-band EPR spectrum of [2]O2 in frozen CH2Cl2 solution at 10 K.
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Figure 4.7. Electronic absorption spectra comparing features observed for species [2]O2
generated at -40 °C and the reaction of 2 with AcFc+ and Et3N at -30 °C. Both spectra were
obtained with CH2Cl2 solutions.

To further confirm that the chromophore observed upon the oxygenation of 2
involves a ligand-based process, we first studied the dioxygen reactivity of complex 3
which incorporates the monoanion of 2-hydroxyacetophenone. The lack of the distal -OH
group makes it difficult to oxidize the ligand to the corresponding (phenoxy) radical. The
complex remained unreactive toward the proposed oxygenation reaction, indicating the
distal –OH group of 2′,5′-DHAP is necessary for conversion of 2  [2]ox. To further
study the reactivity of the 2′,5′-DHAP ligand when bound to a ferrous center, we chose to
develop an additional analog of 2 that incorporates 2-hydroxy-5-methoxyacetophenone as
its ligand (complex 9). Crystals suitable for X-ray structure determination were obtained
from vapor diffusion of pentane into a solution of the complex in 1,2-dichloroethane.
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Details concerning data collection and analysis are provided in Table 4.2. Selected bond
lengths and angles determined for 9 are given in Table 4.1 and compared to previously
established parameters collected for 2 and 3. The new complex, [(Ph2Tp)Fe(2-hydroxy-5methoxyacetophenone)] 9, shown in Figure 4.8, is similar to the previously synthesized
mononuclear Fe-hydroquinonate complexes reported in this paper. Complex 9 displays a
5C, Fe(II) center facially bound by the Ph2Tp ligand as well as the bidentate 2-hydroxy-5methoxyacetophenone ligand. The average Fe-NTp bond length is 2.14 Å, which is
indicative of a high spin ferrous center. The Fe-O1 bond length of 1.9087 Å falls within
the previously mentioned range of Fe(II)-phenolate distances of 5C complexes.
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Table 4.1. Selected bond distances (Å) and bond angles (°)
structures of monoiron(II) hydroquinonate complexes 2, 3 and 9.
2∙2CH2Cl2
3
Fe–O1
1.937(4)
1.927(1)
Fe–N1
2.131(5)
2.108(1)
Fe–N3
2.089(5)
2.093(1)
Fe–N5
2.185(5)
2.228(1)
a
Fe–L
2.079(4)
2.103(1)
O1–C46
1.303(7)
1.304(2)
O2–C49
1.370(7)
O1–Fe–N1
O1–Fe–N3
O1–Fe–N5
O1–Fe–LX
N1–Fe–N3
N1–Fe–N5
N3–Fe–N5
LX–Fe–N1
LX–Fe–N3
LX–Fe–N5
-valueb

129.5(2)
139.9(2)
97.9(2)
86.4(2)
90.6(2)
90.2(2)
81.2(2)
87.4(2)
95.3(2)
175.7(2)
0.60

128.04(5)
140.01(5)
100.61(4)
85.28(4)
91.50(4)
88.25(4)
84.39(4)
91.32(4)
88.47(4)
172.83(4)
0.55

from the X-ray
9
1.9087(10)
2.0990(11)
2.0957(11)
2.2375(11)
2.1097(10)
1.3118(17)
1.3730(17)
129.90(5)
137.43(5)
98.23(4)
85.70(4)
92.55(4)
87.59(4)
84.98(4)
91.98(4)
90.27(4)
175.21(4)
0.63

L is the N or O atom of the pendant donor of the HQ anion. b For a definition of the τ-value, see
ref. 98. A five-coordinate complex with ideal square-pyramidal geometry would have a τ-value of
0.0, while those with ideal trigonal bipyramidal geometry would have a value of 1.0.
a

110

9

Figure 4.8. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
9. Hydrogen atoms, and Ph-rings at the 5-positions of the Ph2Tp ligand have been omitted
for clarity.

Reaction of 9 with O2 in DCM at room temperature was monitored via UV-Vis
spectroscopy. The resulting spectra indicate that 9 does not react readily with dioxygen,
as previously observed for complex 3. This study was further augmented by
electrochemical investigation of 9 which measured an irreversible oxidation at Ep,a= 1132
mV and a quasi-reversible couple at E1/2= -5 mV (ΔE=142 mV) corresponding to the
Fe(II)/Fe(III) couple (Figure 4.9).
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Figure 4.9. Cyclic voltammogram of 9. Data was collected in CH2Cl2 with 100 mM
(NBu4)PF6 as the supporting electrolyte and a scan rate of 100 mV s−1. The voltammogram
was initiated by the anodic sweep.

Comparison of the electrochemical data for 9 versus that collected for complex 2
indicates that the HLB ligand and 2-hydroxy-5-methoxyacetophenone ligands have
approximately equal electron-donating abilities. This trend is demonstrated by the fact
that the redox potential for the Fe(II)/Fe(III) couple of 2 and 9 differ by only 100 mV
(E1/2 = -110 mV and -5 mV, respectively). It is interesting to note this observation when
considering the reactivity of these complexes toward dioxygen as it further underlines the
necessity of a distal –OH group for generation of the observed green chromophore [2]O2.
Due to the inability of complexes 3 and 9 to react with O2 in comparison to
complex 2, it is clear the observed oxygenation reaction is due to a ligand-based process

112

rather than formation of a diferric-(μ-peroxo) species despite the similarities in observed
features of the absorption spectra. As mentioned previously, rRaman data collected for
[2]O2 fails to display isotopically-active modes further refuting the incorporation of
dioxygen into [2]O2. Considering previous reports by Fiedler and Bittner regarding the
dioxygen reactivity of non-heme Fe(II) models of β-diketo dioxygenase (Dke1), this
observation is not surprising.183 In this study, O2 incorporation into a model complex,
leading to dimerization, was only observed for complexes utilizing a Me2Tp ligand
scaffold, which is much less sterically demanding than the Ph2Tp ligand utilizing in our
model complexes.
Based on the spectroscopic evidence and control studies described here, we are
confident that treatment of 2 with dioxygen at -40 °C in CH2Cl2 yields a complex with a
ligand-based radical. Upon initial consideration of the significant differences in the
absorption features of [1]O2 and [2]O2, we were surprised by the apparent ability of each
precursor complex to exhibit similar behavior towards reaction with O2. However, as
previously reported, the absorption features observed for the Fe(II)-pSQ·- species [1c]
arise primarily from ligand-based transitions. This result indicates that it is reasonable for
the absorption spectra of [1]O2 and [2]O2 to vary so much based on the intrinsic difference
of the pendant donors of each ligand (i.e., benzimidazolyl group versus the acetyl donor,
respectively). Further proof for the generation of a substrate-based radical was derived
from the rRaman spectrum of [2]O2 (Figure 4.10). While further computational work
must be done to aid in the assignment of the principal vibrational modes of [2]O2, the
spectrum clearly displays a series of intense features in the range of 1200-1600 cm-1.
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Previous work with similar complexes indicates that intense modes observed in the range
of 1400-1500 cm-1 correspond to stretching motions of (semi)quinonate ligands.136,139,184

Figure 4.10. rRaman spectrum of [2]O2 obtained with 647 nm (10 mW) excitiation in
frozen CD2Cl2 solution. Peaks labeled with an asterisk (*) arise from solvent.

4.C. Conclusion

The dioxygen reactivity of mononuclear Fe(II)-hydroquinonate models 1 and 2
was described in this chapter. Treatment of each complex with dioxygen at low
temperatures (-30 and -40 °C, respectively) in CH2Cl2 has been shown to result in oneelectron oxidation and deprotonation of the ligand rather than incorporation of O2.
Further comparison of the absorption spectra of the oxygenated species with data
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collected for the stepwise treatment of each complex with AcFc+ followed by Et3N
indicates the product of the oxygenation reaction is the Fe(II)-SQ·- form of each complex.
The results presented here have interesting implications for the mechanism of function of
the HQDOs in nature. Previous biomimetic studies of the extradiol catechol dioxygenases
(ECDOs – a similar MNID) indicated that treatment of model Fe(II)-CatH complexes
with O2 first yielded a one-electron oxidized Fe(III)-catecholate species.175-178 It was the
observed that further reaction of the Fe(III)-catecholate species with an additional
equivalent of O2 lead to formation of oxidatively cleaved products upon an appropriate
chemical work up. It is interesting to consider that the o-substituted ECDO models
indicate the necessity for formation of a ferric species before further reaction with O2 to
facilitate oxidative ring cleavage; however, we instead observe generation of a pSQ·ligand-based radical. The difference in reactivity is due to the variance in substitution of
the respective dioxolene ligands. With regards to the catecholate system, the oxidation
facilitated by dioxygen is metal-based, due to the bidentate binding mode of the
catecholate ligand, which stabilizes the π-system of the ligand. Conversely, the HQate
models (and by extension, the HQDOs) instead incorporate hydroquinonate ligands
whose characteristic p-hydroxy substitution pattern leaves the distal -OH group of the
ligand unbound. This arrangement favors formation of the Fe(II)-SQ·- species upon
exposure of O2. The unreactive nature of the “control complexes” (3 and 9) highlights the
importance of a free distal -OH group to allow the oxygenation reactions to occur. While
further investigations of the final reaction products are required, the results reported here
set an interesting precedent for future biomimetic studies of the hydroquinone
dioxygenases.
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4.D. Experimental

4.D.i. General methods

Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Dichloromethane was purified and dried using
a Vacuum Atmospheres solvent purification system. The synthesis and handling of airsensitive materials were performed under inert atmosphere using a Vacuum Atmospheres
Omni-Lab glovebox. Complexes 1, 2 and 3 were prepared according to literature
procedures.112 Elemental analyses were performed at Midwest Microlab, LLC in
Indianapolis, IN. UV-vis absorption spectra were obtained with an Agilent 8453 diode
array spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for temperature control. Fourier-transform infrared (FTIR) spectra of solid
samples were measured with a Thermo Scientific Nicolet iS5 FTIR spectrometer
equipped with the iD3 attenuated total reflectance accessory. 1H spectra were collected at
room temperature with a Varian 400 MHz spectrometer. EPR experiments were
performed using a Bruker ELEXSYS E600 equipped with an ER4415DM cavity
resonating at 9.63 GHz, an Oxford Instruments ITC503 temperature controller, and an
ESR-900 He flow cryostat. Electrochemical measurements were conducted in the
glovebox with an epsilon EC potentiostat (iBAS) at a scan rate of 100 mV s−1 with 100
mM (NBu4)PF6. A three-electrode cell containing a Ag/AgCl reference electrode, a
platinum auxiliary electrode, and a glassy carbon working electrode was employed for
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cyclic voltammetric (CV) measurements. Under these conditions, the
ferrocene/ferrocenium (Fc+/0) couple has an E1/2 value of +0.52 V in CH2Cl2.

4.D.ii. Synthetic Procedures

[Fe(Ph2Tp)(2-hydroxy-5-methoxyacetophenone)] [9] : Under an inert atmosphere in
glove box, 174 mg (1 mmol) of 2-hydroxy-5-methoxyacetophenone was deprotonated
with one equivalent of NaOMe in approximately 10 mL of THF for one hour. Solvent
was removed under vacuum to yield the Na(2-hydroxy-5-methoxyaceophenone) salt as a
bright yellow powder. This salt was then combined with anhydrous FeCl2 (138 mg, 1
mmol) and K(Ph2Tp) (741 mg, 1 mmol) in 20 mL of MeCN. After stirring the reaction
mixture overnight, the solvent was removed under vacuum to yield a pale red solid which
was dried thoroughly. The product was then taken up in 1,2-dichloroethane and filtered
though celite to yield a dark red solution. Vapor diffusion with pentane yielded dark red
crystals suitable for X-ray crystallography. Anal. Calcd for C54H43BFeN6O3 (MW =
890.60 g mol-1): C, 72.82; H, 4.87; N, 9.44. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]:
395 (2411), 506 (290).
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Chapter 5

Synthesis and Spectroscopic Characterization of High-Spin
Mononuclear Iron(II) p-Semiquinonate Complexes

Abstract: The synthesis and characterization of a series of mononuclear Fe(II) complexes
supported by the tris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) ligand and bearing
substituted quinone ligands is detailed in this chapter. Upon successful generation of an
Fe(II)-quinonate species, we explored the abilities of these compounds to generate novel
Fe(II)-p-semiquinone species upon chemical reduction in order to further investigate the
role of a radical species in the catalytic mechanism of the hydroquinone dioxygenases. The
existence of a ligand-based radical was confirmed by extensive spectroscopic and
computational analysis. These results represent the first examples of mononuclear iron
complexes containing p-SO·- ligands and therefore provide a solid foundation for further
investigation of metal-ligand radical interactions similar to those observed in nature.

Reproduced in part with permission from Baum, A. E.; Park, H.; Lindeman, S. V.; Fiedler,
A. T.; Inorganic Chemistry 2014, 53, 12240-12242. Copyright 2014 American Chemical
Society.
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5.A. Introduction

The utilization of substituted p-benzoquinones to facilitate redox reactions is a
common theme in biological processes. The ability of these cofactors to carry out
reversible redox reactions allows them to participate in a variety of processes such as
respiration, photosynthesis, catalytic transformations and protection against oxidative
stress.99, 152 Quinones can take part in one- and two-electron reactions, usually coupled
with proton transfer(s), to generate the corresponding semiquinone and hydroquinone
species, respectively (Figure 5.1).

Figure 5.1. Net reduction of quinone to hydroquinone.

In biological systems, quinones generally function in unison with redox active
metal centers, such as iron and copper. A specific example of a metal-quinone system
found in nature is cytochrome bc1, an essential complex in the electron transport chain.
This complex facilitates the transfer of two electrons from p-hydroquinone ubiquinol to a
Rieske cluster and a heme (bL) site within the ET chain.185 The close proximity of
ubiquinol with the iron centers allows for electronic coupling between sites. Electronic
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paramagnetic resonance (EPR) has recently confirmed the interaction of the ubisemiquinone (SQ∙-) radical and a reduced Fe-S cluster following the primary electron
transfer via detection of a triplet electronic state arising from ferromagnetic interactions
between each paramagnetic moiety.186 In addition, a nonheme ferrous center in
Photosystem II (PSII) operates in conjunction with two p-quinones (QA and QB) that
shuttle electrons away from the photoexcited cofactor, P680* resulting the formation of
transient FeII-pSQ·- as elucidated via EPR studies.187 Most relevant to this document, a
superoxo-FeII-SQ·- intermediate has been proposed as a key intermediate in the
degradative pathways of the hydroquinone dioxygenases, which facilitate the catabolism
of p-hydroquinones in nature.52
Despite these biological precedents of iron-quinone interactions, few synthetic Fe
complexes with bound p-quinone or p-semiquinone ligands have been reported in the
literature. The lack of reported synthetic analogues can be attributed to the weak donor
ability of the carbonyl moieties of p-quinones, which can only bind to metal centers in a
monodentate manner. This difficulty can be overcome by the placement of an anionic
donor adjacent to the carbonyl moiety of the quinone to assist in ligation to a metal
center.
This chapter details our success in the synthesis and characterization of
metastable Fe(II)-pSQ·- species with relevance towards similar metal-radical
intermediates found in biological applications – particularly those observed in
metalloenzymes. In order to achieve our goal, we first sought to synthesize a series of
monoiron(II) complexes which incorporate the monoanion of substituted quinone ligand
derivatives [juglone (HJ), 2,3-dibromojuglone (BrJ), lawsone (HL), 3-chlorolawsone (ClL)
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and 1-hydroxyanthraquinone (AQ)] (Figure 5.2). In order to facilitate binding of each
ligand to the metal center, each naphthoquinone moiety incorporates a pendant phenolate
donor which allows formation of a favorable six-membered ring chelate. The high-spin
Fe(II) center of each mononuclear complex is further supported by the hydrotris(3,5diphenylpyrazol-1-yl)borate (Ph2Tp) facially-capping ligand scaffold.

Figure 5.2. Substituted naphthoquinone ligands utilized in this study. Each incorporates a
hydroxyl group pendant to the carbonyl moiety to facilitate binding.

Upon successful generation of our Fe(II)-quinonate precursors, we explored the
ability of these species to undergo chemical reduction to form Fe(II)-pSQ·- species. We
noted that upon addition of an appropriate one-electron reductant at low temperatures to
11 and 12, we generated two new brown chromophores, 11red and 12red, respectively.
These species were studied extensively via spectroscopic [UV-vis absorption, EPR and
rRaman (rR)] and computational methods, which confirmed the presence of a substratebased radical in the newly-generated Fe(II)-pSQ·-- species – which, to the best of our
knowledge, are the first to be reported in literature. Thus, our synthetic efforts lay
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precedent for further detailed explorations of biologically-relevant iron-(semi)quinone
interactions.

5.B. Results and Discussion

5.B.i. Synthesis and Characterization of monoiron(II) complexes incorporating
substituted quinonate-derived ligands

In our course to develop synthetic models of the HQDOs (Chapter 2), our survey
of bidentate hydroquinonate ligands initially included a naphthalene-derivative, 1,4,5naphthatlenetriol (1,4,5-NTO). Upon generation a mononuclear Fe(II) complex
supported facially by the Ph2Tp ligand and bound to the monoanion of (1,4,5-NTO), we
determined our complex incorporated the unexpected diketo- tautomer of the triol ligand,
even in the presence of base (Figure 5.3).

Figure 5.3. Suggested tautomerization of 1,4,5-naphthalenetriol ligand to 2,3dihydrojugalone (H2J).
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Crystals suitable for X-ray crystallographic analysis were obtained by layering a
concentrated solution of the complex in DCM with MeCN. X-ray diffraction analysis
(XRD) revealed a 5-coordinate complex with an Fe center bound to the anion of 2,3dihydrojugalone formulated as [(Ph2Tp)Fe(2,3-dihydrojugalone)], (10) (Figure 5.4). The
saturation of the C-C bond is evident by the presence of two H-atoms and the twisted ring
conformation of the bound ligand. Details concerning data collection and analysis are
provided in Table 5.4 and selected bond lengths and angles for 10 are given in Table 5.1.

Figure 5.4. Thermal ellipsoid plot (50% probability) derived from the X-ray crystal structure
of [Fe(Ph2Tp)(2,3-dihydrojugalone)] (10). Non-coordinating solvent molecules, hydrogen
atoms, and Ph-rings at the 5-positions of the Ph2Tp ligand have been omitted for clarity.
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Table 5.1. Selected bond distances (Å) and bond angles (°) from the X-ray structures
of monoiron(II) napthoquinone-derivative complexes 10-14.
10
11
12
13
14
Fe–N1
2.1082(17)
2.1022(13)
2.102(4)
2.100(4)
2.072(5)
Fe–N3
2.0959(17)
2.0892(14)
2.084(4)
2.086(4)
2.054(5)
Fe–N5
2.2036(17)
2.2047(14)
2.229(4)
2.191(4)
2.166(5)
Fe–O2
2.0904(14)
2.0624(12)
2.080(3)
2.226(3)
2.217(5)
Fe–O3
1.9384(15)
1.9262(13)
1.933(3)
1.955(3)
1.963 (4)
O1–C1
1.221(3)
1.222(2)
1.221(6)
1.232(6)
1.218(8)
O2-C4
1.241(3)
1.234(2)
1.244(6)
1.218(6)
1.232(7)
O3–C5
1.293(3)
1.298(2)
1.297(6)
1.310(5)
1.279(8)
C2-C3
1.521(3)
1.333(3)
1.337(7)
O3–Fe–N1
O3–Fe–N3
O3–Fe–N5
O3–Fe–O2
N1–Fe–N3
N1–Fe–N5
N3–Fe–N5
O2–Fe–N1
O2–Fe–N3
O2–Fe–N5
τ-valueb

129.69(7)
137.84(7)
100.53(6)
85.56(6)
91.84(6)
89.43(6)
84.71(6)
90.04(6)
87.79(6)
172.46(6)
0.58

130.60(6)
137.32(6)
96.74(5)
86.05(5)
91.98(5)
89.17(5)
84.95(5)
90.15(5)
92.18(5)
174.97(5)
0.63

127.16(2)
139.90(2)
96.42(1)
85.20(1)
92.93(1)
84.90(1)
87.90(1)
93.34(1)
92.06(1)
176.77(1)
0.62

130.78(15)
134.04(15)
105.99(14)
76.99(12)
92.22(15)
88.41(15)
87.98(14)
89.81(14)
89.69(13)
177.01(14)
0.72

129.12(2)
133.70(2)
110.33(19)
77.00(18)
92.85(2)
87.10(2)
87.35(2)
88.63(18)
86.86(18)
172.64(17)
0.65

For a definition of the τ-value, see ref 98. A five-coordinate complex with ideal square-pyramidal
geometry would have a τ-value of 0.0, while those with ideal trigonal bipyramidal geometry would have
a value of 1.0.
a

Due to the tautomeric flexibility of the triol ligand, further studies were aimed at
the synthesis of the dehydro analog, namely [Fe(Ph2Tp)(HJ)] (11). We also generated the
Fe(II)/quinone complexes [Fe(Ph2Tp)(BrJ)] (12), [Fe(Ph2Tp)(HL)] (13) and [Fe(Ph2Tp)(ClL)]
(14). Complexes 11-14 were prepared under anaerobic conditions by mixing equimolar
amounts of the [(Ph2Tp)Fe(OBz)] precursor complex with the corresponding ligands
(HJH, BrJH, HLH and ClLH, respectively) treated with one equivalent of NaOMe in
DCM. Layering concentrated solutions of 11-14 with either MeCN or pentane afforded
crystals suitable for XRD analysis. Details concerning data collection and analysis are
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provided in Table 5.3 and selected bond lengths and angles for 11-14 are given in Table
5.1. As illustrated in Figure 5.5, all three complexes feature a 5C Fe(II) center bound
facially by the Ph2Tp ligand and the bidentate HJ, BrJ, HL or ClL napthoquinone-derived
ligands.

Figure 5.5. Thermal ellipsoid plots (50% probability) derived from the X-ray structures of
complexes 11-14. Non-coordinating solvent molecules, scorpionate-derived hydrogen
atoms and the Ph-rings at the 5-positions of the Ph2Tp ligand have been omitted for clarity.
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Comparison of the Fe-NTp bond lengths of complexes 11-14 indicate an average
value of 2.13 Å, characteristic of high spin, Fe(II) (S=2) centers. Further support for the
formation of ferrous complexes is demonstrated by the Fe-O3 distances which range
between 1.926 Å-1.963 Å, indicative of Fe(II)-phenolate units within 5C iron
complexes.96,97,112 Despite the weak donor ability of quinone ligands toward metal
centers, the presence of pendant anionic donors located on the bidentate ligand positions
the quinone in close proximity to the iron center, ultimately facilitating a binding
interaction. This observation is demonstrated by the bond distances found between the
Fe(II) center and the carbonyl moieties (Fe–O2, Table 5.1) of the naphthalene-derived
ligands, ranging from 2.062 Å-2.226 Å. The coordination geometry of 11, 12 and 13 are
closer to the trigonal bipyramidal limit (τ = 0.63, 0.62 and 0.72, respectively) with the
phenolate (O3) and carbonyl (O2) donors of the RJ-/RL- ligands bound in equatorial and
axial positions, respectively. Complexes 10 and 11 display very similar metric parameters
beyond the difference in the C2-C3 bond distance due to the varying degree of saturation
between the ligands. The donor ligands of 10, 11 and 12 form six-membered ring chelates
with the iron center whereas the RL-derived ligands form a five-membered chelate in 13
and 14 due to the varied position of the pendant hydroxyl donor.
In addition to complexes 11-14, the synthesis of a similar mononuclear
(Ph2Tp)Fe2+ species incorporating 1-hydroxyanthraquinone (AQ; 15) was synthesized.
While crystals suitable for X-ray diffraction analysis were unable to be isolated, an 1HNMR spectrum of 15 obtained in CD2Cl2 displays a number of paramagnetically shifted
and broadened peaks between δ -40-80 ppm, similar to the spectrum observed for 11,
confirming the presence of high-spin Fe(II) (S=2) centers in each complex (Figure 5.6).
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Figure 5.6. 1H-NMR spectra of complexes 11 and 15 in CD2Cl2.

5.B.ii. Spectroscopic and Electrochemical Investigation of Fe(II)-quinonate
Complexes

Electronic absorption spectra of complexes 10-15 are shown in Figure 5.7(a)-(c).
Complex 10; Figure 5.7(a). exhibits an intense feature at λmax = 343 nm (ε = 3.8 mM-1 cm1

) as well as a weak absorption manifold centered at 550 nm (ε = 0.6 mM-1 cm-1). The
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spectrum is strikingly similar to that obtained previously for the Fe(II)-HQate complexes
2 and 3 (Figure 2.8). This is not surprising, given the similar electronic structures of these
ligands which incorporate similar acetyl moieties. The lower energy band of this
spectrum is likely to arise from an Fe(II) → (2,3-H2J) MLCT transition whereas the
higher energy feature can be assigned to a ligand-based π → π* transition. The electronic
spectra of complexes 11-14 display similar band shapes; Figure 5.7(b)-(c), however these
naphthoquinone-based ligands exhibit lower energy bands compared to complex 10.
Complex 11 exhibits a deep-violet color in solution due to the presence of two absorption
bands at 510 and 910 nm ( = 5.7 and 2.4 mM-1 cm-1, respectively; Figure 5.7). Timedependent (TD) density functional theory (DFT) calculations attribute the lower-energy
band to a FeII  HJ- metal-to-ligand charge transfer (MLCT) transition while the higherenergy feature arises from an intraligand π  π* transition on HJ- (Figure 5.8).
Both transitions red-shift by approximately 700 cm-1 in the spectrum of 12
because of the presence of electron-withdrawing Br substituents. The absorption spectra
of complexes 13 and 14 bear resemblance to those of 11 and 12, however vary
significantly in band intensity. Complexes 13 and 14 exhibit intraligand transitions at λmax
= 448 nm ( = 1.5 mM-1 cm-1) and 473 nm ( = 2.7 mM-1 cm-1), respectively, while
simultaneously displaying broad, low energy features between 680-820 nm (mM-1
cm-1) likely representing weak FeIIRL- MLCT transitions.
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Figure 5.7. Electronic absorption spectra for complexes 10-15 obtained in CH2Cl2 at
20°C.
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Figure 5.8. Experimental (red, dashed line) and TD-DFT computed (black, solid line)
absorption spectra for complex 11. The experimental spectrum was measured at room
temperature in CH2Cl2. Electron density difference maps (EDDMs) for two computed
transitions are also provided. The blue and grey regions indicate gain and loss of electron
density, respectively.

Based on the structural similarity of the naphthoquinone- and anthraquinonederived ligands, it is reasonable that complex 15 displays an intense π  π* intraligand
transition at λmax = 471 nm (ε = 6.4 mM-1 cm-1) as well as a series of weaker features at
lower energy corresponding to Fe(II)→ quinone MLCT transitions: λmax = 666 nm (ε =
1.1 mM-1 cm-1) and λmax = 819 nm (ε = 1.5 mM-1 cm-1). Besides a slight blue shift in
energy, this data closely resembles the absorption spectra observed for 11 and 12. In
general, the MLCT bands displayed by complexes 11-15 appear at lower energies
compared to those of 10 due to the ability of quinones to act as better electron acceptors
with respect to acetyl moieties.
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To assess the feasibility of generating iron(II) semiquinonate species via oneelectron reduction, the electrochemical properties of complexes 11-15 were examined in
DCM solutions with 0.1 M [NBu4]PF6 as the supporting electrolyte. In each case, cyclic
voltammetry (CV) exhibits quasi-reversible one-electron oxidations between 0.07 – 0.33
V versus Fc+/0 (Figure 5.9), assigned to the Fe2+/3+ redox couple of each species based on
our experience with related complexes.112 At lower potentials, complex 11 displays a
quasi-reversible couple at -1.33 V and an irreversible peak at -1.97 V. A comparison to
redox potentials measured for 1,4-napthoquinone in MeCN (-1.11 V and -1.74 V)188
indicates that these low-potential events arise from successive one-electron reductions of
the HJ- ligand. The corresponding features in the CV of 12 are shifted to more positive
potentials by 0.23 V (Figure 5.9), reflecting the electron-poor nature of the BrJ- ligand. A
similar pattern is observed upon comparison of the RL- ligand-based reductions for
complexes 13 and 14; the first semireversible ligand redox event for 13 occurs at -1.37 V
while this feature is shifted to a more positive potential in the CV of 14 (-1.26 V) due to
the presence of the electron deficient ClL- ligand relative to HL-. Irreversible peaks are
observed for 13 and 14 at -2.12 V and -2.02 V. A list of all electrochemical data is
provided in Table 5.2.
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Figure 5.9. Cyclic voltammograms of 11-15 in CH2Cl2 with 0.1 M (NBu4)PF6 as the
supporting electrolyte. Each CV was collected at a scan rate of 0.1 V/s.

Similar redox potentials were observed in the CV of 15 (Figure 5.9, Table 5.2).
Two quasi-reversible couples were displayed at +0.073V and -1.56 V. An additional
irreversible peak was observed at -2.11 V. It is interesting to note that compared to the
complexes incorporating RJ- derived ligands (11 and 12), the redox events of 15 occur at
more negative potentials, highlighting the difference in electron density localized on the
naphthoquinone- and anthraquinone-derived ligands, respectively. The apparent ability of
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complexes 11-15 to undergo reduction at potentials lower than that of their respective
Fe(II)/Fe(III) redox couples correlates well with the increased ability of quinones to act
as excellent electron acceptors when bound to a metal center as previously demonstrated
by the low energy bands present in their absorption spectra (Figure 5.7).

Table 5.2. Redox potentials of complexes 11-15.
Complex
Solvent
Redox Potentialsb (V vs. Fc+/0)
11
CH2Cl2
E1/2 (ΔE) = -1.33 (0.15), +0.11 (0.14); Ep,c = -1.97 V
12

CH2Cl2

E1/2 (ΔE) = -1.10 (0.17), +0.20 (0.18); Ep,c = -1.76 V

13

CH2Cl2

E1/2 (ΔE) = -1.37 (0.17), +0.28 (0.16); Ep,c = -2.12 V

14

CH2Cl2

E1/2 (ΔE) = -1.26 (0.14), +0.33 (0.14); Ep,c = -2.02 V

15

CH2Cl2

E1/2 (ΔE) = -1.56 (0.17), +0.07 (0.17); Ep,c = -2.11 V

a

Conditions: solutions contained 100 mM (NBu4)PF6; scan rate of 100 mV s-1 at room temperature. b
E1/2 and ΔE values are provided for (quasi)reversible processes; Ep,c values are given for irreversible
reduction events.

5.B.iii. Acidification Reaction of Complex 11

Based on our electrochemical investigation of 11-15, we sought to generate novel
iron species bound to a semiquinonate ligand. Our initial studies involved the treatment
of 11 with acid, such as trifluoromethanesulfonic acid (HOTf) or HBF4∙O(CH2CH3)2,
which we predicted would lead to the protonation of the distal carbonyl moiety of HJ-,
facilitating an electronic rearrangement to the proposed semiquinone-oxidation level
(Figure 5.10). Due to protonation of ligand in absence of a chemical reductant, the target
complex is proposed to be a ferric-semiquinone species.
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Figure 5.10. Proposed reaction for acidification of 11 to form an Fe(III)-semiquinone
species.

Reaction of 11 with HOTf was monitored via UV-Vis spectroscopy. Initially, the
reaction was carried out in pure DCM but it was observed that the reaction products upon
addition of acid were not stable in solution. Further studies were carried out in methanol
solution or a 1:1 mixture of DCM/MeCN which allowed for formation of stable, yellow
species (11H+) at room temperature. The formation of 11H+ was observed to occur only in
the presence of MeOH or MeCN which seems to indicate a coordinating solvent is
necessary during reaction to stabilize the final product. The initial absorption spectrum of
11 in 1:1 DCM/MeCN displays an intense band at λmax = 507 nm (ε = 0.9 mM-1 cm-1) as
well as two broad features at λmax = 707 nm (ε = 0.3 mM-1 cm-1) and λmax = 908 nm (ε =
0.8 mM-1 cm-1). Upon acidification, a new band is observed at λmax = 425 nm (ε = 1.6
mM-1 cm-1). (Figure 5.11).
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Figure 5.11. Electronic absorption spectra of 11 and final acidification product [11]H+ in a
mixture of CH2Cl2/MeCN at room temperature.

Attempts to isolate solid material, especially crystalline solids, of [11]H+ were
unsuccessful. Additionally, we attempted to characterize [11]H+ by 1H-NMR, but all
collected spectra were contaminated with signals arising from the added acid or excess
solvent. In order to confirm the generation of the protonated species, [11]H+, rather than
potential complex degradation in solution, reversibility tests were carried out and
monitored via UV-Vis spectroscopy. Addition of 2 equivalents of HBF4∙O(CH2CH3)2 to
11 in methanol generated [11]H+. Subsequent addition of 6 equivalents of
tetrabutylammonium methoxide to the protonated species lead to the regeneration of 11.
Comparison of [11]H+ with protonation of a similar species containing carbonyl
donors in a β-position to the phenolate donor, namely [(Ph2Tp)Fe(2,3-dihydrojugalone)]
(10), was conducted via UV-Vis spectroscopy. The observed spectrum for 10 displayed a
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similar high energy band at λ=339 nm (ε = 3.9 mM-1 cm-1) upon treatment with HOTf
(Figure 5.12).

Figure 5.12. Electronic absorption spectra of complexes 10 and 11 treated with HOTf in
a 1:1 mixture of CH2Cl2/MeCN at room temperature.

Interestingly, complex 10 displayed a change upon acidification, which indicates
protonation must be occurring at either the proximal carbonyl donor or more likely, the
anionic phenolate donor, due to the lack of aromaticity within the 2,3-H2J ligand which
would prevent tautomerization upon addition of acid. We therefore surmised that [11]H+
does not coincide with our previously predicted ferric-semiquinonate intermediate.
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5.B.iv. Formation and Spectroscopic Analysis of Fe(II)-pSQ Species via OneElectron Reduction

In a further attempt to generate Fe-pSQ·- species, we proceeded to monitor the
reactivity of 11-15 with chemical reductants. Guided by the CV data we collected,
complexes 11, 13 and 15 were treated with one equivalent of CoCp*2 (E° = -1.94 V in
CH2Cl2), while the more-easily reduced complexes, 12 and 14, were treated with CoCp2
(E° = -1.33 V).189 The addition of reductants to solutions of 11-15 instantly generates
new chromophores (Xred). Complexes 11, 12 and 15 display two intense absorption
features in the near-UV region ( values of 8-10 mM-1 cm-1; Figure 5.13). In addition, 11
and 12 display a shoulder near 600 nm and a broad near-IR feature. Complexes 13 and 14
also display the formation of a single intense band upon addition of one equivalent of
reductant as well as a series of broad features at lower energies. According to further UVvis analysis, the features observed upon addition of reductant to generate the Xred species
of 11 and 12 do not arise from (decamethyl)cobaltocene or its oxidized derivative (Figure
5.14). The Xred species are stable for several minutes under anaerobic conditions and low
temperatures (<-30 °C) but decay rapidly at room temperature to the starting material.
The sizable intensities and sharp nature of the near-UV bands suggest they arise from
ligand-based π- π* transitions, consistent with transient absorption features in the same
region.132 Moreover, the Xred absorption spectra bear close similarities to the one reported
for Riordan’s FeII-oSQ·- complex.130
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Figure 5.13. Solid lines: Electronic absorption spectra of 11-15 in CH2Cl2 at room
temperature. Dashed lines: Spectra measured after the addition of 1 equiv of CoCp *2 (11,
13, 15) or CoCp2 (12, 14) at -30 °C in CH2Cl2 to give corresponding Xred species.
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Figure 5.14. Electronic absorption spectra of 11red (top) and 12red (bottom) in CH2Cl2 at 30 °C. Spectra of the cobaltocene reductants and their oxidized cobaltocenium derivatives
in CH2Cl2 are also shown. From this juxtapositon of spectra it is evident that the cobaltcontaining complexes are not responsible for the intense absorption features assigned to
the Xred species.

The X-band EPR spectra of 11 and 12 were obtained in order to study the
electronic structure of the reduced species. The spectrum of 12red, collected at 20 K in
frozen CH2Cl2, consists of two S = 5/2 signals, as is evident by the low-field peaks at g =
8.6 and 10.1 (Figure 5.15).
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Figure 5.15. X-band EPR spectrum of 12red in frozen CH2Cl2 at 20 K. The sharp feature
(*) arises from a radical impurity. Simulation of the data required two S = 5/2 species with
the following parameters: major (92%), D = -4.0 cm-1, E/D = 0.18, g = 2.0, 2.0, 2.1; minor
(8%), D = 1.6 cm-1, E/D = 0.33, giso = 2.0.

Simulation of the 12red data at multiple temperatures (Figure 5.16) determined
that the dominant S = 5/2 species, accounting for 92% of the total intensity, has a
negative D value and moderate rhombicity (E/D = 0.18). The minor S = 5/2 species is
highly rhombic, characteristic of FeIII ions in low-symmetry environments.
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Figure 5.16. X-band EPR spectra of 12red collected at various temperatures in frozen
CH2Cl2 solution. Experimental parameters: frequency = 9.387 GHz; microwave power =
2.0 mW; modulation amplitude = 10.0 Gauss; modulation frequency = 100 kHz. The sharp
feature at 334 mT (*) arises from a radical impurity. Simulation parameters are provided
in Figure 5.11.

This species accounts for the sharp feature at g = 4.3. Likewise, the 11red
spectrum (Figure 5.17) has contributions from major (88%) and minor (12%) S = 5/2
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species with spin-Hamiltonian parameters nearly identical with their 12red counterparts.
For both species, we propose that the major S = 5/2 signal corresponds to Xred, while the
minor signal is attributed to ferric impurities generated from trace amounts of O2. The
EPR results therefore suggest that the putative pSQ·- ligand is ferromagnetically coupled
to the high-spin FeII center.

Figure 5.17. X-band EPR spectrum of 11red in frozen CH2Cl2 at 20 K. Experimental
parameters: frequency = 9.387 GHz; microwave power = 2.0 mW; modulation amplitude
= 10.0 Gauss; modulation frequency = 100 kHz. The sharp feature at 334 mT (*) arises
from a radical impurity. Simulation of the data required two S = 5/2 species with the
following spin Hamiltonian parameters: major (88%), D = -3.0 cm-1, E/D = 0.18, g = 2.0,
2.0, 2.1; minor (12%), D = 1.6 cm-1, E/D = 0.33, giso = 2.0.

In addition, evidence for the generation of a ligand-based radical in complex 14
upon one-electron reduction observed via EPR spectroscopy. An X-band EPR spectrum
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of 14red was obtained at 20 K (Figure 5.18) and exhibits a similar S = 5/2 signal as
previously observed for species 11red and 12red, indicating the Cl-substituted 2hydroxynaphthoquinone ligand of 14 (3-chlorolawsone) is able to facilitate redox
reactions similar to those observed for the 5-hydroxynaphthoquinone ligands of 11 and
12 (HJ and BrJ, respectively), despite the difference in substitution position of the
phenolate donor.

Figure 5.18. X-band EPR spectrum obtained for [14]red in a frozen solution of CH2Cl2 at
20 K. The sharp feature at 334 mT (*) arises from a radical impurity.

5.B.v. Computational Analysis of Xred Species

Because we were unable to grow X-ray quality crystals of 11red and 12red,
structural models of the reduced species with S = 5/2 were derived from DFT
calculations; Table 5.3 compares the metric parameters for the 11/11red and 12/12red pairs
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of geometry-optimized models. One-electron reduction of 11 to 11red causes the O2-C4
and O1-C1 bonds to elongate by 0.049 and 0.033 Å, respectively. In addition, the
quinoidal character of the ligand is diminished because of the lengthening of the C2-C3
(by 0.037 Å) and comparable shortening of the C1-C2 and C3-C4 bonds. Similar
differences in the ligand bond lengths are observed for the 12/12red pair (Table 5.3). Such
dramatic changes in the O-C and C-C bond distances upon conversion of XXred are
indicative of a change in the ligand oxidation state from a closed-shell quinone to a
semiquinone radical.190 This conclusion is further supported by the Mulliken spin
populations of the iron center (3.78) and the HJ ligand (1.20) in the 11red model.

Table 5.3. Computed Bond Distances (Å) Obtained from DFT Geometry-Optimizations
of Complexes X and Xred (X = 11 or 12).
Bond
Distances
Fe1-N1
Fe1-N3
Fe1-N5
Fe1-O2
Fe1-O3
O1-C1
O2-C4
O3-C5
C1-C2
C2-C3
C3-C4
C4-C10
C9-C10
C1-C9
C5-C6
C5-C10
C6-C7
C7-C8
C8-C9

2.150
2.157
2.297
2.086
1.942

11red
(DFT)
2.218
2.190
2.491
2.031
1.914

1.222
1.251
1.298
1.474
1.366
1.471
1.444
1.423
1.491
1.423
1.430
1.373
1.402
1.380

1.255
1.300
1.323
1.434
1.373
1.422
1.451
1.430
1.481
1.404
1.437
1.391
1.383
1.399

11

0.068
0.033
0.194
-0.055
-0.028

12
(DFT)
2.135
2.148
2.294
2.101
19.45

12red
(DFT)
2.210
2.177
2.491
2.034
1.918

0.075
0.029
0.197
-0.067
-0.027

0.033
0.049
0.025
-0.040
0.037
-0.049
0.007
0.007
-0.010
-0.019
0.007
0.018
-0.019
0.019

1.216
1.242
1.298
1.496
1.347
1.494
1.445
1.420
1.489
1.424
1.434
1.373
1.402
1.381

1.245
1.285
1.319
1.448
1.380
1.434
1.451
1.424
1.481
1.405
1.439
1.388
1.385
1.398

0.029
0.043
0.021
-0.048
0.033
-0.060
0.006
0.004
-0.008
-0.019
0.005
0.015
-0.017
0.017

Δ

Δ
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In agreement with the EPR data, broken-symmetry (BS) calcuations found that
the iron- and ligand-based spins are ferromagnetically coupled, with computed J values
of ~65 cm-1 (H = -2JSA·SB). Moreover, absorption spectra computed using TD-DFT
nicely reproduce key features of the experimental spectra (Figure 5.19); in particular, the
calculations predict that each Xred model will display two pSQ-based π  π* transitions
in the near-UV region, resulting in an intense absorption band with λmax near 410 nm. The
computed spectra also exhibit a moderate FeII  pSQ·- MLCT band at 530 nm (11red) or
645 nm (12red).

Figure 5.19. (Left) Experimental (red, dashed line) and TD-DFT computed (black, solid
line) absorption spectra for 11red and 12red. The experimental spectra were measured at 30 °C in CH2Cl2. (Right) Electron density difference maps (EDDMs) for three transitions
in the computed 11red spectrum. The blue and grey regions indicate gain and loss of
electron density, respectively.
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5.B.vi. Resonance Raman Spectroscopic Studies of Xred

Direct evidence for the presence of a semiquinonate ligand in the 11red/12red
complexes was provided by rR studies. The rR spectrum of 11red (Figure 5.20) displays
an intense peak at 1392 cm-1 that is not evident in the precursor spectrum; 2red exhibits a
similar feature at 1382 cm-1 (Figure 5.21). Both peaks are strongly enhanced by
excitation into the near-UV absorption bands. Coordinated SQ radicals typically display
an intense peak in the 1400-1500 cm-1 region that arises primarily from stretching
motions of the C-O bonds.136, 139, 184 While the observed 11red and 12red frequencies fall
slightly below this range, the C-O bonds of the semiquinonate ring are likely weakened
by charge donation from the phenolate moiety of the RJ2- ligand. This conclusion is
supported by DFT frequency calculations with the 11red mode, which predict a mode at
1407 cm-1 with mixed (C-O) and ring breathing character (Figure 5.22).
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Figure 5.20. rRaman spectra obtained with 413.1 nm excitation (40 mW) of 11red (black;
top) and 11 (red; bottom) in frozen CD2Cl2 solutions. Peaks with an asterisk (*) arise from
solvent.

Figure 5.21. rRaman spetra obtained with 413.1 nm excitation (40 mW) of 12red (black;
top) and 12 (red; bottom) in frozen CD2Cl2 solutions. Peaks marked with an asterisk (*)
arise from solvent.
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Figure 5.22. Pictorial representation of mixed (C-O) and ring breathing character at a
predicted mode of 1407 cm-1 as derived from DFT frequency calculations.

Further evidence that the newly observed peak at 1392 cm-1 in the rRaman
spectrum of 11red arises from the formation of a ligand-based radical, a spectrum of 11red
upon warming the original sample to room temperature was taken, resulting in the
decomposition of this species (Figure 5.23). Upon warming to room temperature, the
sample was refrozen and rR data was collected under the same conditions as the initial
11red spectrum. The new spectrum indicates that the peak at 1392 cm-1 is dramatically
diminished in the “decomposed” trial, indicating that it arises from 11red not CoCp*2 or
[CoCp*2]+. Interestingly, the rRaman spectrum of 14red did not provide direct evidence
for the formation of a ligand-based radical as observed for the analogous complexes
incorporating juglone ligands (11red and 12red) due to the varied position of the phenolate
donor of the lawsone-derived ligand of 14/14red.
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Figure 5.23. (a) Resonance Raman spectrum of 11red obtained with 413.1 nm excitation
(40 mW). (b) Spectrum obtained after warming sample to room temperature, resulting in
the decomposition of 11red.

5.B.vii. Nitric Oxide Reactivity Studies of Complex 11

In an effort to generate a comprehensive model of an enzymatic Fe/O2·--radical
intermediate, we chose to employ nitric oxide as a functional model of dioxygen. Upon
treatment of the ferrous precursor complex 11 in DCM solutions with nitric oxide we
observed formation of a new purple-brown species that is stable at room temperature
under anaerobic conditions (Figure 5.24).
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Figure 5.24. Comparison of UV-vis absorption spectra of 11 and species formed upon
bubbling NO through a solution of 11 in DCM at room temperature (11 + NO).

Direct evidence for formation of an Fe-NO adduct upon addition of gaseous nitric
oxide to DCM solutions of 11 was derived from the use of FTIR spectroscopy. Figure
5.25 displays a new peak at ~1740 cm-1 upon bubbling NO through a sample of 11 for
several minutes in DCM. Isotopic labelling studies using 15NO were completed and FTIR
indicated a reasonable isotopic shift of ~32 cm-1 (1708 cm-1) for 1115NO. XRD quality
crystals of 11NO were obtained by bubbling NO through a concentrated solution of 11 in
for five minutes and transferring the sample to a -10 °C freezer to initiate crystallization.
Despite significant disorder in the juglone ligand, XRD indicates the binding of NO to
the iron center with an Fe-NNO distance of 1.797 Å (Figure 5.26).
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Figure 5.25. Solution FTIR spectra of 11 and the NO adducts formed upon bubbling either
NO (red spectrum) or 15NO (green spectrum) through a CH2Cl2 solution of 11 at room
temperature.

Figure 5.26. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
complex 11NO. Non-coordinating solvent molecules, scorpionate-derived hydrogen atoms
and the Ph-rings at the 5-positions of the Ph2Tp ligand have been omitted for clarity.
Selected bond lengths (Å) and angles (°): Fe1–O2 2.000(16), Fe1–O3 2.041(15), Fe1–N1
2.210(17), Fe1–N3 2.163(18), Fe1–N5 2.148(17), Fe1-NNO 1.799(19), O3–Fe1–N1
86.0(7), O3–Fe1–N3 165.5(7), O3–Fe1–N5 96.6(7), O2–Fe1–N1 88.9(6), O2–Fe1–N3
89.9(6), O2–Fe1–N5 176.7(7), N1–Fe1–N3 82.0(7), N1–Fe1–N5 89.2(6), N3–Fe1–N5
87.1(7).
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In our effort to trap biologically relevant reactive intermediates similar to those
proposed to exist in the catalytic mechanism of the HQDOs, we predicted that treatment
of the NO adduct of 11 with one equivalent of an appropriate chemical reductant would
generate an NO-Fe-SQ·- type species. We first aimed to generate this species by a
stepwise treatment of 11 with NO, followed by addition of one equivalent of a chemical
reductant. Upon addition of CoCp*2 to the NO adduct of 11, it is clear that a new species
is formed as evidenced by UV-vis absorption spectroscopy. However, upon further
analysis of this data, we confirmed that reaction of excess NO with CoCp*2 lead to the
generation of the newly observed chromophore rather than formation of the predicted
ligand-based radical (Figure 5.27).

Figure 5.27. UV-vis absorption spectra of 11 treated with NO at -70 °C and a combination
of NO and CoCp*2 in THF. Data obtained from a control experiment in which CoCp*2 was
added to a solution of THF treated with nitric oxide is included for comparison.
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In an attempt to avoid reaction of NO with CoCp*2, we sought to utilize an organic
chemical reductant rather than a metal-based one, specifically sodium naphthalenide. UVvis spectroscopy indicated treatment of 11 with 5 equivalents of sodium napthalenide in
THF at room temperature allowed for conversion of 11 to 11red in THF. However, upon
treatment of 11red with nitric oxide, UV-vis spectroscopy seemed to indicate loss of the
electron, leading to generation of previously observed NO-bound form of 11 (Figure 5.28).

Figure 5.28. UV-vis absorption spectra indicating the formation of 11red upon addition of
5 equivalents of sodium napthalenide to 11 in THF at room temperature (solid line). NO
was then bubbled through the solution, resulting in formation of the Fe-NO adduct (dashed
line).

We therefore attempted to treat a solution of the previously isolated Fe-NO
adduct, 11NO, with sodium napthalenide in THF. Unfortunately, upon monitoring the
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reaction via UV-vis spectroscopy, we observed that the addition of reductant to 11NO
caused the complex to revert back to the precursor ferrous complex, 11 (Figure 5.29).

Figure 5.29. The addition of 5 equivalents of sodium napthalenide to 11NO in THF at -40
°C seems to cause the complex to release NO and revert to starting material.

5.C. Conclusion

In this chapter, we reported the synthesis and structural analysis of a series of
mononuclear ferrous complexes that incorporate a variety of substituted 1,4naphthoquinone ligands (11-14). In order to facilitate a binding interaction between the
iron center and the quinone moiety, each naphthoquinone ligand includes an anionic
group pendant to a carbonyl donor of the quinone unit. Each complex features a 5C highspin ferrous center supported facially by the Ph2Tp scorpionate ligand and incorporates a
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naphthoquinone ligand (HJ, BrJ, HL or ClL) bound in a bidentate fashion. A similar
mononuclear complex featuring 1-hydroxyanthraquinone (15) as a ligand donor was
synthesized, but crystals suitable for X-ray structural analysis were unable to be isolated.
The electrochemical and spectroscopic properties of complexes 11-15 were
investigated in order to explore their propensity to undergo a 1 electron reduction in order
to generate biologically-relevant FeII-pSQ·- species. We observed that treatment of
complexes 11 and 12 with strong 1 electron reductants gives rise to species, Xred, with
coordinated pSQ·- radicals ferromagnetically coupled to the high spin ferrous centers.
A similar procedure was used in an attempt to generate a similar Fe-pSQ species
from 15, which incorporates a substituted anthraquinone ligand. While similar absorption
features are displayed in the UV-vis spectrum of 15 upon treatment with 1 equivalent of
CoCp(*)2, further spectroscopic confirmation of this electronic assignment has not been
completed. In addition, complexes 13 and 14 were included in this study to explore the
effects of the position of the phenolate donor with respect to the carbonyl moiety of the
naphthoquinone ligand. Rather than utilize a juglone-derived ligand, complexes 13 and
14 instead incorporate lawsone-derived ligands (HL and ClL) which incorporate a
hydroxyl donor at the 2-position of the naphthoquinone ring. As demonstrated by UV-vis
absorption spectroscopy, each complex displays new sharp features upon addition of an
appropriate chemical reductant. The generation of a ligand-based radial, specifically in
14red, is supported by an X-band EPR spectrum of CoCp2 which displays an S = 5/2
signal, similar to that observed for 11red and 12red. Unfortunately, rRaman spectroscopy
did not provide evidence for the presence of a ligand-based radical as the measured
spectra did not indicate resonance enhancement of any observed modes upon chemical
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reduction of 14. This could be due to the varied substitution of the lawsone-derived
ligand with respect to the juglone ligands of 11 and 12, and further characterization is
required to confirm the presence of a ClL-based radical.
Additional studies were focused on the generation of biologically-relevant
intermediates, with regards to the reactive intermediates of the HQDOs, by the stepwise
treatment of the Fe(II)-quinonate precursor 11 with nitric oxide and an appropriate
chemical reductant. Up to this point in time, we have not been able to identify an
appropriate method of preparation and future studies should focus on the determination of
a more suitable chemical reductant.
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Table 5.4. Summary of X-ray Crystallographic Data Collection and Structure Refinement of Complexes 10-14.
10
empirical formula
formula weight
crystal system
space group
a, Å
b, Å
c, Å
, deg
deg
, deg
V, Å3
Z
Dcalc, g/cm3
, Å
mm-1
 -range, deg
reflections collected
independent reflections

C55H41BFeN6O2
900.60
Monoclinic
P21/n
10.3510(2)
31.0420(7)
13.5971(3)
90
93.6876(19)
90
4359.94(16)
4
1.372
1.5418
3.208
7 to 148
24148
8558
[Rint = 0.0414]

11
C55H39BFeN6O3
898.58
Monoclinic
P21/n
10.4080(3)
30.9033(9)
13.4858(4)
90
91.703(3)
90
4335.7(2)
4
1.377
0.7017
0.403
7 to 59
32339
10656
[Rint = 0.0300]

data / restraints /
8558/12/635
10656/12/644
parameters
GOF (on F2)
1.022
1.039
a
R1/wR2 (I > 2(I))
0.0434 / 0.1038
0.0409 / 0.0922
R1/wR2 (all data)
0.0532 / 0.1104
0.0524 / 0.0993
a
R1 =  ||Fo|  |Fc|| / |Fo|; wR2 = [w(Fo2  Fc2)2 / w(Fo2)2]1/2

12∙DCE
C57H41BFeN6O3Br2Cl2
1155.34
Monoclinic
P21/n
9.7856(14)
37.3826(4)
13.4121(14)
90
92.196(12)
90
4902.7(10)
4
1.565
1.5418
5.811
7 to 147
46439
9717
[Rint = 0.0456]

13∙2(MeCN)
C59H45BFeN8O3
980.69
Orthorhombic
Pna21
36.3957(5)
9.82077(13)
13.53469(17)
90
90
90
4837.8(11)
4
1.346
1.5418
2.949
7 to 148
34799
9487
[Rint = 0.0588]

14·2(DCM)
C57H42BFeN6O3Cl5
1102.88
Monoclinic
Pc
13.4477(7)
9.8666(6)
97.8770(3)
90
90.882(7)
90
5025.0(6)
4
1.458
0.7017
0.620
5 to 59
34047
34047
[Rint = 0.0000]

9717/0/649

9487/1/624

34047/695/1318

1.142
0.0647/0.1598
0.0691/0.1624

1.024
0.0660 / 0.1551
0.0737 / 0.1606

1.034
0.0822/0.2083
0.1094/0.2245
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5.D. Experimental

5.D.i. General methods

Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Acetonitrile and dichloromethane were
purified and dried using a Vacuum Atmospheres solvent purification system. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox. The ligands K(Ph2Tp)103, 1,4,5naphthalenetriol191-192, 2,3-dibromojuglone193 as well as the precursor complex
[(Ph2Tp)Fe(OBz)]93 and chemical reductant sodium naphthalenide189 were prepared
according to literature procedures. Elemental analyses were performed at Midwest
Microlab, LLC in Indianapolis, IN. UV-vis absorption spectra were obtained with an
Agilent 8453 diode array spectrometer equipped with a cryostat from Unisoku Scientific
Instruments (Osaka, Japan) for temperature control. Fourier-transform infrared (FTIR)
spectra of solid samples were measured with a Thermo Scientific Nicolet iS5 FTIR
spectrometer equipped with the iD3 attenuated total reflectance accessory. All solution
FTIR data was collected using a Thermo Scientific Nicolet spectrophotometer (Model
670 Nexus) with an MCT detector. 1H spectra were collected at room temperature with a
Varian 400 MHz spectrometer. EPR experiments were performed using a Bruker
ELEXSYS E600 equipped with an ER4415DM cavity resonating at 9.63 GHz, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat.
Electrochemical measurements were conducted in the glovebox with an epsilon EC
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potentiostat (iBAS) at a scan rate of 100 mV s−1 with 100 mM (NBu4)PF6. A threeelectrode cell containing a Ag/AgCl reference electrode, a platinum auxiliary electrode,
and a glassy carbon working electrode was employed for cyclic voltammetric (CV)
measurements. Under these conditions, the ferrocene/ferrocenium (Fc+/0) couple has an
E1/2 value of +0.52 V in CH2Cl2.

5.D.ii. Synthetic Procedures

[Fe(Ph2Tp)(H2J)] (10): In glove box, 367 mg of [(Ph2Tp)Fe(OBz)] (0.43 mmol) was
combined with 77.6 mg of 1,4,5-naphthalenetriol in DCM and stirred overnight. Once
reaction had completed, mixture was filtered through celite to isolate a purple solution.
Layering with MeCN yielded purple crystals suitable for X-ray diffraction (261mg) Yield
= 67%. Anal. Calcd* for C55H41BFeN6O3 (MW = 900.60 g mol-1): C, 73.35; H, 4.59; N,
9.33. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 343 (3830).
[Fe(Ph2Tp)(HJ)] (11): Under an inert atmosphere, 79.0 mg (0.45 mmol) of 5-hydroxynaphthoquinone (HJH) was stirred for 5 minutes with 1 equivalent of NaOMe in CH2Cl2 ,
at which point a solution of [(Ph2Tp)Fe(OBz)] (377 mg, 0.45 mmol) in CH2Cl2 was added
to the reaction vial. After stirring overnight, the solution was filtered through celite and
the resulting solution was layered with MeCN to provide dark violet crystals suitable for
X-ray diffraction (249 mg). Yield = 62%. Anal. Calcd. for C55H39BFeN6O3 (MW = 898.58
g mol−1): C, 73.51; H, 4.37; N, 9.35. Found: C, 73.24; H, 4.47; N, 9.41. UV-vis [λmax, nm
(ε, M−1 cm−1) in CH2Cl2]: 510 (5230), 910 (2460). FTIR (cm-1): 2961, 2618 [(BH)],
1654 [(C=O)], 1618, 1418, 1165, 802, 754, 691, 666. μeff = 4.79 μB
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[Fe(Ph2Tp)(BrJ)] (12): The synthesis of complex 12 followed the same procedure as the
one described above for 11, with the exception that 2,3-dibromojuglone (BrJH) was
substituted for 5-hydroxynaphthoquinone. Reddish-violet crystals were isolated by
layering a 1,2-dichloroethane (DCE) solution of the crude solid with pentane. Yield =
54%. Anal. Cald. for C55H37BBr2FeN6O3 (MW = 1056.38 g mol-1): C, 62.53; H, 3.53; N,
7.96. Found: C, 62.01; H, 3.63; N, 7.68. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 528
(5240), 974 (2620). FTIR (cm-1): 3038, 2601 [(BH)], 1653 [(C=O)], 1589, 1414, 1163,
811, 758, 691, 665. μeff = 4.91 μB
[Fe(Ph2Tp)(lawsone)] (13): Under an inert atmosphere, 120 mg of [(Ph2Tp)Fe(OBz)] (0.2
mmol) was dissolved in 10 mL of DCM and combined with an equimolar amount of
lawsone (27 mg; 0.2 mmol) in approximately 5 mL of MeOH. The reaction was stirred
overnight. Solvent was then removed under vacuum and the resulting solid was dried.
The product was taken up in 1,2,-dichloroethane and filtered through celite. Layering
with MeCN yielded feathery green crystals suitable for X-ray diffraction. Anal. Calcd.*
for C55H39BFeN6O3∙2MeCN (MW = 980.69 g mol−1): C, 72.26; H, 4.63; N 11.43. UV-vis
[λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 449 (3250), 613 (650), 682 (850), 788 (460).
[Fe(Ph2Tp)(3-chlorolawsone)] (14): Complex 14 was synthesized in a manner similar to
13 except that 3-chlorolawsone was used in place of lawsone. Dark brown needles
suitable for X-ray diffraction were isolated from layering a concentrated solution of 14 in
DCM with hexane. Anal. Calcd.* for C55H38BFeN6O3Cl (MW = 933.05 g mol−1): C, 70.80;
H, 4.11; N, 9.01. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 473 (3080), 648 (700), 691
(820), 830 (410).
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[Fe(Ph2Tp)(1-HAQ)] (15): In glove box, 378 mg of [(Ph2Tp)Fe(OBz)] (0.5 mmol)
dissolved in 10 mL of DCM. To this solution, 106 mg of 1-hydroxyanthraquinone (0.5
mmol) in 5 mL of MeOH was added. Once the reaction was stirred overnight, the solvent
was removed and the resulting solid was dried. The product was taken up in 1,2dichloroethane and filtered through celite. All attempts to isolate crystalline material have
proven to be unsuccessful. (Predicted MW = 948.64 g mol-1). UV-vis [λmax, nm (ε, M−1
cm−1) in CH2Cl2]: 474 (6460), 670 (1150), 828 (1490).
Generation of Xred species. Under anaerobic conditions, 4 mL of a 0.32 mL solution of
11 (or 12) in CH2Cl2 was added to a quartz cuvette equipped with a stir bar. The cuvette
was sealed with a rubber septum and transferred to an Agilent 8453 diode array UV-vis
spectrometer, where it was cooled to -30 °C in the cryostat. Using a gas-tight syringe,
200 μL of CoCp2 (or CoCp*2) in air-free MeCN (9 mM, 1.5 eq) was injected into the
cuvette and the formation of Xred was monitored at low temperature. To prepare
resonance Raman samples, more concentrated solutions of 11 or 12 (~5 mM) in CD2Cl2
were added to solid CoCp2 (or CoCp*2) at -40 °C under anaerobic conditions. After
formation of the Xred species, the solutions were rapidly transferred to cooled NMR tubes
and immediately frozen in liquid N2.

5.D.iii. Crystallographic studies

Each complex was characterized with X-ray crystallography; details concerning
the data collection and analysis are summarized in Table 5.4. The X-ray diffraction data
were collected at 100 K with an Oxford Diffraction SuperNova kappa-diffractometer
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equipped with dual microfocus Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD
detector and a low-temperature Cryojet device. The data were processed with
CrysAlisPro program package (Oxford Diffraction Ltd, 2010) typically using a numerical
Gaussian absorption correction (based on the real shape of the crystal) followed by an
empirical multi-scan correction using SCALE3 ABSPACK routine. The structures were
solved using the SHELXS program and refined with the SHELXL program105 within the
Olex2 crystallographic package.106 All computations were performed on an Intel PC
computer with Windows 7 OS. Some structures contain disorder that was detected in
difference Fourier syntheses of electron density and accounted for using capabilities of
the SHELX package. In most cases, hydrogen atoms were localized in difference
syntheses of electron density but were refined using appropriate geometric restrictions on
the corresponding bond lengths and bond angles within a riding/rotating model (torsion
angles of methyl hydrogens were optimized to better fit the residual electron density).

5.D.iv. DFT Computations

DFT calculations were performed using the ORCA 2.9 software package
developed by Dr. F. Neese (MPI for Chemical Energy Conversion).194 All calculations
employed Becke’s three-parameter hybrid functional for exchange along with the LeeYang-Parr correlation functional (B3LYP).156-157 These calculations utilized Ahlrichs’
valence triple-ζ basis set (TZV) snf TZV/J auxiliary basis set, in conjunction with
polarization functions on all atoms.160-162 In the geometry optimized models, the Ph2Tp
ligand was modified by replacing the Ph-groups on the 5-position of the imidazolyl rings
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with H-atoms. To avoid spurious transitions, time-dependent DFT (TD-DFT) calculations
used a truncated version of the optimized model with Me groups (instead of Ph groups) at
the 3-positions of the pyrazolyl rings. TD-DFT calculations163-165 calculated absorption
energies and intensities for 50 excited states with the Tamm-Dancoff approximation.166167

Vibrational frequency calculations were performed using truncated models with

hydrogen atoms at the 3- and 5-positons of the Tp ligand. Calculation of the harmonic
force fields proved that the optimized structure is a local minimum on the potential
energy surface. Exchange coupling constants (J) were obtained using Noodleman’s
broken symmetry approach (H = -2JSA·SB).195-196 Isosurface plots of molecular orbitals
and electron-density maps (EDDMs) were prepared with Laaksonen’s gOpenMol
program.168
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Chapter 6

Preparation of a Semiquinonate-Bridged Diiron(II)
Complex and Elucidation of its Geometric and
Electronic Structures

Abstract: The synthesis and crystal structure of a diiron(II) complex containing a
bridging semiquinonate radical are presented. The unique electronic structure of this S =
7/2 complex is examined with spectroscopic (absorption, EPR, resonance Raman) and
computational methods.

Reproduced in part with permission from Baum, A. E.; Lindeman, S. V.; Fiedler, A. T.
Chem. Commun. 2013, 49, 6531-6533. Copyright 2013 Royal Society of Chemistry.
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6.A. Introduction

p-Hydroquinone (1,4-dihydroxybenzene; HQ) and its substituted derivatives are
important biological cofactors due to the ability to participate in multiple proton- and
electron-transfers.152, 197 HQs undergo reversible one- and two-electron oxidations to
yield semiquinone radicals (SQs) and quinones (Qs), respectively. These redox events
typically involve loss of proton(s), such that the net reaction is H-atom transfer.99, 198 In
biochemical processes, HQ cofactors are often associated with one or more redox-active
metal ions. For instance, photosystem II incorporates two quinones (QA and QB) that
shuttle electrons away from the primary electron donor, P680.187, 199 In close proximity to
both quinones is a nonheme mononuclear Fe center, and recent spectroscopic studies
have detected significant magnetic interactions between the high-spin Fe(II) center and
semiquinone forms of QA and QB.200-201 In addition, substituted HQs are generated as part
of the microbial breakdown of halogenated and nitro aromatic compounds. In these cases,
the HQs are oxidatively degraded by ring-cleaving dioxygenases (HQ dioxygenases,
HQDOs) with nonheme monoiron active sites.6 Even in these enzymes the electroactive
nature of HQs is critical, since the key intermediate in the putative catalytic cycle is a
superoxo–Fe(II)–semiquinonate complex.52
In the course of our efforts to develop synthetic models of HQDOs, we have
prepared the diiron(II) complex [Fe2(Ph2Tp)2(μ-DMHQ)] (5; Figure 6.1), where DMHQ is
the dianion of 2,5-dimethoxyhydroquinone andPh2Tp is hydrotris(3,5-diphenylpyrazol-1yl)-borate(1-).112
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Figure 6.1. Schematic representation of the structure of the diiron(II) complex, 5,
formulated as [(Ph2Tp)2Fe2(μ-DMHQ)].

X-ray diffraction (XRD) analysis revealed that 5 is a centrosymmetric complex
with two high-spin, five-coordinate Fe(II) centers linked by a closed-shell phydroquinonate ligand (the Fe Fe separation is 8.15 Å). We examined the magnetic and
electrochemical properties of 1 and observed that the one-electron oxidation of 5 yields a
unique diiron(II) complex, [5b]+, containing a bridging p-semiquinonate ligand
(DMSQ˙−). The geometric and electronic structures of [5b]+ are verified on the basis of
crystallographic, spectroscopic, and computational methods. To the best of our
knowledge, [5b]+ is the first crystallographically-characterized complex to feature Fe(II)
center(s) bound to a SQ radical.a,70 The results therefore have the potential to advance our
fundamental understanding of metal–SQ interactions in biological systems. Moreover,
dinuclear complexes with “noninnocent” bridging ligands have attracted considerable
attention lately due to their novel electronic and magnetic behavior;202-204 this chapter
contributes a new member to this fascinating class of compounds.

a

Min et al. reported a diiron(II) complex bridged by a chloranilate radical (ref. 176). However, this
complex did not provide suitable crystals for X-ray crystallography.
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6.B. Results and Discussion

6.B.i. Synthesis and Characterization of a Diiron(II)-hydroquinonate Complex

Complex 16 is easily generated by mixing equimolar amounts of FeCl2 and
K(Ph2Tp) with 0.5 equiv. of Na2(DMHQ) in MeCN, followed by recrystallization from
CH2Cl2/Et2O.112 The 1H NMR spectrum of 5 in CD2Cl2, (shown in Figure 6.2) reveals an
abundance of paramagnetically-shifted peaks between δ = +60 and −20 ppm. Using the
Evans method, an effective magnetic moment (μeff) of 6.3 μB was measured at room
temperature for 5, which is reasonably close to the spin-only value of 6.93 μB expected
for a molecule with two uncoupled high-spin (S = 2) Fe(II) centers. Consistent with this
result, broken symmetry (BS) calculations196 using density functional theory (DFT)
computed a J-value (exchange coupling parameter) of −2 cm−1 for 5, indicative of very
weak antiferromagnetic interactions.205
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Figure 6.2. 1H NMR spectrum of 5 in CD2Cl2. Peak intensities for the outer portions of
the spectra were enlarged (X 2) for the sake of clarity. The solvent-derived peak is
indicated with an asterisk(*).

The redox activity of 5 was examined in CH2Cl2 with 0.1 M [NBu4]PF6 as the
supporting electrolyte. The cyclic voltammogram (CV) exhibits a reversible couple
at E1/2 = −570 mV versus Fc+/0 (ΔE = 130 mV), along with several irreversible events at
more positive potentials (Figure 6.3). It is instructive to compare this CV to the one
reported previously for [Fe(Ph2Tp)(2-MHQ)] (4; where 2-MHQ is the anion of 2methoxyhydroquinone).
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Figure 6.3. Cyclic voltammograms of complex 5 measured in CH2Cl2 with 100 mM
(NBu4)PF6 as the supporting electrolyte and a scan rate of 100 mVs-1

Even though 5 and 4 feature nearly identical Fe coordination environments, the
latter complex is oxidized at a much higher potential (−50 mV).112 We therefore surmised
that the −570 mV redox couple of 5 corresponds to a ligand-based event.

6.B.ii. Isolation and Characterization of a Semiquinonate-Bridged Diiron (II)
Complex via One-Electron Oxidation

To explore this possibility, complex 5 was treated with 1.0 equivalent of AgPF6 in
CH2Cl2. The resulting orange-brown species, [5b]+, displays two intense absorption
features with λmax = 365 and 440 nm (ε= 13.2 and 8.0 mM−1 cm−1, respectively), along
with shoulders at

480 and 540 nm (Figure 6.4). Needle-like crystals of [5b]PF6 were

obtained by layering a concentrated CH2Cl2 solution with pentane.
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5
[5b]PF6

Figure 6.4 Electronic absorption spectra of 5 and [5b]PF6 measured in CH2Cl2 at 20 °C.

The X-ray structure of [5b]+ reveals a centrosymmetric diiron unit with the same
atomic composition as 5 (Figure 6.5) Metric parameters for both complexes are provided
in Table 6.1. The average Fe–NTp bond length of [17]+ (2.094 Å) is only slightly shorter
than the value observed for 5 (2.143 Å), suggesting that both Fe centers belong to the
ferrous state. The Fe coordination environments are distorted between trigonalbipyramidal and square pyramidal (τ98 = 0.34). The most dramatic structural changes
upon conversion of 5 → [5b]+ involve the bridging ligand. In the crystal structure of 5,
the C–C bond lengths of the DMHQ2− ligand are essentially identical (1.391 ± 0.004 Å)
and the O1–C1 distance is 1.329(5) Å – typical values for p-hydroquinonate anions.112 By
contrast, the corresponding ring in [5b]+ displays a pronounced quinoid distortion
involving elongation of the C1–C2 and C1–C3 bonds and shortening of the C2–C3 bond.
In addition, the O1–C1 distance of [5b]+ contracts to 1.287(2) Å (Table 6.1). Such metric
parameters require a semiquinone assignment for the bridging ligand in [5b]+, based on
well-established guidelines for the evaluation of dioxolene oxidation states.136, 206-207
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Thus, the X-ray diffraction data support our hypothesis that oxidation of 5 is a ligand
based process, such that [5b]+ is best formulated as [(Fe2+)2(Ph2Tp)2(μ-DMSQ)]+.

[5b]PF6

Figure 6.5. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[5b]PF6∙CH2Cl2. Non-coordinating solvent molecules and hydrogen atoms have been
omitted for clarity. Key metric parameters are provided in Table 6.1.
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Table 6.1. Experimental and computed bond distances (Å) for 5 and [5b]+ b

Fe1–N1
Fe1–N3
Fe1–N5
Fe1–O1
Fe1–O2
O1–C1
O2–C2
C1–C2
C1–C3
C2–C3
τ-Value98

5 (XRD)
2.107(4)
2.108(3)
2.213(4)
1.904(3)
2.328(3)
1.329(5)
1.388(6)
1.395(7)
1.388(6)
1.389(7)
0.59

[5b]PF6 (XRD)
2.125(2)
2.076(2)
2.082(2)
1.940(1)
2.403(1)
1.287(2)
1.358(2)
1.446(2)
1.415(2)
1.366(2)
0.34

[5b]PF6 (DFT)
2.072
2.051
2.067
1.909
2.682
1.303
1.360
1.449
1.419
1.381
0.74

The electronic structure of [5b]PF6 was examined with spectroscopic and computational
techniques. The X-band EPR spectrum exhibits a peak at geff = 13.9 and a derivativeshaped feature at geff = 5.4 (Figure 6.6). Since half-integer spin systems cannot give rise
to features with geff > 4S (assuming real g-values near 2.0),208 the EPR results suggest that
[5b]+ possesses a spin of 7/2. Indeed, as shown in Figure 6.6, the data is nicely simulated
assuming S = 7/2 and the following spin-Hamiltonian parameters: D = +7(2) cm−1, E/D =
0.11(2), and greal = 2.3, 2.2, 2.1.c

b
c

Both 5 and [5b]PF6 are centrosymmetric compounds.
Attempts to reproduce the data assuming a spin of 5/2 required unrealistically large greal values.
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Figure 6.6. X-band EPR spectrum of [5b]PF6 in a frozen CH2Cl2 solution (4 mM)
collected at 10 K. Parameters used to generate the simulated spectrum are provided in the
text.

These values were obtained by fitting EPR spectra measured at temperatures
ranging from 5 to 20 K. The g = 13.9 peak therefore arises from the lowest-energy MS =
±1/2 doublet, while the derivative signal at 5.4 is due to the MS = ±3/2 doublet;109 as
expected, the former diminishes at higher temperatures while the latter gains in relative
intensity (Figure 6.7).
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Figure 6.7. X-band EPR spectra of [5b]PF6 at various temperatures (5, 10, 15 and 20 K)
in frozen CH2Cl2 solution (4 mM). Experimental parameters: frequency = 9.38 GHz;
microwave power = 2.0 mW; modulation amplitude = 10.0 Gauss; modulation frequency
= 100 kHz.

The electronic origin of this unique EPR signal was elucidated with the aid of
DFT. Using the crystallographic coordinates, a calculation with S = 7/2 converged to a
wavefunction consisting of two high-spin Fe(II) centers antiferromagnetically coupled to
the bridging DMSQ radical (Figure 6.8, left). Geometry optimizations indicate that this
electronic configuration is the most stable one on the S = 7/2 surface (bond distances for
the optimized model are shown in Table 6.1). A J-value of −83 cm−1 per Fe–DMSQ
interaction was computed using the BS formalism.d Thus, unlike the closed-shell DMHQ
ligand, the bridging radical in [5b]+ is capable of mediating significant exchange

d

Experimentally, the variable-temperature EPR data (Figure 6.6) provides a lower-limit for the J-value.
Since a signal from the S = 5/2 excited state is not observed in the 20 K spectrum, we can assume its
population is less than ~ 1% at this temperature. This requires a J-value greater than -40 cm-1.
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interactions between the Fe-based spins, which are separated by 8.22 Å in the crystal
structure. A similar spin topology was observed by Dei and Gatteschi for
a diferric complex containing a bridging SQ ligand.69 In this case, the overall spin is 9/2
and the J-value is considerably larger at −370 cm−1.

Figure 6.8. (Left) Spin coupling topology for [5b]+ that gives rise to overall spin of 7/2.
(Right) DFT-generated isosurface plot of the [5b]+ SOMO.

The radical character of the [5b]+ bridging ligand is illustrated by the singlyoccupied molecular orbital (SOMO) shown in Figure 6.8, which is almost exclusively
localized on DMSQ. This MO contributes to the intense electronic transitions that appear
in the visible region, according to time-dependent DFT (TD-DFT) calculations that
reproduce the experimental [5b]+ spectrum reasonably well (Figure 6.9). TD-DFT
attributes the absorption manifold centered at 440 nm to multiple Fe(II) → DMSQ metalto-ligand charge transfer (CT) transitions, while the higher-energy feature at 365 nm
arises from a single DMSQ → Fe(II) ligand-to-metal CT transition. It appears that the
existence of a ligand radical in [5b]+ is favored by the presence of low-symmetry, five-
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coordinate Fe(II) geometries, which stabilize the Fe 3d-orbitals and remove their
degeneracy.209

Figure 6.9. Top: Experimental (dashed) and TD-DFT computed (solid line) absorption
spectra for [5b]PF6. Red sticks represent the energies and intensities of prominent
transitions in the TD-DFT spectrum. Bottom: Electron density difference maps (EDDMs)
for the computed transitions labeled in the upper spectrum. Blue and grey regions indicate
gain and loss of electron density, respectively.
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The nature of the bridging ligand was further probed via resonance Raman (rR)
spectroscopy. As shown in Figure 6.10, the [5b]+ spectrum exhibits several intense peaks
that are not evident in the precursor spectrum. The dominant feature at 1466 cm−1 is
strongly enhanced by excitation into 440 nm absorption feature (Figure 6.11) indicating
that it corresponds to a DMSQ-based mode. The rR spectra of metal-bound o-dioxolenes
typically display prominent peaks arising from C–O stretching modes. The frequencies of
these modes are diagnostic of ligand oxidation state, appearing at 1250–1275 cm−1 for
catecholates, 1400–1500 cm−1 for o-semiquinones, and 1620–1640 cm−1 for obenzoquinones.207 It is therefore reasonable to assign the dominant feature at 1466
cm−1 to the symmetric ν(O1–C1) mode of [5b]+. Literature precedents indicate that the
575 cm−1 peak corresponds to the breathing mode of the five-membered chelates formed
by each Fe center and the DMSQ ligand, while the resonance-enhanced peaks at 1412
and 1480 cm−1 likely involve modes that strongly mix ν(O1–C1) and intraligand C–C
bond motions.137, 210 The rR data thus provides additional evidence for the presence of a
DMSQ ligand in [5b]+.
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Figure 6.10. rR spectra of frozen CD2Cl2 solutions of 5 (red, bottom) and [5b]PF6 (black,
top) obtained with 457.9 nm excitation. * = solvent peaks.

Figure 6.11. rR excitation profiles of various modes of [5b]PF6 measured with a frozen
CD2Cl2 solution ([Fe] = 3.1 mM) at 77 K. Profiles are superimposed on the room
temperature absorption spectrum of [5b]PF6 in CH2Cl2.
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6.C. Conclusion

The results presented here open up intriguing possibilities for future research. The
fact that the ligand-to-metal and metal-to-ligand CT bands of [5b]+ appear in close
proximity (vide supra) indicates that the Fe- and DMSQ-based orbitals are nearly
isoenergetic, making it difficult to predict whether further oxidations would be ligand- or
iron-centered. Further oxidiation of [5b]+ was briefly studied through trials to
synthetically isolate the two-electron oxidized species. Initially, the oxidation of 5 by two
equivalents of AgPF6 was attempted, but it was determined that Ag+ is not a strong
enough reagent to oxidize this complex by two electrons. Recent studies involved
attempts to synthesize the [(Ph2Tp)Fe2(μ-DMHQ)] complex using two equivalents of
ferric salts [Fe(ClO4)3 or FeCl3] in place of FeCl2 in the previously reported procedure.112
It was hypothesized that if a stable product could be isolated, perhaps the redox activity
of the 2,5-dimethoxyhydroquinone ligand would lead to the creation of a mixed valent
[(Ph2Tp)Fe(II)Fe(III)-(μ-DMSQ)] complex thorough an internal electron transfer.
Unfortunately, attempts to generate this species were unsuccessful as they led to the
isolation of a powdery blue solid determined to be insoluble in all available organic
solvents (DCM, MeCN, toluene, acetone, ether, DMF, THF, pentane/hexane, etc) as well
as H2O and further characterization was not completed.
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6.D. Experimental

6.D.i. General methods

All reagents and solvents were purchased from commercial sources and used as
received unless otherwise noted. Dichloromethane was purified and dried using a
Vacuum Atmospheres solvent purification system. The compounds 2,5dimethoxyhydroquinone104 and K(Ph2Tp)103 were prepared according to literature
procedures. The synthesis of complex 5 was reported preciously in Chapter 2.112 The
synthesis and handling of air-sensitive materials were carried out under an inert
atmosphere using a Vacuum Atmospheres Omni-Lab glovebox. Elemental analyses were
performed at Midwest Microlab, LLC in Indianapolis, IN. Infrared (IR) spectra of solid
samples were measured with a Thermo Scientific Nicolet iS5 FTIR spectrometer
equipped with the iD3 attenuated total reflectance accessory. UV-vis spectra were
obtained with an Agilent 8453 diode array spectrometer. Magnetic susceptibility
measurements were carried out using the Evans NMR method. Cyclic voltammetric (CV)
measurements were conducted in the glovebox with an epsilon EC potentiostat (iBAS) at
a scan rate of 100 mV/s with 100 mM (NBu4)PF6. A three-electrode cell containing a
Ag/AgCl reference electrode, a platinum auxiliary electrode, and a glassy carbon working
electrode was employed. Under these conditions, the ferrocene/ferrocenium (Fc+/0)
couple has an E1/2 value of +0.52 V in CH2Cl2. EPR experiments were performed using a
Bruker ELEXSYS E600 equipped with an ER4415DM cavity resonating at 9.63 GHz, an
Oxford Instruments ITC503 temperature controller and ESR-900 He flow cryostat. The
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program EasySpin154 was used to simulate the experimental spectra. Resonance Raman
(rR) spectra were obtained upon excitation with a Coherent I-305 Ar+ laser with ~45 mW
of laser power at the sample. The scattered light was collected using a 135°
backscattering arrangement, dispersed by an Acton Research triple monochromator
equipped with a 1200 grooves/mm grating and analyzed with a Princeton Instruments
Spec X 100BR deep depletion, back-thinned CCD camera. Solution samples of 5 and
[5b]PF6 were prepared in CD2Cl2 with concentrations of 4.8 and 3.1 mM, respectively.
Spectra were accumulated at 77 K by inserting the samples (contained in an NMR tube)
in an EPR dewar filled with liquid N2. rR excitation profiles were measured by
quantifying the sample peak intensities relative to the 1032 cm-1 peak of frozen CD2Cl2.

6.D.ii. Synthetic Procedures

Preparation of [5b]PF6: [Fe2(Ph2Tp)2(μ-DMHQ)] (5, 98.0 mg, 0.0605 mmol) was treated
with one equivalent of AgPF6 (16.1 mg, 0.0637 mmol) in CH2Cl2 (10 mL) for one hour.
The resulting dark brown solution was filtered through celite and concentrated to
approximately half of its original volume. Layering of this solution with pentane
provided dark brown needles suitable for X-ray crystallography (69 mg, 62%). The X-ray
structure found one uncoordinated CH2Cl2 molecule per unit cell, and elemental analysis
indicates that some solvent (~0.4 equiv.) remains after drying. Anal. Calcd for
C98H76B2F6Fe2N12O4P∙0.4CH2Cl2 (MW = 1797.99 gmol-1): C, 65.73; H, 4.31; N, 9.35.
Found: C, 65.77; H, 4.00; N, 9.54. FTIR (cm-1, solid): 3051, 2616 [ν(B-H)], 1516, 1495,
1477, 1464, 1431, 1414, 1207, 1163, 1065, 1009, 833, 759, 694, 668.

181

6.D.iii. Crystallographic studies

X-ray diffraction (XRD) data were collected with an Oxford Diffraction
SuperNova kappa-diffractometer (Agilent Technologies) equipped with dual microfocus
Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD detector, and low-temperature
Cryojet device. The data were processed with CrysAlis Pro program package (Agilent
Technologies, 2011) typically using a numerical Gaussian absorption correction (based
on the real shape of the crystal), followed by an empirical multi-scan correction using
SCALE3 ABSPACK routine. The structures were solved using SHELXS program and
refined with SHELXL program105 within Olex2 crystallographic package.106 B- and Cbonded hydrogen atoms were positioned geometrically and refined using appropriate
geometric restrictions on the corresponding bond lengths and bond angles within a
riding/rotating model (torsion angles of methyl hydrogens were optimized to better fit the
residual electron density).
Crystallographic data for [5b]PF6•CH2Cl2: C99H78B2Cl2F6Fe2N12O4P, Mr = 1848.95 g
mol-1, triclinic, space group P-1, a = 9.7382(3), b = 13.2530(4), c = 18.0619(7) Å, α =
103.453(3), β = 104.559(3), γ = 97.098(3)°, V = 2152.89(13) Å3, Z = 1, ρ = 1.428 g cm-3,
total data 42432, independent reflections 8566 (Rint = 0.0395), 624 parameters, R1 =
0.0393 for I ≥ 2σ(I) and wR2 = 0.1024.
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6.D.iv. DFT Computations

DFT calculations were performed using the ORCA 2.8 software package
developed by Dr. F. Neese.155 Geometry optimizations employed the Becke-Perdew
(BP86) functional,158-159 while single-point (SP) and time-dependent DFT (TD-DFT)
calculations used Becke’s three-parameter hybrid functional for exchange along with the
Lee-Yang-Parr correlation functional (B3LYP).156-157 SP and TD-DFT calculations were
based on modified crystallographic coordinates in which the phenyl groups at the 5position of the pyrazole ligands were replaced by hydrogen atoms. Ahlrichs’ valence
triple-ζ basis set (TZV), in conjunction with the TZV/J auxiliary basis set,160-161 were
used for all calculations TD-DFT calculations163, 165 computed absorption energies and
intensities within the Tamm-Dancoff approximation.166-167 In each case, at least 60
excited states were calculated. The gOpenMol program168 developed by Laaksonen was
used to generate isosurface plots of molecular orbitals.
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Chapter 7

Preparation of (Hydro)quinonate-bridged Dimetal(II)
Complexes with Relevance Towards the Generation
of Unique Magnetic Materials

Abstract: The ability of single molecules to exhibit magnetic hysteresis of purely
molecular origin at low temperature is currently of great interest. While many magnetic
materials studied in this field are best represented as large, polynuclear metal clusters
bridged by closed-shell ligands, the incorporation of radical ligands bridging two metal
centers has allowed for the generation of a new class of single molecule magnets (SMMs).
This chapter details the synthesis and preliminary characterization of a series of dimetal(II)
complexes that incorporate a variety of bridging (hydro)quinone ligands with metal centers
supported by either the hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) or the tris(4,5diphenyl-1-methylimidazol-2-yl)phosphine (Ph2TIP) ligand scaffold. Motivated by
previous work with a similar complex (5; Chapter 6), we aim to generate one-electron
oxidized/reduced species that incorporate a ligand-based radical between two divalent
metal centers. Because the incorporation of a bridging ligand radical has been observed to
increase the amount of electronic coupling between the paramagnetic centers, we anticipate
that these high-spin complexes will have unique magnetic and electronic properties.
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7.A. Introduction

Over the past few decades, a significant amount of interest has been paid to the
development of a class of molecular materials known as single molecule magnets
(SMMs) due to their potential applications in molecular spintronics and quantum
information storage and processing.72-75 By definition, SMMs are compounds that possess
a slow relaxation of magnetization, below a certain blocking temperature (Tb), derived
purely from the molecule itself and not long-range magnetic ordering. The ability of these
molecules to maintain magnetization in the absence of an applied field makes them
perfect candidates for utilization as novel materials in applications such as quantum
computing. Because the intrinsic spin of a SMM can be recognized as one quantum bit
(qubit), unparalleled data densities can be achieved allowing for the development of
efficient solid state and other useful nanoscale devices.211-213 However, one of the major
challenges facing the development of this technology is the low temperatures required for
the observation of this magnetic behavior.
The inherent slow relaxation of magnetization of a single molecule magnet is
derived from the essential magnetic spin of the material. For each SMM, a thermal
energy barrier, or anisotropy barrier, exists that describes the amount of energy required
to reverse the orientation of the molecule’s anisotropy, thereby causing the compound to
lose magnetization.214 This therefore suggests that a compound with a larger anisotropy
barrier would function more efficiently as a single molecular magnet.215 The anisotropy
of each SMM is based upon key physical parameters of the compound, particularly the
magnitude of the ground state spin (S) and zero-field splitting parameter (D).215 To

185

improve SMMs, higher relaxation barriers must be accomplished. Harris, et al. suggest
that while key parameters such as spin ground state (S) and the zero field splitting
parameter (D) of each complex must be considered when attempting to design a
successful SMM, more attention should be paid to the exchange coupling constant (J) of
the system. This value numerically describes the degree of separation between the ground
and excited spin-states of the molecule. Harris notes that this factor must be significantly
large enough in magnitude to enforce slow magnetic relaxation dynamics at high
temperatures while also blocking fast quantum tunneling pathways within the manifold of
a single spin state.215-216
To date, much of the effort devoted to the development of transition metal single
molecule magnets has focused on species incorporating paramagnetic metal centers
bridged by closed-shell, diamagnetic ligands. While molecular magnetization has been of
interest for many years, SMM behavior was first observed in 1993 by Sessoli, et al.76
They reported the synthesis of a high spin [Mn12O12(O2CMe)16(H2O)4] cluster compound
[8Mn(III), 4Mn(IV)] that displays a high degree of magnetic coupling with an overall S =
10 ground state mediated by indirect superexchange coupling interactions. The advent of
this novel cage compound attracted a great deal of interest in the generation of other
transition metal complexes, high in nuclearity and spin state, in order to study their
unique spectroscopic and magnetic properties.217-219 In pursuit of increased global
anisotropy and therefore SMM behavior at higher temperatures, it is logical to focus
efforts on the generation of polynuclear complexes with large predicted spin states;
however their formation presents a challenge as the synthesis of these large clusters tends
to be unpredictable. Furthermore, the use of closed-shell, diamagnetic bridging ligands by
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researchers in the development of these compounds seems to remain a common theme
despite their inability to facilitate strong magnetic exchange. Recently, efforts focused on
the generation of species incorporating radical ligands linking paramagnetic centers in
low nuclearity complexes have garnered success.77-79 While limiting the number of metal
nuclei in the target system may seem counterintuitive, the incorporation of radical ligands
bridging the centers can functionally increase the observed spin state of the molecule
while increasing the magnitude of the magnetic exchange coupling between metals.77-78,
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During our efforts to develop FeII-HQate species as small molecule mimics of the
enzyme-substrate complex of the HQDOs, we synthesized a diiron(II) species bridged by
the closed-shell dianion of 2,5-dimethoxyhydroquinone (5; Chapter 6).139 We observed
that upon one-electron oxidation, we could isolate a new species [5b]+ which is best
described as a dinuclear ferrous complex bridged by a semiquinonate radical.
Interestingly, upon oxidation of 5  [5b+], we noted a substantial change in the exchange
coupling parameter (J-value). Using broken symmetry (BS) DFT methods, we calculated
J-values of -2 cm-1 and -83 cm-1, for complexes 5 and [5b]+, respectively. This increase in
magnitude of the computed J-values indicates that the bridging ligand radical mediates
larger exchange interactions between the Fe2+ centers (separated by 8.22 Å) as compared
to the closed-shell HQate ligand of 5. Inspired by the development of this interesting S =
7/2 species, we sought to pursue additional homodinuclear divalent transition metal
complexes bridged by a variety of (semi)quinone radical ligands in order to study their
unique physical properties, particularly compounds that incorporate bridging ligands
derived from naphthoquinone and anthraquinone. We hypothesized that by preparing
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compounds that incorporate a ligand such as 5,8-dihydroxynaphthoquinone (5,8-DHNQ),
which functionally incorporates both a hydroquinone and quinone moiety, we could
potentially observe both ligand oxidation and reduction through separate redox reactions.
Our goal was to ultimately generate a series of related complexes with distinct spin-states
and therefore, differing amounts of magnetic exchange. This chapter reports the synthesis
and characterization of such compounds followed by brief descriptions of preliminary
electrochemical and spectroscopic investigations. The intention of this study was to
develop dinuclear compounds that exhibited explicit redox behavior similar to that
observed for complex 5 (Chapter 6) in order to generate a series of species which
represented varying degrees of magnetic coupling which we aimed to study
spectroscopically as we predicted they would exhibit interesting electronic and magnetic
properties. Unfortunately, we observed that the incorporation of substituted naptho- and
anthraquinone ligands into our dinuclear systems lead to the generation of a series of
complexes that display extremely ill-defined redox behavior, as evidenced by
electrochemical experiments. We were, therefore, unable to isolate stable oxidized or
reduced species to investigate further and this project was not pursued to completion.

7.B. Results and Discussion

7.B.i. Synthesis and Characterization of Dinuclear-(H)Qate Complexes

In an attempt to generate (M)22+-SQ type complexes (M = Fe2+, Mn2+), we first
sought to synthesize a series of complexes supported by either the hydridotris(3,5-
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diphenylpyrazol-1-yl)borate (Ph2Tp) or tris(4,5-diphenyl-1-methylimidazol-2yl)phosphine (Ph2TIP) ligands and bridged by a variety of (hydro)quinone ligands shown
in Figure 7.1.

Figure 7.1. Series of (hydro)quinone ligands used in this study. The dianion of each ligand
was utilized to facilitate binding of two metal centers (M = Fe2+, Mn2+) in a bidentate
fashion.

Complex 16 is a dimanganese(II) analog of complex 5 and was prepared in a
similar fashion by mixing 0.5 equiv of Na2(2,5-DMHQ) with equimolar amounts of
MnClO4·6H2O and K(Ph2Tp) in MeCN followed by recrystallization from DCM/pentane
(Figure 7.2). Complexes 17-20, however, instead feature two divalent metal centers (Fe2+
or Mn2+) bound facially by the neutral Ph2TIP scorpionate ligand and bridged by either
5,8-DHNQ (17,18) or 1,4-DHAQ (19,20). Each [(Ph2TIP)Fe22+]-species (17,19) was
generated by combining 0.5 equiv of the corresponding ligand with the previously
reported [(Ph2TIP)Fe(MeCN)3](OTf)2 precursor complex in THF followed by
recrystallization from a vapor diffusion of either Et2O into MeCN or pentane into DCE,
respectively (Figure 7.3). The [(Ph2TIP)Mn22+]-complexes were prepared by mixing 0.5
equiv of the appropriate ligand with equimolar amounts of MnClO4·6H2O and (Ph2TIP) in
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MeCN followed by a salt anion metathesis reaction in MeOH with 2 equivalents of
NaBPh4. Each complex was easily recrystallized from DCM/MeOH (Figure 7.4). Metric
parameters for complexes 16-20 are presented in Table 7.1.
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Table 7.1. Selected bond distances (Å) and bond angles (°) from the X-ray structures of dimetal(II) (hydro)quinonebridged complexes 16-20. (M = Fe, Mn)
16
[17](OTf)2·4Et2O
[18](BPh[19](OTf)2·DCE
[20](BPh4)2·5DCMb
4)2·2DCM
M–N1
2.175(18)
2.136(13)
2.191(2)
2.129(3)
2.194(4) / 2.149(5)
M–N3
2.172(17)
2.143(12)
2.202(2)
2.128(3)
2.188(5) / 2.178(5)
M–N5
2.250(16)
2.199(12)
2.236(2)
2.198(2)
2.230(5) / 2.242(5)
M–O1
1.969(14)
1.956(10)
2.038(19)
1.950(2)
2.023(5) / 2.026(4)
M–O2
2.321(15)
1.984(11)
2.064(18)
1.979(2)
2.043(5) / 2.052(4)
O2–C2
1.398(2)
1.282(17)
1.285(3)
1.277(4)
1.280(7) / 1.286(7)
O1-C1
1.336(2)
1.289(17)
1.277(3)
1.287(4)
1.278(7) / 2.026(4)
O1–M–N1
O1–M–N3
O1–M–N5
O1–M–O1
N1–M–N3
N1–M–N5
N3–M–N5
O2–M–N1
O2–M–N3
O2–M–N5
-valuea

130.73(7)
140.06(7)
104.18(6)
74.56(6)
87.32(7)
88.66(6)
85.73(6)
91.49(6)
95.84(6)
178.43(5)
0.64

106.62(5)
162.95(5)
92.78(4)
86.28(4)
90.26(5)
90.65(5)
84.44(5)
100.21(5)
93.22(4)
168.91(5)
0.10

107.69(8)
157.71(8)
91.56(8)
83.54(7)
94.31(8)
90.85(8)
84.37(8)
110.69(8)
92.21(8)
158.40(8)
0.01

108.33(10)
158.09(10)
94.69(9)
86.52(9)
93.46(10)
89.88(9)
82.80(10)
97.71(10)
92.94(10)
171.53(10)
0.22

118.06(19) / 112.70(18)
158.10(18) / 155.64(18)
95.51(18) / 95.88(17)
84.37(18) / 84.18(17)
90.84(17) / 91.66(18)
89.59(18) / 92.59(18)
84.60(19) / 83.06(19)
99.47(18) / 100.43(19)
91.92(18) / 91.08(18)
170.36(19) / 165.88(29)
0.20 / 0.17

For a definition of the τ-value, see ref 98. A five-coordinate complex with ideal square-pyramidal geometry would have a τ-value of 0.0, while
those with ideal trigonal bipyramidal geometry would have a value of 1.0. bComplex [20](BPh4)2 is quasi-centrosymmetric, values
corresponding to each Mn center (A and B) are given on the left and right sides of the column, respectively.
a
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Figure 7.2. Thermal ellipsoid plot (50% probability) derived from X-ray structure of 16, a
dimanganese(II) analog of 5 (see Chapter 6). Non-coordinating solvent molecules,
hydrogen atoms and the Ph-rings at the 5-positions of the Ph2Tp ligand have been omitted
for clarity.

Figure 7.3. Thermal ellipsoid plots (50% probability) derived from the X-ray structures of
[17](OTf)2 and [18](BPh4)2. Non-coordinating solvent molecules, counter anions, all
hydrogen atoms and the Ph-rings at the 5-positions of the Ph2TIP ligands have been
omitted for clarity.
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Figure 7.4. Thermal ellipsoid plots (50% probability) derived from the X-ray structures
of [19](OTf)2 and [20](BPh4)2. Non-coordinating solvent molecules, counter anions, all
hydrogen atoms and the Ph-rings at the 5-positions of the Ph2TIP ligands have been
omitted for clarity.

X-ray diffraction analysis indicates that 16 is a centrosymmetric complex
consisting of 2 Mn(II) centers bridged by a closed-shell p-hydroquinonate ligand with an
Mn···Mn distance of 8.227 Å (Figure 7.2). The coordination geometry of each Mn is
intermediate between square pyramidal and trigonal bipyramidal (τ = 0.64).98 An average
Mn-NTp bond length of 2.20 Å indicates the presence of high-spin Mn(II) centers in 16
and the Mn1-O1 and Mn1-O2 bond lengths of 2.303 and 1.969 Å nicely mirror the
corresponding Fe-O bond distances in 6 representing the methoxy and phenolate donors,
respectively.139, 221
The X-ray crystal structures of [17](OTf)2 and [18](BPh4)2 also reveal
centrosymmetric complexes featuring 5C metal centers linked by the dianion of the 5,8-
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dihydroxynaphthoquinone ligand (Figure 7.3). Both complexes incorporate divalent
metals centers (Fe2+ and Mn2+, respectively) bound to the neutral (Ph2TIP) scorpionate in
a facial orientation. Complex [17](OTf)2 displays an average Fe-NTIP bond length of 2.16
Å and Fe1-O1 and Fe1-O2 distances of 1.984 and 1.956 Å, respectively, with an Fe···Fe
separation of 8.307 Å. The similarity of the four Fe-O bond lengths indicates that the
bridging ligand has a delocalized structure, further supported by the observation of
shortened Cβ-Cβ bond lengths (1.351 Å versus C-Cring avg. length of 1.433 Å). The 5C
Fe-centers of complex [17](OTf)2 also display square pyramidal coordination geometries
(τ = 0.10)98 which differs from the intermediate square planar/trigonal bipyramidal
geometries of the [(Ph2Tp)2(M)2(μ-DMHQ)]-species, 5 and 16. X-ray diffraction analysis
indicates that complex [18](BPh4)2 bears resemblance to [17](OTf)2 except that it
incorporates two Mn(II) centers (Mn···Mn separation = 8.412 Å) in place of the diiron(II)
centers of 17 with average Mn-NTIP bond lengths of 2.21 Å and Mn1-O1 and Mn1-O2
distances of 2.064 and 2.038 Å, respectively. In addition, [18](BPh4)2, like complex
[17](OTf)2, displays a square pyramidal coordination geometry (τ = 0.01)98 at each 5C
manganese center. The square planar coordination geometries displayed by complexes
[17](OTf)2 and [18](BPh4)2 in comparison to the intermediate coordination geometry of
16 is likely the result of π-stacking interactions between the naphthoquinonate moiety and
a 3-phenyl substituent of each Ph2Tp ligand.
Like complexes 16-18, the XRD analysis confirms that 19 and 20 lay on
crystallographic inversion centers requiring the bridging anthraquinone ligand to be
disordered over two positions (as indicated in the metric parameters provided in Table
7.1). Complex [19](OTf)2 displays an Fe···Fe separation of 8.285 Å with an average Fe-
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NTIP bond length of 2.15 Å. The Fe1-O1 and Fe1-O2 bond lengths are 1.950 and 1.979 Å
and 19 displays an intermediate Fe coordination geometry lying closer to the square
pyramidal limit (τ = 0.22).98 Compared to complex [19](OTf)2, the manganese(II) centers
of [20](BPh4)2 exhibit similar coordination geometries (τ = 0.20/0.17) 98 and a Mn···Mn
distance of 8.425 Å. In addition, the X-ray crystal structure of [20](BPh4)2 displays
average Mn-NTIP bond length of 2.20 Å and Mn1-O1 and Mn1-O2 distances of 2.043 and
2.023 Å, respectively.

7.B.ii. Spectroscopic and Electrochemical Investigation of 16

The redox behavior of 16 was examined in CH2Cl2 with 0.1 M [NBu4]PF6 as the
supporting electrolyte. The resulting cyclic voltammogram exhibits a quasi-reversible
couple at E1/2 = -718 mV vs Fc+/0 (ΔE = 104 mV) with several additional irreversible
redox events at higher potentials (Figure 7.5). This redox behavior is similar to that of 5
including the quasi-reversible event observed at negative potentials, assigned to the
oxidation of the HQate ligand to its SQate form. Interestingly, in the case of 16, the
ligand-based event is shifted to more negative potentials (ΔE1/2 = 148 mV) with respect to
5. In order to explore whether or not the isolation of a one-electron oxidized
[(Ph2Tp)2Mn2(μ-DMSQ)]+-type species was feasible, we monitored the reaction of 16
with a chemical oxidant via UV-vis spectroscopy (Figure 7.6).
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Figure 7.5. Cyclic voltammogram of 16 in CH2Cl2 with 0.1 M [NBu4]PF6 as the supporting
electrolyte collected at a scan rate of 0.1 V/s. The cyclic voltammogram of 5 is provided
for comparison (data was collected in similar conditions; see Chapter 6).

Figure 7.6. Electronic absorption data demonstrating the conversion of 16 to [16]ox via
addition of 1 equivalent of AcFc+ in CH2Cl2 at -30 °C.
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Upon addition of one equivalent of acetylferrocenium tetrafluoroborate to 16 in
CH2Cl2 at -30 °C, a new quasi-stable species is formed, [16]ox. Unlike [5b]+, the
[(Ph2Tp)2Fe2(μ-DMSQ)]+ analogue, [16]ox is not stable at room temperature. The resulting
red-brown chromophore displays two new absorption features with λmax = 412 nm and
481 nm ( = 1.6 and 2.1 mM-1 cm-1, respectively). An attempt to isolate crystals of [16]ox
at low temperature was made. Under anaerobic conditions, 16 was treated with 1
equivalent of AgPF6 at approximately -30 °C and the subsequent red-brown solution was
layered with cold pentane placed in a -30 °C freezer to initiate crystallization. The
resulting crystalline needles were submitted for X-ray diffraction analysis, however the
corresponding crystallographic solution indicated over-oxidation of the bridging ligand
(XRD analysis predicts an overall charge of approximately +1.27 for the dimanganese
complex).
While our method of preparation for crystalline [16]ox needs some refining, it is
clear that the addition of oxidant to 16 results in a ligand-centered oxidation. Comparison
of observed bond lengths of 16 and [16]ox indicate relatively similar average Mn-NTp
bond lengths (2.20 vs 2.15 Å), however, upon oxidation, [16]ox displays a pronounced
change in the C-C bond lengths, namely, elongation of the C1-C2 and C1-C3 bonds and
shortening of the C2-C3 bonds. Additionally, there is a noticeable shortening of the C3O2 bond from 1.336 Å for 16 to 1.292 Å for [16]ox. Based on well-established guidelines
for metal-ligand bond lengths with regards to dioxolene oxidation states136, 206-207 and our
previous experience with complex 5, these changes in metric parameters suggest
formation of a ligand-based radical to yield a species best described as [(Ph2Tp)2Mn2(μDMSQ)]+.
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Attempts to collect X-band EPR spectra of [16]ox were made and while it is clear
there is a significant rearrangement of electron density upon oxidation of 16  [16]ox, the
combination of Mn hyperfine splitting and small zero-field splitting resulted in extremely
complicated EPR spectra that resisted attempts at simulation.
Further evidence for generation of a ligand-based radical was derived from
rRaman spectroscopy. The spectrum of [16]ox obtained with 514 nm excitation exhibits
several new peaks that are not present in that of 16. The intense feature at 1484 cm-1 is
greatly enhanced by excitation into the absorption band of [16]ox suggesting that it
corresponds to a DMSQ-based mode (Figure 7.7). Based on previous studies of metalbound dioxolenes, it has been reported that o-semiquinones exhibit intense peaks arising
from C-O stretching modes ranging between 1400-1500 cm-1, therefore, the feature
observed at 1484 cm-1 likely corresponds to the symmetric (C-O) mode of [16]ox.136
Literature precedents suggests the peak at 580 cm-1 can be assigned as the breathing
mode of the five-membered chelate formed by the O-donors of the DMSQ ligand and
each Mn center, while the resonance-enhanced features at 1432 and 1494 cm-1
correspond to the mixing of (C-O) and C-C based modes.137,139,210 As reported in
Chapter 6, similar rRaman features were observed for [5b]+.139 We generated the
dimanganese(II) version of [5b]+ with intention of generating a similar complex with an
increased spin state, since antiferromagnetic coupling between the Mn(II) centers and the
bridging DMSQ ligand would yield an overall S = 9/2 state. Additional investigation into
the spin state of [16]ox still remains to be done, especially with regards to solving the EPR
spectra obtained in order to confirm the newly generated spin state.
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Figure 7.7. rR spectra obtained with 514 nm excitation (50 mW) of 16 (black) and [16]ox
(red) in frozen CD2Cl2 solutions. Peaks with an asterisk (*) arise from solvent.

7.B.iii. Preliminary Studies of Dimetal Complexes Featuring Naphtho- and
Anthraquinone-derived Bridging Ligands

The first series of complexes we aimed to synthesize are similar to 5 and 16, but
incorporate 5,8-DHNQ as the bridging ligand. Several attempts were made to generate a
bis-(PhTp) version of this complex, but crystalline material was unable to be isolated. We
therefore turned to the neutral (Ph2TIP) scorpionate and were able to easily isolate
[17](OTf)2 – which has a chemical formula of [(Ph2Tp)2Fe(μ-DHNQ)](OTf)2 according to
X-ray diffraction analysis (vide supra). Preliminary electrochemical studies of [17](OTf)2
have been carried out (Figure 7.8); however the resulting data seems to be rather
inconclusive as the redox behavior observed by cyclic voltammetry is somewhat illdefined.
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Figure 7.8. Cyclic voltammogram of [17](OTf)2 obtained in CH2Cl2 in the presence of 0.1
M [NBu4]PF6 as the counter electrolyte. Data was obtained at a sweep rate of 0.1 V/s.

While the electrochemical data obtained for [17](OTf)2 in DCM does not display
a ligand-based (quasi)reversible redox couple as was displayed previously by complexes
5 and 16, the CV indicates the presence of two irreversible oxidative events at E = -502
and +309 mV (vs Fc+/0). A series of ill-defined cathodic events are displayed at more
negative potentials, particularly an irreversible reduction at E = -907 mV. The absence of
a distinct (quasi)reversible couple could be due to the delocalized nature of the bridging
(5,8-DHNQ) ligand, as previously indicated by XRD analysis (vide supra).
To further investigate the ability of [17](OTf)2 to facilitate ligand-based electron
transfers, either to or away from its ligand bridge via a chemical oxidation, we treated
[17](OTf)2 with one equivalent of AcFc+ in CH2Cl2 at -30 °C and monitored the resulting
reaction via UV-vis absorption spectroscopy (Figure 7.9).
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Figure 7.9. Electronic absorption spectra of [17](OTf)2 and the chromophore resulting
from reaction with one equivalent of AcFcBF4 in CH2Cl2 at -30 °C.

As demonstrated in Figure 7.9, complex [17](OTf)2 displays a series of
absorption features in the visible region with λmax = 399, 556 and 578 nm (ε = 7.4, 6.9
and 6.8 mM-1 cm-1, respectively). However, upon addition of 1 equivalent of AcFc+ at -30
°C, the higher energy band exhibits a slight blueshift (λmax = 395 and 541 nm) while the
lower energy feature with λmax = 578 nm decreases slightly in intensity and experiences a
redshift as it broadens (λmax = 629 nm, ε = 5.7 mM-1 cm-1). Based on our previous
experience with the oxidation of complex 5, it is predicted that the 3-band spectroscopic
pattern evident in the UV-vis absorption spectrum of [17]ox is due to the oxidation of the
bridging ligand; however, further spectroscopic analysis is required to confirm this
assignment, especially due to the ill-defined nature of the electrochemical data that has
been collected up to this point.
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Additional reactivity studies using 1 equivalent of CoCp2* were completed as the
reaction between complex [17](OTf)2 and reductant was observed via UV-vis
spectroscopy (Figure 7.10). Addition of 1 equivalent of CoCp2* significantly alters the
absorption spectrum of [17](OTf)2 as the features between 550-580 nm completely
diminish and a new, sharp absorption band appears at λmax = 380 nm (ε = 7.4 mM-1 cm-1)
with two shoulders at approximately 428 and 466 nm. While further experimental
evidence is required to determine the identity of [17]red, it is clear that addition of one
equivalent of reductant causes a substantial change in the absorption features of
[17](OTf)2. Although [17]ox and [17]red are both only stable at temperatures < -30 °C,
attempts to crystallize these species at low temperatures should be make in order to gain
insight into their geometric structures via XRD analysis. Further insight into the spin state
of the molecule up removal or addition of an electron as well as the oxidation state of the
bridging ligand upon oxidation or reduction can be gained from spectroscopic studies
using EPR and rRaman spectroscopies.
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Figure 7.10. Electronic absorption spectra of [17](OTf)2 and the chromophore resulting
from reaction with one equivalent of CoCp2* in CH2Cl2 at -30 °C.

Our second class of dinuclear quinone-bridged complexes incorporates 1,4dihydroxyanthraquinone (1,4-DHAQ) as the bridging ligand. We sought to use this
ligand in an attempt to study the effects of incorporating a bridging substituent with an
extended π-system on the ability of a radical-bridged dinuclear complex to mediate
magnetic exchange interactions. Complex [19](OTf)2 is therefore an analog of
[17](OTf)2, and features two diiron(II) centers linked by the dianion of 1,4-DHAQ.
Preliminary electrochemical data for [19](OTf)2 has been collected in CH2Cl2 and is
presented in Figure 7.11.
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Figure 7.11. Cyclic voltammogram of [19](OTf)2 obtained in CH2Cl2 in the presence of
0.1 M [NBu4]PF6 as the counter electrolyte. Data was obtained at a sweep rate of 0.1 V/s.

The cyclic voltammogram of complex [19](OTf)2 appears to be more complicated
as that obtained for [17](OTf)2. Interestingly, the irreversible cathodic features of this
data seem to be more resolved that those previously observed for the 5,8-DHNQ analog
(Eirrev = -1.531 and -1.884 V vs Fc+/0) which likely correspond to reduction of the
bridging 1,4-DHAQ ligand. Irreversible oxidation events at higher potentials are poorly
resolved as the potentials of the events seem to lie very close to one another. However,
square wave data collected in the same region displays two discrete events with Eirrev =
0.035 and 0.299 V, which are tentatively assigned to the oxidation of the two diiron(II)
centers. Future studies will first focus on the observation of this complex’s reactivity with
respect to chemical reductants in order to isolate a putative [(Ph2TIP)2Fe2+2(μ-DHSQ-)]-
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type species. Because of the indication that the oxidation of two Fe(II) centers lies close
to one another in potential, the chemical oxidation of this complex could yield an
interesting result. Unfortunately, we have yet to isolate a dinuclear species that
incorporates either a mixed valent diiron core or one incorporating (di)ferric ions within
our series of dinuclear Fe(II)-(H)Qate systems.
A further outgrowth of this study was aimed at the generation of complexes with
larger spin systems. We therefore prepared dimanganese(II) analogs of both [17]2+ and
[19]2+ ([18]2+ and [20]2+, respectively), proposing that upon generation of a Mn(II)2SQate bridged species, each d5, S = 5/2 Mn2+ center would couple antiferromagnetically
to the SQ-bridging ligand, resulting in a S = 9/2 species. As previously mentioned, we
have been successful in the synthesis and structural characterization of these species,
however further spectroscopic characterization and reactivity studies remain to be
completed.

7.C. Conclusion

The ability of ligand-based radicals to mediate significant magnetic exchange
between paramagnetic metals centers has been of much interest to researchers in the
development of small molecule magnets which have interesting applications towards the
development of solid state storage devices.211-213 Upon successful generation of our
diiron(II) species bridged by a (semi)quinonate ligand radical ([5b]+, Chapter 6), we
chose to pursue similar dimetal(II) (M = Fe2+, Mn2+) species bridged by a variety of
(hydro)quinonate ligands based on the ability of (hydro)quinones to facilitate multiple
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electron transfers. We noted that upon oxidation of the bridging 2,5dimethoxyhydroquinone ligand of 5, the magnitude of the computed J-value (exchange
coupling parameter) increased from -2 cm-1 to -83 cm-1, indicating a net increase in
magnetic exchange between the diiron(II) centers. Inspired by this observation, our
ultimate goal is to generate novel species bridged by ligand-based radicals in order to
study their geometric structure and their interesting electronic and magnetic properties
via spectroscopy and computational methods. Up to this point, we have successfully
synthesized and structurally characterized a dimanganese(II) version of 5 (complex 16)
that, according to the results described here, experiences one-electron oxidation to yield a
(semi)quinonate-bridged species at low temperatures.
Additional studies were aimed at the generation of diiron(II) species that
incorporate the dianion of 5,8-DHNQ or 1,4-DHAQ to generate [17](OTf)2 and
[19](OTf)2, respectively. While these complexes were synthesized and characterized with
XRD, further investigation of these compounds is required. Future studies will examine
the ability of these complexes to undergo one-electron oxidation or reduction reactions.
Dimanganese analogs of these complexes ([18](BPh4)2 and [20](BPh4)2, respectively)
have been successfully prepared and structurally characterized via XRD analysis. We
expect that the incorporation of two high-spin Mn2+ centers in these complexes will lead
to species with a larger observed spin state than their diiron(II) analogs upon generation
of a substrate-based radical; however additional investigation is required. The
preliminary results reported here lay a foundation for the continued study of these
compounds and similar dinuclear species.
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Table 7.2. Summary of X-ray Crystallographic Data Collection and Structure Refinement for Complexes 16-20.
16
[16]ox·PF6a
[17](OTf)2·4Et2O
empirical formula
C98H76B2Mn2N12O4
C98H76B2F6Mn2N12O4P1
C124H122F6Fe2N12O14P2S2
1617.21
1800.79
2356.10
formula weight
Triclinic
Monoclinic
Triclinic
crystal system
P-1
P21/c
P-1
space group
9.7042(2)
13.5467(2)
12.3155(3)
a, Å
13.4568(5)
15.8981(4)
13.1640(3)
b, Å
17.8105(4)
23.4908(5)
18.5849(4)
c, Å
92.194(2)
90
80.0260(17)
, deg
103.619(2)
96.5943(17)
75.9486(18)
deg
100.236(2)
90
77.4474(17)
, deg
3
2215.21(10)
5025.70(17)
2829.82(10)
V, Å
1
2
1
Z
3
1.212
2.791
1.383
Dcalc, g/cm
1.5148
1.5418
1.5418
, Å
-1
2.773
2.791
3.331
mm
7 to 148
7 to 149
7 to 147
 -range, deg
41369
48161
46785
reflections collected
independent reflections
8873
10134
11227
data / restraints / parameters
8873 / 0 / 533
10134 / 0 / 593
11227 / 0 / 766
1.073
1.048
1.026
GOF (on F2)
b
0.0467 / 0.1224
0.0812 / 0.2224
0.0335 / 0.0865
R1/wR2 (I > 2(I))
0.0568 / 0.1338
0.0934 / 0.2306
0.0362 / 0.0891
R1/wR2 (all data)
a

The PF6- ion refined to occupation of only 0.63 and is rotationally disordered. bR1 =  ||Fo|  |Fc|| / |Fo|; wR2 = [w(Fo2  Fc2)2 / w(Fo2)2]1/2
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Table 7.2. (cont.) Summary of X-ray Crystallographic Data Collection and Structure Refinement for Complexes 16-20.
[18](BPh4)2· 3DCMc
[19](OTf)2·2DCEd
[20](BPh4)·5DCM
empirical formula
C158H128B2Cl6Mn2N12O4P2
C116H92Cl4F6Fe2N12O10P2S2
C163H134B2Cl10Mn2N12O4P2
2677.48
2307.58
2826.05
formula weight
Triclinic
Triclinic
Triclinic
crystal system
P-1
P-1
P-1
space group
14.2755(4)
13.9219(4)
13.2692(3)
a, Å
14.8992(4)
14.9501(4)
15.8678(4)
b, Å
19.6567(4)
16.7903(4)
19.0587(4)
c, Å
94.1359(18)
100.961(2)
94.2271(18)
, deg
106.699(2)
96.054(2)
109.855(2)
deg
115.058(3)
115.833(3)
94.6975(18)
, deg
3
3535.97(15)
3017.06(15)
3739.51(14)
V, Å
1
1
1
Z
3
1.257
1.270
1.255
Dcalc, g/cm
1.5418
1.5418
1.5418
, Å
-1
3.270
3.886
3.491
mm
7 to 148
7 to 149
7 to 148
 -range, deg
67185
49891
54770
reflections collected
independent reflections
14219
12073
24890
data / restraints / parameters
14219 / 0 / 846
12073 / 0 / 723
24890 / 1052 / 1764
1.079
1.098
1.055
GOF (on F2)
b
0.0613 / 0.1839
0.0641 / 0.1874
0.0729 / 0.2048
R1/wR2 (I > 2(I))
0.0698 / 0.1979
0.0750 / 0.2000
0.0815 / 0.2194
R1/wR2 (all data)
R1 =  ||Fo|  |Fc|| / |Fo|; wR2 = [w(Fo2  Fc2)2 / w(Fo2)2]1/2. cUnidentified solvent and one of the DCM solvate molecules in [18](BPh4)•3DCM are only
partially populated. cOnly one DCE molecule was localized. dOne DCM solvate molecule is only partially populated.
b
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7.D. Experimental

7.D.i. General methods

Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Acetonitrile and dichloromethane were
purified and dried using a Vacuum Atmospheres solvent purification system. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox. The ligands K(Ph2Tp)103, (Ph2TIP)122,
and 2,5-dimethoxyhydroquinone (2,5-DMHQ)104 as well as the
[(Ph2TIP)Fe(MeCN)3](OTf)2122 precursor complex were prepared according to literature
procedures.
UV-vis absorption spectra were obtained with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for temperature control. EPR experiments were performed using a Bruker
ELEXSYS E600 equipped with an ER4415DM cavity resonating at 9.63 GHz, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat.
Electrochemical measurements were conducted in the glovebox with an epsilon EC
potentiostat (iBAS) at a scan rate of 100 mV s−1 with 100 mM (NBu4)PF6. A threeelectrode cell containing a Ag/AgCl reference electrode, a platinum auxiliary electrode,
and a glassy carbon working electrode was employed for cyclic voltammetric (CV)
measurements. Under these conditions, the ferrocene/ferrocenium (Fc+/0) couple has an
E1/2 value of +0.52 V in CH2Cl2.
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7.D.ii. Synthetic procedures

[Mn2(Ph2Tp)2(μ-DMHQ)] (16). 2,5-Dimethoxyhydroquinone (0.173 g, 1.0 mmol) was
first deprotonated by treatment with two equivalents of NaOMe in THF. After removal of
the solvent, the resulting solid Na2(2,5-DMHQ) was mixed with equimolar amounts of
Mn(ClO4)2·6H2O (0.736 g, 2.0 mmol) and K(Ph2Tp) (1.450 g, 2.0 mmol) in MeCN, and
the solution was stirred overnight under an inert atmosphere. After removal of the solvent
under vacuum, the pale yellow solid was taken up CH2Cl2 and the solution filtered
through celite in a syringe filter to remove unwanted salts. A concentration solution of
DCM layered with pentane provided pale yellow crystals suitable for X-ray
crystallography. Anal. Calcd for C98H76B2Mn2N12O4 (MW = 1616.25 g mol−1): C, 72.83; H,
5.08; N 10.40. UV-vis [λmax, nm (ε, M−1 cm−1) in CH2Cl2]: 327 (4630).

[Fe2(Ph2TIP)2(μ-DHNQ)](OTf)2 [17(OTf)2]. 5,8-dihydroxynapthoquinone (10.6 mg,
0.055 mmol) was deprotonated with two equivalents of Et3N in 5 mLs of THF. Upon
generation of the doubly deprotonated (5,8-DHNQ)2- ligand, two equivalents of the
[(Ph2TIP)Fe(MeCN)3](OTf)2 precursor (0.132 g, 0.11 mmol) were added in an additional
5mLs of THF and the reaction mixture was stirred overnight. The reaction solvent was
removed and the crude product was taken up in MeCN and filtered through celite in a
syringe filter. Vapor diffusion of Et2O into a concentrated solution of 17 in MeCN
provided bright violet crystals suitable for X-ray crystallography. Anal. Calcd for
C108H82P2Fe2N12O10F6S2 (MW = 2059.67 g mol−1): C, 62.98; H, 4.01; N 8.16. UV-vis [λmax,
nm (ε, M−1 cm−1) in CH2Cl2]: 399 (7350), 556 (6850), 578 (6780).
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[Mn2(Ph2TIP)2(μ-DHNQ)](BPh4)2 [18(BPh4)2]. 5,8-dihydroxynapthoquinone (19.3 mg,
0.1 mmol) was stirred with two equivalents of NaOMe in 5 mLs of THF. After 30
minutes, the solvent was removed under vacuum to yield Na2(5,8-DHNQ) which was
then stirred with equimolar amounts of Mn(ClO4)2·6H2O (73.1 mg, 0.2 mmol) and Ph2TIP
(0.144 g, 0.2 mmol) in 10 mLs of MeCN overnight. Upon removal of the reaction solvent
under vacuum, the crude product was taken up in DCM and filtered through celite in a
syringe filter to yield a bright blue-violet solution. The DCM was pumped off and the
product was taken up in MeOH and stirred with two equivalents of NaBPh4 to facilitate
an anion metathesis reaction. Upon completion of the reaction, MeOH was stripped under
vacuum and the final product was taken up in DCM. Layering a concentrated solution of
18 with MeOH provided blue-violet crystals suitable for X-ray crystallography. Anal.
Calcd for C150H118B2Mn2N12O4P2 (MW = 2346.12 g mol−1): C, 76.79; H, 5.07; N 7.16.

[Fe2(Ph2TIP)2(μ-DHAQ)](OTf)2 [19(OTf)2]. The method of preparation was similar as
that used for complex 17 except that 1,4-dihydroxyanthraquinone was used in place of
5,8-dihydroxynaphthoquinone. Dark violet crystals suitable for X-ray diffraction were
generated by vapor diffusion of pentane into a concentrated solution of 19 in 1,2dichloroethane. Anal. Calcd for C112H84P2Fe2N12O10F6S2 (MW = 2109.73 g mol−1): C,
63.76; H, 4.01; N 7.97.

[Mn2(Ph2TIP)2(μ-DHAQ)](BPh4)2 [20(BPh4)2]. Complex 20 was prepared in a similar
manner as complex 18 except 1,4-dihydroxyanthraquinone was substituted for 5.8dihydroxynaphthoquinone. Dark violet crystals suitable for X-ray diffraction were
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generated by layering a concentrated DCM solution of 20 after anion methathesis with
MeOH. Anal. Calcd for C112H84P2Fe2N12O10F6S2 (MW = 2396.18 g mol−1): C, 77.19; H,
5.05; N 7.01.
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